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This dissertation describes the development of simplified microreactors to be used in 
multi-step reaction sequences. Microreactors are a developing technology with 
numerous benefits and whose modular design permits multi-step reaction sequences to 
be performed in a continuous flow process.  The first chapter discusses the physical 
properties of microreactors and describes how performing reactions in these 
miniaturized reactors leads to safer, more efficient and more selective chemical 
transformations. A brief discussion of multi-step reaction sequences already 
performed in flow will also be presented.  These multi-step reaction sequences, 
however, rarely rely on catalysis to facilitate chemical transformations.  This area 
therefore has room for great improvement.  The next two chapters discuss the 
development and application of solid-supported catalysts to be used in flow.  In the 
first of these two chapters, two catalysts are immobilized on a solid-support and used 
in a simplified flow reactor.  These reactions proved to be more efficient than similar 
batch reaction and the catalysts were highly recyclable.  The next chapter presents a 
supported TEMPO catalyst used to oxidize alcohols to carbonyl species.  These three 
catalysts set the foundation for multi-step flow reaction to be potentially performed in 
the group.  The ensuing chapter uses a flow reactor to facilitate a two-step click 
reaction starting from an alkyl halide, sodium azide and a terminal acetylene.  This 
process proved to be high throughput and rapidly synthesized vast libraries of 
 compounds to be submitted for biological testing.  The next two chapters discuss the 
synthesis of the ibuprofen and atropine in flow.  Initial studies were carried out to 
synthesize both of these drugs in flow as part of a project geared toward synthesizing 
drugs on-demand.  Later, a continuous flow synthesis of ibuprofen was realized using 
a series of reactions in which excess reagents and byproducts were compatible with 
downstream reactions.  Finally, on-going work to develop asymmetric, multi-step 
reaction sequences in flow will be discussed in which the majority of reaction steps 
utilize solid-supported catalysts. 
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CHAPTER 1 
The Application of Microreactors to Organic Synthesis 
 
Abstract 
 This dissertation describes the application of microreactors to organic synthesis 
with the ultimate goal of performing multi-step reaction sequences in a continuous 
flow framework.  In this introduction to microreactors, the benefits of performing 
reactions in these devices will be highlighted, followed by a discussion of multi-step 
reaction sequences already presented in the literature.  It will then conclude by 
discussing how McQuade group technology is being applied to new multi-step 
continuous reactions. 
 
Introduction 
 Microreactor technology has gained a substantial amount of attention in both 
industrial and academic laboratories.1-12 While a majority of the seminal publications 
focused on engineering aspects of microreactors, 2, 3, 13 an increasing body of literature 
has begun to apply these devices to organic synthesis.  
Organic synthesis is a powerful enterprise that continues to develop more 
selective and efficient chemical methods and synthetic routes.  For the most part, 
however, the technology used to perform chemical reactions has remained unchanged 
for the past 140 years: that is, syntheses continue to be performed in batch reactors 
(round bottom flasks or tank reactors).14 While these methods have proven to be 
successful, they are also wasteful and are potentially  unsustainable.15 Applying new 
technologies, such as microreactors, to organic synthesis can be used to improve 
synthetic efficiency as microreactors produce less waste than traditional methods due 
to precise reaction control, resulting in cleaner, more efficient syntheses. The modular 
 2 
nature of microreactors also permits multi-step reaction sequences to be performed in 
a continuous flow process, thereby removing wasteful purification and isolation steps. 
Petrochemical plants often perform reactions in flow using reactors with 
diameters as large as 4 m.16 Microreactors, on the other hand, are devices that facilitate 
reactions by passing starting materials through a series of channels on order of 10-
1000 µm in diameter.1 This chapter discusses the benefits of performing reactions in 
microreactors, in both academic and industrial settings, and presents three different 
methods to perform multi-step reaction sequences in flow.  The chapter concludes 
with a discussion of how McQuade group technology is being applied to these systems 
to increase their already highly efficient nature. 
 
Increased Surface Area-to-Volume Ratios in Flow 
 Microreactors offer far superior surface area-to-volume ratios than batch 
reactors (Figure 1.1).  As a result, heat transfer and mixing are greatly improved, 
which leads to safer, more efficient chemical reactions.17 
 
 
 
Figure 1.1.  Surface area-to-volume ratios of two 1 mL reactors. 
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Figure 1.1 shows two reactors with an internal volume of one milliliter.  
Placing a 1 mL reaction into a 1 cm cubic tube provides a surface area-to-volume ratio 
of 4 cm2 mL-1.  Alternatively, stretching this cubic reactor into a channel 100 m long 
and 100 µm wide increases the surface area-to-volume ratio to 400 cm2 mL-1.17 Heat 
transfer and mixing are dictated by surface area-to-volume ratios for the reasons 
outlined below. 
 Heat transfer is one of the most important variables to be considered when 
performing a chemical reaction.  Heat is either supplied in order to facilitate slow 
reactions or removed from exothermic reactions to prevent runaway reactions/ 
undesired pathways.  Temperature profiles of a batch reactor can be very broad 
(Figure 1.2). 18 For an exothermic reaction being cooled in a large batch reactor,  
 
 
 
Figure 1.2.  Temperature profiles for a batch reactor (left) and a flow reactor (right).  
The blue area represents areas where the reaction is cooled effectively.  The red area 
represents areas with poor heat transfer (i.e. hot spots).18 
 
for instance, the temperature around the periphery of the reactor is cooler than the 
temperature toward the center.18 This heterogeneity of the temperature leads to areas 
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known as hot spots.  Hot spots are localized temperature gradients that allow access to 
undesired pathways.1, 19 The presence of hot spots leads to greater byproduct 
formation, and ultimately diminishes the efficiency of a given process.  Conversely, 
when cooling a microreactor, no temperature gradients exist (Figure 1.2).  Heat 
transfer is proportional to the diameter of the reactor (Equation 1.1). 20, 21   In this 
equation, k represents the overall heat transfer coefficient, Q is heat flow (expressed in 
W), 2 is the mean logarithmic temperature difference in degrees K, and A is the cross-
sectional area (expressed in m2).  Heat transfer therefore increases with a decrease in 
reactor diameter, and is therefore higher for microreactors.  This improved heat 
transfer in microreactors subsequently enables reactions to proceed much more cleanly 
and efficiently.  
 
! 
k =
Q
2A
                                        (Equation 1.1) 
 
 Mixing is also greatly improved when using microreactors.2 Common batch 
reactors, such as round bottom flasks or tank reactors, suffer from inhomogeneities in 
mixing that are caused by their stirring mechanisms.1, 22, 23 These mechanisms lead to 
chaotic mixing and convection, which causes weak to no mixing in parts of the reactor 
(Figure 1.3).18 Poor mixing may lead to local concentration gradients, causing more 
byproduct formation.  It has been shown that rapid mixing results in faster and cleaner 
chemical transformations, but this can be difficult to accomplish in batch for the 
reasons outlined above.   
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Figure 1.3.  Mixing profiles in a batch reactor (left) and a flow reactor (right).  Two 
components are being mixed, red and blue, to give green color after effective mixing.  
In the batch reactor, better mixing occurs close to the impellers and poor mixing 
occurs toward the middle and periphery.  In the flow reactor, the two phases rapidly 
diffuse due to the narrow dimensions of the reactor.18 
  
It has been shown that complete mixing in batch occurs within seconds, 
whereas complete mixing in microreactors takes a matter of microseconds.19  The 
narrow dimensions of microreactors allow for rapid mixing to take place (Figure 1.3).  
For example, two reagent streams can be flowed together in lamellae on the order of 
50-200 µm thick.  These small dimensions permit rapid mixing to take place by 
diffusion in as little as 100 µs.  Microreactors can achieve this rapid mixing because 
the lamellae are capable of achieving surface area-to-volume ratios of 30,000 m2 m-3.  
In comparison, in a typical laboratory batch reactor, the lamellae have surface area-to-
volume ratios ranging from 4-100 m2 m-3.24, 25 
This increased heat transfer and mixing is highly beneficial from a waste 
perspective as well.  Solvents are used for a number of reasons in organic synthesis, 
one of which is their ability to help dissipate heat.  Batch reactions frequently require 
more dilute conditions in order to assist with heat transfer.  Microreactors permit 
reactions to be run at higher concentrations (or even neat) because heat transfer is so 
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rapid, thereby generating fewer by-products, and ergo less waste.1, 8, 22 Products 
typically elute from the microreactors having higher purity profiles, meaning 
intermediate purification steps can be eliminated.  A growing number of chemical 
manufacturers are beginning to capitalize on the benefits of microreactors not only 
because this unprecedented reaction control, but also because of safety and marketing 
concerns.16 
 
Improved Safety and Scale-Up 
 As stated earlier, microreactors permit the careful control of exothermic 
reactions.  Microreactors also enable hazardous reactions to be safely used due to 
limited active chemistry volumes and rapid reaction times.  This is perhaps best 
highlighted by the microreactor-enabled production of an intermediate for the drug 
naproxconid (Figure 1.4). 
 
O
O
O
N
-O
O
O
naproxcinod
OH
OO
N
-O
O
O
Cl
1  
 
Figure 1.4.  A retrosynthetic analysis of the drug naproxcinod. 
 
 NiCox, a France-based chemical manufacturer, in collaboration with 
manufacturers DSM and Corning, has designed a microreactor-based synthesis to 
safely generate a nitrated intermediate 1 (Figure 1.4).  The use of microreactors in this 
process permits large quantities of 1 to be synthesized in a safe, and cost-effective 
manner.26 Nitrations are notoriously dangerous processes on industrial scale as they 
can be uncontrollably exothermic and generate explosive products and byproducts.27 
In order to achieve high yields in batch, very strict control of reaction conditions must 
be maintained, and dilute reaction conditions are used to prevent exotherms.  In a 
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microreactor, small dimensions allow heat transfer to be efficiently controlled and the 
residence time of unstable materials to be limited.  Also, because the product stream is 
immediately quenched at the reactor outlet, a high concentration of dangerous material 
is never reached, as would occur in a batch reactor. Excellent reaction control in the 
microreactor thus permits the reaction to proceed with higher yield and purity, in a 
much safer overall process.26 
 Reaction scale-up of the flow reactions can be performed using one of three 
simplified methods.13, 28, 29 The first process is known as ‘numbering up,’ which 
entails the addition of identical reactors in parallel, changing only the flow rate of the 
reagent stream.  Alternatively, the microchannels could also be made longer or the 
flow reactions simply could be run for a longer period of time.30 These processes are 
highly advantageous since reactions do not need to be reengineered to work on a 
larger scale.  As a result, the development of a large-scale synthesis of compounds 
such as intermediate 1 is much faster, and the expenses associated with this scale-up 
are greatly diminished.16 
 
Multi-step Reaction Sequences in Flow 
 While the majority of microreactor work in organic synthesis has focused on 
single reaction steps,1-12 recent examples have demonstrated multi-step reaction 
sequences in flow.  Microreactors have a modular nature that allows the outlet stream 
of one reaction to be mixed with a new set of reagents, thereby permitting multiple 
reactions to be run in sequence and limiting the number of isolation and purification 
steps.  Three different methods for running continuous flow syntheses will be 
highlighted in the sections to come. 
 Continuous Flow Synthesis Using Solid-Supported Reagents and 
Scavengers.  The Ley group at Cambridge is a pioneer in the field of flow chemistry.  
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The work done by Ley and co-workers relies on a catch-and-release strategy coupled 
with supported-reagents and scavengers that permits pure product to elute from the 
microreactor.9  In their most elaborate continuous flow synthesis, Ley and co-workers 
synthesized the natural product oxomaritidine in a continuous flow process, requiring 
no intermediate purification steps (Figure 1.5).31  Five of the seven steps in this 
synthesis involve passing starting materials through cartridges containing solid-
supported reagents, permitting a pure stream of product to elute from the cartridge 
before being relayed directly into the next reaction step.  In all, a 40% yield was 
obtained after seven steps with a purity of 90% by NMR.   
 
 
 
Figure 1.5.  Ley’s continuous flow synthesis of the natural product oxomaritidine 
using solid-supported reagent cartridges. 
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More recently, Ley and co-workers developed a three-step synthesis of 1,4-
disubstituted 1,2,3-triazoles using a combination of solid-supported reagent and 
scavenger cartridges in series (Figure 1.6).32 The reaction sequence starts with two 
inlet streams, one containing the Bestmann-Ohira reagent 2,33-35 an alcohol 3, and an 
organic azide 4, and another stream containing a solution of KOtBu in methanol.  This 
stream is passed through a cartridge packed with an immobilized TEMPO reagent, 
used to oxidize the alcohol to the aldehyde.  This stream is subsequently mixed with a 
solution of KOtBu in methanol and heated to 100 ˚C for 48 minutes.  The Bestmann-
Ohira reagent converts the aldehyde into a terminal acetylene, which  
 
 
 
Figure 1.6.  Ley’s continuous flow synthesis of 1,4-disubstituted 1,2,3-triazoles. 
 
elutes from the channel and enters a cartridge packed with immobilized copper.  This 
immobilized copper cartridge facilitates the click reaction between the terminal 
acetylene and the organic azide.  Residual copper is removed from the reaction stream 
using a cartridge packed with an immobilized-thiourea scavenging resin.  Three 
successive scavenger cartridges are then used to remove residual starting materials, 
and basic and acidic residues from the reaction stream.  A stream of pure triazole 5 
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elutes from the reactor in a 55% yield with greater than 95% purity after 
recrystallization. 
While these methods are effective, they rely on solid-supported reagent and 
scavenger cartridges that over time become depleted and need to be regenerated or 
discarded.  Intermediate purification steps have been eliminated, but having to dispose 
of reagent/scavenger cartridges becomes a downfall of this process. 
 Continuous Flow Synthesis Using In-Line Microextractors.  Another 
method developed by the Jensen group at MIT uses solution-phase reactions coupled 
with in-line microextractors to purify products before being passed into the next 
reaction (Figure 1.7).36  Jensen and co-workers synthesized various carbamates in a 
three-step process, starting from acid chlorides with two in-line purification steps 
(Scheme 1.1). 
 
 
 
Figure 1.7.  The experimental setup for the carbamate synthesis in flow. Reproduced 
with permission from: Sahoo, H. R.; Kralj, J. G.; Jensen, K. F. Multistep Continuous-
Flow Microchemical Synthesis Involving Multiple Reactions and Separations.  
Angew. Chem. Int. Ed. 2007, 46, 5704-5708. Copyright 2007 Wiley-VCH Verlag 
GmbH & Co. KGaA. 
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Scheme 1.1.  Model reaction for carbamate synthesis. 
  
The first step of the reaction sequence converts an acid chloride to the acyl 
azide intermediate (Scheme 1.1).  An in-line microextractor removes the water from 
the system before heating the organic stream to generate the isocyanate (the Curtius 
rearrangement).  The isocyanate is subsequently mixed with an alcohol stream, 
affording various carbamates (6) in nearly quantitative yield with no breaks in the 
synthesis.  This continuous flow synthesis benefits from generating and consuming 
intermediates such as acyl azides and isocyanates in situ, eliminating the need to store 
these dangerous compounds.   
 The microextractors used in this work use a fluoropolymer membrane that is 
selectively wetted by organic solvents.37-40 This wetting enables the organic phase to 
pass through the membrane, separating it from the aqueous and gaseous phases. While 
these proof-of-concept cases are very promising, excess waste is generated due to the 
intermediate purification steps.  Having the ability to run multiple reactions in 
sequence without purification or isolation brings about a significant advantage in 
terms of not only increased waste, but also in terms of maximizing the speed and 
efficiency of the process. 
 Continuous Flow Syntheses Requiring No Intermediate Purification Steps.  
Recently Cosford and co-workers have developed a multi-step synthesis for 1,2,4-
oxadiazoles in a continuous flow framework, requiring no intermediate purification 
steps.41 The goal of this work was to develop a three-step, continuous flow process 
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that could generate sufficient amounts of product to be supplied for biological testing 
in a short amount of time (~30 minutes) (Figure 1.8). 
 
 
 
 
Figure 1.8.  Cosford’s three-step continuous flow synthesis of 1,2,4-oxadiazoles. 
  
 Mixing a stream of aryl nitrile with hydroxylamine hydrochloride and Hunig’s 
base at 150 ˚C showed complete conversion to the corresponding amidoxime 7 after 
12 minutes in the flow reactor.  This outlet stream was cooled to 0 ˚C before adding a 
solution of acid chloride.  The amidoxime and acid chloride reacted at room 
temperature to give the O-acyl amidoxime, which was immediately relayed into a 
reactor heated to 200 ˚C, yielding 1,2,4-oxadiazoles 8. 
These syntheses were very efficient, and purification by preparative HPLC was 
performed after the entire sequence had been completed.  This methodology permits 
the facile development of chemical libraries of 1,2,4-oxadiazoles in 40-60% yield 
solely by changing the aryl nitrile and acid chloride inputs.  Furthermore, this work by 
Cosford and co-workers is a prime example of how reaction kinetics can be increased 
using flow.  An identical reaction sequence in batch takes in upwards of four days to 
complete.  The flow sequence is much faster as reactions are superheated to 
temperatures well above reagent boiling points using backpressure regulators. 
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Conclusion 
The multi-step reaction sequences outlined above are very elegant techniques, 
but could potentially be improved using other technology.  Perhaps one of the most 
significant innovations in organic chemistry is the development of highly efficient 
catalytic reactions.  While the continuous flow syntheses discussed in this chapter are 
groundbreaking, they are essentially void of any catalytic steps!  The use of catalysis 
oftentimes increases reaction efficiency and selectivity.42 Additional benefits include 
reduced use and cost of raw materials such as solvents and reagents, as well as the 
ability to introduce chemical complexity.43 Few reports discuss the use of catalytic 
microreactors in series to realize multi-step reactions, although recent advances using 
catalysts in flow for single-step reactions suggest that coupling catalysts in series is 
soon to be achieved.  
Perhaps even more promising is the use of heterogeneous catalysis in these 
microflow systems.  Catalysts are typically the most expensive component of a 
reaction mixture and can be difficult to separate.  Immobilizing a catalyst for use in 
flow is advantageous since it permits facile recycling and does not need to be 
separated from reaction streams.  Furthermore, no agitation or stress is exerted on 
these supported catalysts, which oftentimes shortens the lifetime of these materials.  
As a results, these catalytic systems can be used continuously, enabling a high 
throughput of material.44, 45 In this dissertation, the development of innovative 
strategies to make small molecules continuously in microreactors will discussed, with 
the ultimate goal being entirely catalytic routes to important small molecules in flow. 
These continuous routes will ensure that these molecules are produced more 
efficiently, selectively and with a higher degree of safety, thus leading to reduced 
waste and cost. 
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CHAPTER 2 
Improving Solid-Supported Catalyst Productivity by Using Simplified 
Packed-Bed Microreactors 
 
Preface 
 Upon my arrival in the McQuade group, former McQuade group members 
Jeremy Steinbacher and Elizabeth Quevedo were developing a simplified microfluidic 
device using syringe pumps, syringes, needles and tubing.  While this platform was 
initially used to synthesize polymeric materials, we saw the potential to run organic 
reactions within these channels as well.  We therefore started to development of a 
novel microreactor to be used in organic synthesis that relied on solid-supported 
catalysts.  The work described in this chapter set the foundation for future flow 
chemistry work performed in the group. 
 
Abstract* 
Packed-bed microreactors are formed from polymeric tubing and a resin-
supported catalyst. By using supported catalysts in flow systems, productivity and 
recycling are greatly improved. This approach can be used to couple multiple catalysts 
together for generating complex molecules in one flow-through process. 
 
Introduction 
Catalysts supported on polymeric resins are readily synthesized and offer the 
promise of recycling and easy removal from reaction mixtures through filtration.1-4 
                                                
* Reproduced in part with permission from: Bogdan, A. R.; Mason, B. P.; Sylvester, K. 
T.; McQuade, D. T. Improving Solid-Supported Catalyst Productivity Using Packed-
Bed Microreactors.  Angew. Chem. Int. Ed. 2007, 46, 1698-1701. Copyright 2007 
Wiley-VCH Verlag GmbH & Co. KGaA. 
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Often, however, such a support significantly diminishes a catalyst’s activity.5 
Although homogeneous catalyst loadings in a batch reactor are simply increased by 
the addition of more catalyst, additional supported catalyst can hinder reagent mixing 
within a reaction vessel. These issues are circumvented by using continuous-flow 
systems. The use of flow is advantageous as the support does not need to be removed 
from the reaction mixture and continuous processing is also possible.6, 7 Our interest in 
microreactors prompted us to ask if supported catalysts would work when packed into 
small channels.   
Microreactors are a relatively new technology for performing safer, more-
efficient, and more-selective reactions.1, 8-13 The improved performance is attributed to 
faster heat transfer and mixing as a result of the increased surface area-to-volume 
ratio.8 Despite the increasing body of literature on microreactors, few reports discuss 
the use of packed-bed microreactors applied to synthetic chemistry 
(Figure 2.1). What literature does exist concerning synthesis within these channels 
describes reactions performed by using solid-supported reagents that require 
regeneration.14-25  
 
 
 
Figure 2.1. Flow reactions with a packed-bed microreactor. 
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A major issue encountered in packing microchannels with supported-catalysts 
is the pressure drop across the channel caused by either the swelling or size of the 
packing material.26-28 Common Merrifield-type and gel-like resins are not appropriate 
for microchannel packing as they clog the channels when swollen with solvent, 
leading to irreproducible flow.26, 27 Other than monolithic materials,29-35 no material 
investigated so far permits facile flow through packed-bed microreactors in a wide 
range of solvents. Herein, we demonstrate that a commercially available resin works 
well as a catalyst support in a high throughput, packed-bed microreactor and that 
supported catalysts in flow systems yield greater productivity (Equation 2.1).  We 
limit this discussion to commercially available polymeric resins. 
 
! 
productivity =  
moles product
reactor volume "  time "  moles catalyst
   (Equation 2.1) 
 
Results and Discussion 
Although the use of electroosmotic flow permits flow through a wider range of 
packing materials,36 these systems are far more complex than pressure-driven  systems 
and only work with polar solvents. We subsequently examined a wide range of resins 
to be used in a pressure-driven system by passing different solvents through a 10-cm 
packed bed and qualitatively assessing whether flow was free or constricted (Table 
2.1). Typically, lightly cross-linked resins swell in certain solvents, which prohibits 
flow through the microchannels. Highly cross-linked or macroreticular resins and 
silicas, on the other hand, allow flow under nearly all solvent conditions as they do not 
swell.  Numerous solid-supported catalysts have been reported in the literature, 
including analogues of the supported catalysts discussed herein.1 Nonetheless, our 
flow experiments showed that many polymeric resins do not permit flow in a wide 
array of solvents. A packing material that does not restrict flow is desired as higher 
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flow rates and output can be attained. 
 
Table. 2.1  Packing materials tested as supports for packed-bed microreactors. 
 
Packing 
Material 
Composition H2O EtOH Acetone CHCl3 THF 
Silica Gel 
(225-420 mesh) 
SiO2 +a + + + + 
Amberlite 
XAD2 
PS + + +   
Amberlite 
CG50 
methacrylate, 
carboxylic 
functionalization 
– – –   
Amberlite 
IRA-900 
PS, quaternary 
ammonium 
 –    
PS Beads 
(1% DVB) 
PS – +/– +/– – – 
PS Beads 
(2% DVB) 
PS – – + – – 
Amberlyst 
15(dry) 
acrylic, 
macroreticular 
 +  +  
Dowex 1X2-200 
(2% crosslink) 
PS, quaternary 
ammonium 
– –    
Dowex 
50WX8-200 
(8% crosslink) 
PS, sulfonic acid + +  +  
PS-DMAP PS, 2% DVB  –  – + 
Amberzyme 
Oxirane 
methacrylic, 
macroreticular 
+ + + + + 
a (+) – unencumbered flow, (–) – restricted flow 
 
Of the two supports that passed our flow tests (flow with no pressure drop), we 
favored the methacrylate-based Amberzyme Oxirane resin (AO, 1), a macroreticular 
resin with a large, fixed pore volume and pendant epoxide groups designed for 
enzyme immobilization. Catalysts were attached to the resin by direct nucleophilic 
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attack or by a Huisgen cycloaddition to an azide-modified AO. These catalysts showed 
excellent batch activity, but when they were used in packed-bed microreactors, their 
productivity increased significantly (Equation 2.1). 
We tethered organocatalysts containing nucleophilic groups to AO. As an 
example, we reacted 1,5,7-triazabicyclo-[4.4.0]undec-3-ene (TBD, 2) with the epoxide  
 
 
O
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N
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N N
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3
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37 ˚C, 20 hrs
 
 
Scheme 2.1.  Preparation of AO-TBD resin. 
 
(Scheme 2.1). Solid-supported TBD has been demonstrated to catalyze a number of 
reactions1, 37 but has not yet been used in a pressure-driven flow system.36, 38 TBD on 
AO (AO–TBD, 3, Scheme 2.1) is a highly active, Knoevenagel catalyst in batch 
systems but works significantly better in flow systems. We selected a Knoevenagel  
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Scheme 2.2.  The Knoevenagel condensation between benzaldehyde and ethyl 
cyanoacetate.  
 
condensation between benzaldehyde (4) and ethyl cyanoacetate (5) as a demonstration 
(Scheme 2.2). All flow experiments were performed by using a simplified packed-bed 
microreactor based on a platform developed within our group and also by others 
(Figure 2.2).39-42 The present device consisted of fluoroelastomeric tubing (1.6-mm 
inner diameter) packed with functionalized AO resins (Figure 2.2b). 
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Figure 2.2. The simplified microreactor: empty tubing (a) filled with AO resin (b) 
with filter caps (c) and attached to syringe pumps (d). 
 
For the flow Knoevenagel condensation experiments, a 30-cm segment of 
tubing was packed with AO–TBD and placed in an HPLC column oven set to 60 ˚C. A 
solution of benzaldehyde in acetonitrile was prepared, to which ethyl cyanoacetate 
was added prior to the flow experiment. At a flow rate of 50 µL min-1 (approximately 
280 s residence time), a conversion of 93% was obtained (Figure 2.3). This flow rate 
gives over 200 mg of product per hour from a single channel.  The device presented 
provides roughly forty times the output of previously reported flow devices.29 The 
increased performance of a packed-bed microreactor is due to the small dimensions of 
the channel, allowing rapid and uniform heating. In addition, all packed-bed reactors 
benefit from flowing reagents over the catalyst-bound resin. This feature allows the 
catalyst loading to be maximized and for transfer of reagents and starting materials 
into and out of the beads. 
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As anticipated, increasing the flow rate (decreasing the residence time) gave 
lower conversions (Figure 2.3). The process of numbering up could be applied to 
acquire higher outputs since reactor conditions need not be changed upon reaction 
scaling.43 The AO–TBD packed channel was used 30 times without apparent catalyst 
degradation. After each trial, the column was simply regenerated with aqueous  
ammonia and washed with acetonitrile to maintain activity.  
 
 
 
Figure 2.3. Conversion of flow Knoevenagel condensations as a function 
of residence time. 
 
Knoevenagel condensations were run on an identical scale and concentration in 
both the batch and flow experiments. In both cases, the resulting reaction-mixture 
volume and amount of AO–TBD catalyst were the same. A conversion of 90% was 
achieved in the flow system (at 50 µL min-1, resulting in 3 mL total volume in one 
hour), and the reaction mixture could be concentrated under high vacuum to yield the 
product. Batch reactions, however, yielded only 69% conversion after one hour 
(reaction volume of 3 mL). The microreactor productivity for the flow reactions was 
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3.4 times greater than the batch reaction owing to the decreased dimensions of the 
reactor and better mixing (Table 2.2). 
 
Table 2.2.  Flow reaction productivities. 
 
Reaction Flow Productivitya Batch Productivity Flow/Batch 
Productivity 
TBD Knoevenagel 1.12 0.33 3.4 
TBD Knoevenagel 
(double scale) 
0.75 0.13 5.8 
DMAP acylationb 3.2 1.0 3.2 
a  Productivities are measured in mmol product mL-1 min-1 mmol catalyst-1.  
b  Batch reaction for the acylation run by using 10 mg of catalyst compared with 215 
mg for the flow reaction. 
 
Increasing the scale of the reaction emphasizes the benefits of using the 
packed-bed reactor. By doubling the reaction size and maintaining a constant mass of 
AO–TBD, the productivity for batch reactions decreased by 2.5, whereas the 
productivity of the flow reactions changed very little. We propose that the 
microreactor performs better because the molar ratio of the starting material for AO–
TBD remains constant in the microreactor as new reaction mixture is continuously 
introduced. The productivity at this larger scale is 5.8, which should increase as the 
scale of the reaction increases (Table 2.2). 
We then prepared a packed-bed reactor by using immobilized 4-
dimethylaminopyridine (DMAP), a catalyst that has been studied extensively on solid 
supports.5, 44-46 Azide-functionalized AO resin (AO-N3, 6) was prepared by treatment  
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Scheme 2.3.  Preparation of AO-N3 resin. 
 
of AO with sodium azide (Scheme 2.3).47  An acetylene-functionalized DMAP (7), 
synthesized by using a Michael addition,48 was conjugated to AO–N3, affording the 
DMAP-functionalized resin (AO-DMAP, 8, Scheme 2.4). The acylation of sec-
phenethyl alcohol (9) was used as a test reaction (Scheme 2.5). 
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Scheme 2.4. Preparation of AO-DMAP resin. 
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Scheme 2.5.  The acylation of sec-phenethyl alcohol. 
 
Acetic anhydride was added to a stock solution of sec-phenethyl alcohol and 
triethylamine in hexanes and used immediately in the flow experiment. Full 
conversion was achieved at a flow rate of 0.5 mL min-1 (approximately 48 s 
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residence time; Figure 2.4).  At 0.5 mL min-1, extrapolation of this output suggests that 
1.6 g of product per hour could be obtained from a single 60-cm channel. Use of the 
highest flow rate of the syringe pump (3.9 mL min-1) gave the highest throughput of 
the acylated product (50.5 mmol h-1), albeit the lowest conversion (68.5%). 
 
 
 
Figure 2.4. AO-DMAP-catalyzed flow acylation of sec-phenethyl alcohol. 
 
As with the Knoevenagel condensation, the flow acylation was run in direct 
comparison with the batch reaction by using identical amounts of catalyst, reagent 
concentrations, and final reaction volumes (3 mL). In this case, the flow acylation 
was marginally superior to the batch reaction, generating 95% conversion in flow 
experiments (at 50 mL min-1, resulting in 3-mL total volume in one hour) versus 92% 
conversion in one hour in batch experiments. 
However, AO-DMAP catalyzed acylations were more productive in flow 
experiments compared with batch experiments (Table 2.2). Furthermore, the AO-
DMAP packed columns were reusable, and each column could be used in 35 trials 
without showing any apparent loss in catalytic activity (no regeneration was required). 
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For this reason the AO-DMAP packed-bed microreactor is again superior to the batch 
system, because in flow systems, the catalyst is left in place and does not have to be 
recovered from the reaction.   
 Reaction scale-up of flow reactions comprises of a process known as 
numbering up.43, 49, 50 Numbering up a reaction entails the addition of identical reactors 
in parallel and requires only changing the flow rate of the reagent stream.  This 
process is highly advantageous as small scale reactions do not need to be reengineered 
to work on a larger scale.  As a result, the development of large-scale synthesis is 
much faster, and the expenses associated with this scale-up are greatly diminished. 
 We chose to demonstrate this simplified reaction scale-up using the AO-TBD-
catalyzed Knoevenagel condensation between benzaldehyde and ethyl cyanoacetate 
(Scheme 2.2).  Using a single AO-TBD packed bed at a flow rate of 50 µL/min, 
approximately a 93% conversion was obtained.  This corresponded to an output of 210 
mg/hr product (90% yield) (Figure 2.5).  Simple concentration of the output stream 
afforded an off-white crystalline material. 
 
 
 
Figure 2.5.  Yield from a single-channel AO-TBD packed-bed microreactor. 
 
 The activity of this single-channel system was monitored over the course of 
one hour (Figure 2.6).  After about 60 minutes of continuous use, the conversion starts 
to diminish, indicating that the AO-TBD packed bed needs to be regenerated.  After 
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flushing the column with 1 M aqueous ammonia, the system once again reached its 
high activity. 
 
 
 
Figure 2.6.  Long-term activity of single channel AO-TBD microreactor. 
 
 The Knoevenagel condensation was subsequently scaled-up to an eight-
channel system.  The only variable that needed to be changed in this case was the flow 
rate; having increased the flow rate eightfold, from 50 µL/min to 400 µL/min.  In this 
scaled-up reaction, the hourly output increased from 210 mg/hr to 1.85 g/hr (98% 
yield) (Figure 2.7). 
 
 
 
Figure 2.7. Yield from an eight-channel AO-TBD packed-bed microreactor. 
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 The activity of this 8-channel system also remained high, however, after an 
hour of continuous use, the activity started to drop sharply (Figure 2.8).  As with the 
one-channel system, the AO-TBD resin needed to be regenerated in order to maintain 
its high activity. 
 
 
 
Figure 2.8.  Long-term activity of eight-channel AO-TBD microreactor. 
 
 A higher yield was obtained during the 8-channel system, a result that may be 
attributed to the different heating sources that were employed.  For the single-channel 
example, an HPLC column heater over was utilized which may not have provided 
intimate contact with the microchannels.  For the 8-channel system, however, a new 
heat exchanger was developed (Figure 2.9).  The eight channels were connected using 
a series of Y-junctions to split the flow of the reagent stream. The 8-channel AO-TBD 
packed bed was subsequently placed within a piece of PVC tubing, having been 
equipped with a water inlet and outlet (similar to that which is present on a 
condenser).  Using a temperature controller and a pumping mechanism, a stream of  
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Figure 2.9.  Heat exchanger for large-scale flow reactions. 
 
60 ˚C water was passed through the heat exchanger.  This method of heating ensured 
that the tubing was in intimate contact with the heat source, whereas in the column 
heater, this was not necessarily guaranteed. 
 To permit continuous processing in this packed-bed system, the issue of 
regeneration must be addressed.  To do this, one could envision a dual reactor set-up, 
in which one reactor is being regenerated and one reactor is functioning (Figure 2.10). 
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Figure 2.10. Two channel packed-bed microreactor with one functioning and one 
regenerating AO-TBD channel. 
 
 
Using a series of valves, the flow could be diverted through one AO-TBD channel 
while the aqueous ammonia stream is regenerating the other channel.  Once the 
activity of the functioning packed-bed starts to diminish and the other packed-bed has 
been regenerated, the valves can be switched to maintain the high output of product.  
This process would enable continuous processing as the system would not need to be 
stopped at any time to regenerate the catalyst. 
 
Conclusion 
Aside from increased productivity and ease of use, packed-bed microreactors 
containing AO-modified resins are superior to batch reactions for other reasons. The 
resin within the reactor remains intact throughout the course of the flow reaction, 
whereas in batch systems, most resins, including AO, showed signs of structural 
damage.33 Flow reactions also increase mixing without destroying the packing 
material by splitting the substrate stream into smaller segments of flow, leading to 
turbulent mixing.51 
Though monolithic packed beds may provide more efficient contact between 
reagents and starting materials, we feel that the use of resins has advantages; namely 
the resin’s ease of modification and characterization prior to channel packing. 
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These materials showed remarkable activity when used in batch reactors, yet 
were even more productive in the continuous-flow system. The device also enables a 
facile method to run high-throughput processes compared with previous literature that 
used microreactors. Compared with batch reactors, both AO–TBD and AO–DMAP 
show increased productivity owing to the improved mixing and decreased dimensions 
of the channel. This simplified approach to continuous catalytic chemistry can be used 
to couple multiple catalysts together for generating complex molecules in one flow-
through process. The use of purely catalytic-flow reactors will provide higher 
throughput and efficiency relative to the groundbreaking continuous-flow systems that 
use both resin-bound catalysts and reagents.14-20 Finally, the use of packed-bed 
microreactors instead of larger bore-flow reactors will allow much faster heating and 
heat removal. Consistent temperature across the channel will combine the advantages 
of microreactors with packed-bed reactors. 
 
Experimental Section 
General Considerations.  Solvents were purified by standard procedures. 
Triethylamine was purified by sequential treatment with benzoyl chloride, drying over 
CaH2, and distillation. All other reagents were used as received, unless otherwise 
noted.  1H NMR spectra were recorded in CDCl3 on Varian Mercury 300MHz and 
Inova 400 MHz spectrometers operating at 299.763 MHz and 399.780 MHz, 
respectively, using residual solvent as the reference. ATR-IR was performed on a 
Nicolet Avatar DTGS 370 infrared spectrometer with Avatar OMNI sampler and 
OMNIC software. Elemental analysis was performed by Robertson Microlit 
Laboratories, Inc., in Madison, New Jersey. Gas chromatographic (GC) analyses were 
carried out on a Varian Model 3800 using a CP-Sil regular phase column (30.0 m x 
0.25 mm i.d.). 
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Channel Packing. A 60 cm section of tubing (Swagelok PFA Tubing, 1/8” outer 
diameter) was attached to a Swagelok PFA union packed with glass wool. A separate 
union (not packed with glass wool) was attached to the inlet side of the 60 cm column.  
Two 10 cm sections of tubing were attached to the channel, serving as the outlet. A 
1/16” female Luer was attached to the inlet. Functionalized (3 or 4) resin was 
suspended in CH2Cl2 and the column slurry packed using a syringe.  
 
AO-TBD (1).  AmberzymeTM Oxirane (302.9 mg, 1.0 mmol epoxide/g resin, 0.30 
mmol epoxide) was suspended in a solution of TBD (193.7 mg, 1.4 mmol, 4.6 eq.) in 
dry toluene (10 mL). The suspension was shaken for 24 hrs at 37 ˚C.  The resin was 
filtered and washed with CH2Cl2 (2x 10 mL), MeOH (2x 10 mL), and Et2O (1x 10 
mL) and dried under vacuum to give 322.7 mg of resin (0.44 mmol TBD/g resin). The 
loading was calculated by mass difference. 
 
Representative Flow Knoevenagel Condensation Procedure. A 2.5 mL aliquot of a 
stock solution containing benzaldehyde (0.39 M, 0.98 mmol, 1.0 eq) in acetonitrile 
was placed in a 4 mL screw cap vial. Ethyl cyanoacetate (120 µL, 1.13 mmol, 1.1 eq) 
was added to the aliquot and transferred to a 5.0 mL syringe. A 30 cm channel was 
packed with 102.4 mg AO-TBD, flushed with acetonitrile and placed in an HPLC 
column oven set to 60 ˚C. The syringe was placed on the syringe pump, attached to the 
microchannel and flow initiated.  Reaction mixtures were collected in a 4 mL screw 
cap vial until the entire solution had been flushed from the syringe. After each trial, 
the column was regenerated with 5 mL 1 M NH3, followed by 5 mL acetonitrile. 
Conversions were calculated as the area of product divided by the sum of product and 
starting material area. 
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Batch Knoevenagel Condensations. A 2.5 mL aliquot of a stock solution containing 
benzaldehyde (0.39 M, 0.98 mmol, 1.0 eq) in acetonitrile was placed in a 4 mL screw 
cap vial. Ethyl cyanoacetate (120 µL, 1.13 mmol, 1.1 eq.) and 3 (103.3 mg, 0.0424 
mmol, 0.043 eq.) were added to the stock solution and heated to 60 ˚C with gentle 
stirring. 20 µL samples were quenched using CH2Cl2 and conversions were calculated 
as the area of product divided by the sum of product and starting material area. 
 
AO-N3 (6).  Sodium azide (5.26 g, 81 mmol, 8.1 eq.) and ammonium chloride (2.27 g, 
42.4 mmol, 4.2 eq.) were dissolved in 500 mL 90:10 v/v water in methanol. 
AmberzymeTM Oxirane (10.0 g, 1.0 mmol epoxide/g resin, 10.0 mmol, 1.0 eq.) was 
suspended in the azide solution and the reaction mixture refluxed overnight with 
gentle stirring. The resin was filtered using a Buchner funnel, washed with DI H2O (2x 
50 mL), MeOH (2x 50 mL), Et2O (1x 25 mL), and dried under vacuum. Elemental 
analysis afforded a loading of 1.0 mmol N3/g resin. 
 
Acetylene-Modified DMAP (7). N-methylamino pyridine (500 mg, 4.6 mmol) and 
propargyl acrylate (2.0 mL, 18.1 mmol) were heated to 90°C for 2 hours. The residual 
acrylate was removed by vacuum distillation. The product was purified by column 
chromatography (silica gel, 10:1 CH2Cl2/MeOH) to afford a tan solid (653 mg, 65%). 
1H NMR (400 MHz, CDCl3) δ 8.19 (d, J = 5.55 Hz, 2H), 7.14-7.36 (m, 5H), 6.65 (d, J 
= 6.43 Hz, 2H), 4.59 (s, 2H), 3.08 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 171.05, 
153.22, 149.91, 110.00, 106.93, 75.49, 52.54, 47.29, 37.88, 31.82. 
 
AO-DMAP (8).  3 (72.6 mg, 0.33 mmol, 1.0 eq), CuBr(PPh3)3 (35.0 mg, 0.037 mmol, 
0.11 eq) and DIPEA (280 µL, 1.7 mmol, 5.1 eq) were dissolved in anhydrous THF (20 
mL). 2 (305 mg, 1.0 mmol N3/g resin, 0.31 mmol, 0.9 eq) was added to the solution 
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and placed under a N2 atmosphere.  The suspension was heated to 50 ˚C for 3 days. 
The resulting resin was green, most likely due to Cu chelation. The resin was washed 
with THF (2x 10 mL), MeOH (1x 10 mL), 1 M HCl (2x 10 mL), DI H2O (1x 10 mL), 
sat. NaHCO3 (2x 10 mL), DI H2O (1x 10 mL), MeOH (1x 10 mL) and Et2O (1x 10 
mL), and dried under vacuum to yield the beige AO-DMAP resin (342 mg, 0.50 mmol 
DMAP/g resin).  The loading was calculated by mass difference.  ICP showed a 
negligible Cu loading (0.01 mmol/g resin) and this was concluded to be too small to 
be catalyzing the acylation reaction.  
 
Representative Flow Acylation Procedure. A 2.5 mL aliquot of a stock solution 
containing sec-phenethyl alcohol (0.33 M, 0.825 mmol, 1.0 eq) and TEA (0.50 M, 
1.25 mmol, 1.5 eq) in hexanes was placed in a 4 mL screw cap vial. Acetic anhydride 
(120 µL, 1.25 mmol, 1.5 eq) was added to the aliquot and transferred to a 5.0 mL 
syringe.  Prior to syringe attachment, the channel was flushed with hexanes. The 
syringe was placed on the syringe pump and flow was initiated. The reaction mixture 
was collected in a 4 mL screw cap vial until the sample had eluted through the 
channel. After each trial, the channel was washed with 5 mL CH2Cl2 followed by 5 
mL hexanes. Conversions were calculated as the area of product divided by the sum of 
product and starting material area. 
 
Representative Batch Acylation Procedure. A 2.5 mL aliquot of a stock solution 
containing sec-phenethyl alcohol (0.33 M, 0.825 mmol, 1.0 eq) and TEA (0.50 M, 
1.25 mmol, 1.5 eq) in hexanes was added to a vial containing 2 (10.9 mg, 0.005 mmol, 
0.007 eq). Acetic anhydride (120 µL, 1.25 mmol, 1.5 eq.) was added to the sample and 
rocked gently. Conversions were calculated as the area of product divided by the sum 
of product and starting material area.  
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Representative Batch Acylation Procedure. A 2.5 mL aliquot of a stock solution 
containing sec-phenethyl alcohol (0.33 M, 0.825 mmol, 1.0 eq) and TEA (0.50 M, 
1.25 mmol, 1.5 eq) in hexanes was added to a vial containing 2 (10.9 mg, 0.005 mmol, 
0.007 eq). Acetic anhydride (120 µL, 1.25 mmol, 1.5 eq.) was added to the sample and 
rocked gently. Conversions were calculated as the area of product divided by the sum 
of product and starting material area. 
 
Equivalent Acylation Reactions in Batch and Flow.  Batch - Three 4 mL screw 
vials were each charged with 2 (30.0 mg, 0.015 mmol, 0.015 eq). A 3.0 mL aliquot of 
a stock solution containing sec-phenethyl alcohol (0.33 M, 0.990 mmol, 1.0 eq) and 
TEA (0.50 M, 1.50 mmol, 1.5 eq) in hexanes was added to each vial. Acetic anhydride 
(150 µL, 150 mmol, 1.5 eq) was added to the reaction vessels. Each batch reaction 
was gently rocked and sampled at 20, 40, and 60 minutes. Conversions were 
determined by calculating the area of product divided by the sum of product and 
starting material areas. 
Flow - Flow reactions were run using a 6 cm column packed with 2 (30.5 mg, 0.0015 
mmol, 0.011 eq). The column was rinsed with methylene chloride and hexanes prior to 
each flow experiment. A 4 mL aliquot of stock solution containing sec-phenethyl 
alcohol (0.33 M, 1.32 mmol, 1.0 eq) and TEA (0.50 M, 2.00 mmol, 1.5 eq) was added 
to a 20 mL screw cap vial along with acetic anhydride (195 µL, 2.04 mmol, 1.5 eq). 
The mixture was collected in a syringe and flowed through the column containing 2 
and then stirred vigorously. Product was collected for one hour at a flow rate of 50 
µL/min and sampled directly from the channel at 10, 20, 23, 36, 40, 50, and 60 
minutes. At the end of the hour, roughly 3.0 mL had been flowed through the column 
making the flow reaction identical to the batch reaction. Also, the entire 3.0 mL 
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volume collected was sampled. Product conversion was measured by comparing the 
GC area of the product to the sum of the areas of the product and starting material. 
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CHAPTER 3 
A Biphasic Oxidation of Alcohols to Aldehydes and Ketones Using a Simplified 
Packed-Bed Microreactor 
 
Preface 
Aldehydes and ketones are common building blocks in organic synthesis, but 
have the disadvantage of readily decomposing.  Having the ability to generate 
aldehydes in situ from more stable alcohols in a reaction sequence is, therefore, highly 
advantageous.  We chose to develop a packed-bed microreactor that could oxidize 
alcohols to their corresponding carbonyl species, with the ultimate goal of developing 
multi-step reaction sequences that required a carbonyl (i.e. the Knoevenagel 
condensation or the proline-catalyzed α-aminoxylation). 
 
Abstract* 
We demonstrate the preparation and characterization of a simplified packed-
bed microreactor using an immobilized TEMPO catalyst shown to oxidize primary 
and secondary alcohols via the biphasic Anelli-Montanari protocol.  Oxidations 
occurred in high yields with great stability over time.  We observed that the aqueous 
oxidant and organic alcohol entered the reactor as plugs but merged into an emulsion 
on the packed-bed.  The emulsion coalesced into larger plugs upon exiting the reactor, 
leaving the organic product separate from the aqueous by-products.  Furthermore, the 
microreactor oxidized a wide range of alcohols and remained active in excess of 100 
trials without showing any loss of catalytic activity. 
 
                                                
* Reproduced with permission from: Bogdan, A. R.; McQuade, D. T. A Biphasic 
Oxidation of Alcohols to Aldehydes and Ketones Using a Simplified Packed-Bed 
Microreactor.  Beilstein Journal of Organic Chemistry 2009, 5, 17.  
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Introduction 
Microreactors have gained attention because they can help run chemical 
transformations more efficiently, more selectively, and with greater safety.1-12  
Alcohol oxidations are well suited for microreactors due to high by-product formation, 
catalyst contamination and safety concerns often associated with scale-up in batch 
reactors.13  Recent developments in microreactor technology and solid-supported 
catalysis have aimed to solve these issues.   Numerous flow oxidations have been 
presented in the literature,13-16 however many rely on stoichiometric reagents,17, 18 
suffer from catalyst deactivation,19, 20 or rely on soluble catalysts,21 all of which limit 
their potential as continuous flow processes.  Realizing this, we developed a catalytic 
packed-bed microreactor that could be used for the continuous flow oxidation of 
alcohols to aldehydes or ketones.   
Oxidations that do not require transition metal catalysts are particularly 
appealing since there is neither leaching nor the need for catalyst regeneration.22  
Nitroxyl radicals, such as 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO), 
immobilized on silicates,23-32 fluorous supports,33 soluble and insoluble polymers,22, 34-
36 magnetic nanoparticles,37 and ionic liquids38 have been extensively studied and are 
useful because the oxidation conditions are mild, selective, and the catalysts do not 
require regeneration (Figure 3.1 and Figure 3.2). TEMPO, however, is expensive and 
difficult to remove from reaction mixtures.  For these reasons, TEMPO 
immobilization is an important goal because it enables facile removal and recycling.  
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Figure 3.1.  The catalytic cycle of the TEMPO-catalyzed oxidation of alcohols 
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Figure 3.2.  Redox reactions for the generation of the oxoammonium cation. 
 
We recently reported the development of an effective solid-support for use in 
packed-bed microreactors,39 AMBERZYME® Oxirane (AO, 1), a commercially 
available resin with pendant epoxide functionalities designed for enzyme 
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immobilization. AO is readily functionalized with a range of catalysts and works well 
as packing material for flow chemistry.39  In this report, we demonstrate the 
immobilization of TEMPO and its use in a flow system using the Anelli-Montanari 
protocol for the oxidation of primary and secondary alcohols.30, 40  Our simplified 
reactor is advantageous because the reactions not only run continuously, but since the 
microreactor is made of cheap, disposable fluoroelastomeric tubing, wall oxidation 
that is commonplace with metal microchannels is not observed.21  The narrow 
dimensions of the microreactor also allows excellent heat transfer, increasing the 
safety of large-scale oxidations.  Furthermore, it was determined that the use of a 
packed-bed microreactor facilitates efficient mixing of a biphasic system without 
destroying the solid-support, a common problem with stirred systems.4 
 
Results and Discussion 
Previously we reported that catalysts functionalized with an acetylene moiety 
can be tethered to AO using a Huisgen cycloaddition.39 Azide-functionalized AO resin 
(AO-N3, 2) was prepared by treating AO with sodium azide (Scheme 3.1).41  The 
coupling of 4-hydroxy-TEMPO 3 with propargyl bromide 4 using sodium hydride 
yielded the acetylene-modified TEMPO species 5.33, 34, 37  TEMPO derivative 5 was 
then covalently bound to AO-N3 using copper(I) iodide,42-45 yielding the TEMPO-
functionalized resin (AO-TEMPO, 6, Scheme 3.2, 0.46 mmol TEMPO/g resin). 
 
O OH
N3
NaN3, NH4Cl
MeOH/H2O
reflux 20 hr
1 2  
 
Scheme 3.1. Preparation of AO-N3 resin. 
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Scheme 3.2. Preparation of AO-TEMPO resin. 
 
Using a simplified procedure developed within our group and others,39, 46-49 
flow reactions were performed by packing fluoroelastomeric tubing (60 cm, 1.6 mm 
i.d.) with the AO-TEMPO resin.  The tubing was subsequently woven between metal 
bars, to improve mixing and to enable facile microreactor cooling (Figure 3.3).  A Y-
junction placed at the inlet of the microreactor allowed the immiscible bleach 
(adjusted to pH 9.1 using NaHCO3) and organic alcohol solutions to form plugs before 
reaching the packed bed (Figure 3.4A).  When passing through the AO-TEMPO 
catalyst bed, the plugs emulsified, as indicated by visual inspection and by the plug 
coalescence at the microchannel outlet (Figure 3.4B).  The effective mixing was later 
supported by the high yields and conversions that were achieved for this biphasic 
reaction. 
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Figure 3.3. The simplified microreactor setup.  Empty tubing (A) is packed with 
functionalized AO resin and attached to caps (B).  The packed bed is woven between 
metal bars (C) and connected to syringe pumps (D). 
 
 
 
 
Figure 3.4.  The organic (colored solution) and aqueous phases (colorless solution) 
forming plugs at the Y-junction (A).  The phases mix upon reaching the packed bed, 
leading to a coalescence of drops at the outlet of the microchannel (B). 
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Preliminary reactions were performed using benzyl alcohol as the test substrate 
in order to establish the optimal flow conditions (Scheme 3.3).  A solution of benzyl 
alcohol in CH2Cl2 (0.2 M), an aqueous NaOCl solution (0.25 M, adjusted to pH 9.1 
using NaHCO3), and an aqueous KBr solution (0.5 M) were prepared.  The organic 
phase was loaded into one syringe and a mixture of NaOCl and KBr (30 µL KBr 
solution per mL NaOCl solution) was added to another.  The syringes were placed on 
separate syringe pumps and the flow rates were regulated such that 1.0 eq alcohol min-
1, 1.5 eq NaOCl min-1, and 0.10 eq KBr min-1 were delivered to the packed bed.  
Various flow rates were examined to determine the optimal flow conditions for the 
oxidation. For data relating flow rate to residence time, see Appendix 1.  During our 
optimization studies, it was shown that a total flow rate of 100 µL min-1 (aqueous flow 
rate 56 µL min-1 and organic flow rate 44 µL min-1, approximately 4.8 minute 
residence time) afforded quantitative conversion of benzyl alcohol to benzaldehyde, 
indicating that efficient mixing was occurring in the column at this flow rate.  Faster 
flow rates (200 or 400 µL min-1) could also be used to obtain higher outputs of 
benzaldehyde, however these reaction conditions did not provide complete conversion 
of starting material. 
 
OH O
AO-TEMPO
NaOCl, KBr
H2O/CH2Cl2, 0 
oC  
 
Scheme 3.3.  The AO-TEMPO-catalyzed oxidation of benzyl alcohol. 
 
Using these optimized flow conditions for the benzyl alcohol oxidation, a 
number of different substrates were examined to test the generality of the AO-TEMPO 
packed-bed microreactor.  High conversions were achieved when using both aromatic 
and aliphatic alcohols (Table 3.1, Entries 1-6).  Secondary alcohols, which are known 
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to be oxidized at a slower rate than primary alcohols, could effectively be oxidized to 
ketones by increasing the equivalents of NaOCl with respect to the alcohol 
concentration (Table 3.1, Entries 7-9).  Primary alcohols were shown to be oxidized 
selectively over secondary alcohols (Table 3.1, Entry 10).  Interestingly, it was also 
demonstrated that ethyl acetate was almost as effective a solvent as methylene 
chloride, opening the possibility of making this process “green” (Table 3.1, Entry 11).  
While reactions range from modest to high yields, systems that do not perform as 
efficiently could readily be optimized to afford higher conversions and yields.  In this 
paper however, we were solely testing the generality of the method and, therefore, did 
not optimize every substrate.  Similar to our previous packed-bed systems, these AO-
TEMPO microchannels showed a high degree of recyclability, in some cases being 
used in excess of 100 trials without any apparent loss of catalytic activity.  Channels 
also maintained a high activity after three months of not being used. 
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Table 3.1. Oxidation of alcohols using AO-TEMPO packed-bed microreactor. 
 
Method A, B or C R R'
O
R R'
OH AO-TEMPO Packed-Bed
 
 
Entry Alcohol Method Product Conversione Yielde 
1 OH
 
Aa O
 
>99% 95% 
2 OH
Cl  
A O
Cl  
>99% 93% (86%)f 
3 
OH
 A 
O
 88% 85% 
4 OH
 
A O
 
89% 86% 
5 
OH
 
A 
O
 
88% 71% 
6 OH
 
A O
 
80% 74% 
7 
OH
 
Bb 
O
 
>99% 95% 
8 
OH
 
B 
O
 
95% 84% 
9 
OH
 
B 
O
 
89% 85% 
10 
OH
OH
 
1:1 mixture 
Cc OO
 
79%/16% 71%/11% 
11 OH
 
Ad O
 
84% 81% 
a  Method A: Organic Phase - Alcohol (0.2 M) in CH2Cl2 or EtOAc set to 44 µL min-1 
(8.8 µmol alcohol min-1, 1.0 eq min-1).  Aqueous Phase - Aqueous NaOCl (0.25 M), 
adjusted to pH 9.1 with NaHCO3, mixed with aqueous KBr (0.5 M, 30 µL per mL 
NaOCl) set to 56 µL min-1 (1.5 eq NaOCl min-1, 0.10 eq KBr min-1).  The phases 
combined at a Y-junction and passed through a 60 cm channel packed with AO-
TEMPO (300 mg, 0.138 mmol TEMPO) submerged in an ice bath. 
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Table 3.1 (continued).  
 
b  Method B: Organic Phase - Alcohol (0.1 M) in CH2Cl2 set to 44 µL min-1 (4.4 µmol 
alcohol min-1, 1.0 eq min-1).  Aqueous Phase - Aqueous NaOCl (0.25 M), adjusted to 
pH 9.1 with NaHCO3,  mixed with aqueous KBr (0.5 M, 30 µL per mL NaOCl) set 
to 56 µL min-1 (3.0 eq NaOCl min-1, 0.20 eq KBr min-1).  The phases combined at a 
Y-junction and passed through a 60 cm channel packed with AO-TEMPO (300 mg, 
0.138 mmol TEMPO) submerged in an ice bath. 
c  Method C:  Organic Phase – Benzyl alcohol (0.2 M) and 1-phenyethanol (0.2 M) in 
CH2Cl2 set to 44 µL min-1 (8.8 µmol alcohol min-1, 1.0 eq min-1).  Aqueous Phase - 
Aqueous NaOCl (0.20 M), adjusted to pH 9.1 with NaHCO3, mixed with aqueous 
KBr (0.5 M, 30 µL per mL NaOCl) set to 56 µL min-1 (1.25 eq NaOCl min-1, 0.10 eq 
KBr min-1).  The phases combined at a Y-junction and passed through a 60 cm 
channel packed with AO-TEMPO (300 mg, 0.138 mmol TEMPO) submerged in an 
ice bath. 
d  EtOAc solvent. 
e  Conversions and yields determined by GC using cyclooctane as an internal standard. 
f  Number in parentheses corresponds to isolated yield. 
 
To test the long-term activity of the AO-TEMPO packed beds, the oxidation of 
4-chlorobenzyl alcohol to 4-chlorobenzaldehyde was run continuously and sampled 
periodically to monitor its activity.  As seen in Figure 3.5, the activity of the catalyst 
bed remained high even after hours of use.  Furthermore, the work-up of this 
simplified oxidation scale-up comprised only of phase separation followed by 
concentration, yielding a white crystalline solid with greater than 95% purity by 1H 
NMR. 
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Figure 3.5.  The long-term activity of AO-TEMPO packed beds in the oxidation of 4-
chlorobenzyl alcohol. A solution of 4-chlorobenzyl alcohol (0.2 M in CH2Cl2) set to 
44 µL min-1 (8.8 µmol min-1, 1.0 eq min-1) and an aqueous solution consisting of 
NaOCl (0.25 M), adjusted to pH 9.1 with NaHCO3, and KBr (0.5 M, 30 µL per mL 
NaOCl) set to 56 µL min-1 (1.5 eq NaOCl min-1, 0.10 eq KBr min-1) were passed 
through the AO-TEMPO packed bed for nine hours.  Fractions were collected and 
analyzed by GC using an internal standard. 
 
Conclusion  
We demonstrated that using supported TEMPO is an efficient method to 
oxidize alcohols using a simplified packed-bed microreactor.  A biphasic mixture was 
thoroughly mixed by passing the immiscible liquids through the catalytic packed-bed, 
leading to no disruptions or degradation of the packing material.  Thus, the AO-
TEMPO resins are recyclable, showing no loss of catalytic activity and a substrate 
scope that encompasses many primary and secondary alcohols.  The devices presented 
are predicted to be readily scaled-up to achieve the desired output of a reaction and is 
of higher throughput than other reported packed-bed microreactors. 
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Experimental Section 
General Considerations.  Solvents were purified by standard procedures.  All other 
reagents were used as received, unless otherwise noted.  Sodium hypochlorite solution 
(reagent grade, available chlorine 10-15%) was purchased from Aldrich and titrated 
before use.  1H NMR and 13C NMR spectra were recorded in CDCl3 on Varian 
Mercury 300 MHz operating at 300.070 MHz and 75.452 MHz, respectively, using the 
residual solvent peak as reference.  ATR-IR was performed on a Nicolet Avatar DTGS 
370 infrared spectrometer with Avatar OMNI sampler and OMNIC software. 
Elemental analysis was performed by Robertson Microlit Laboratories, Inc., in 
Madison, New Jersey. Gas chromatographic (GC) analyses were performed using an 
Agilent 7890A GC equipped with an Agilent 7683B autosampler, a flame ionization 
detector (FID), and a J&W Scientific 19091J-413 column (length = 30 m, inner 
diameter = 320 µm, and film thickness = 250 µm).  The temperature program for GC 
analysis held the temperature constant at 80 ˚C for 1 minute, heated samples from 80 
to 200 ˚C at 20 ˚C/min and held at 200 ˚C for 1 minute.  Inlet and detector 
temperatures were set constant at 220 and 250 ˚C, respectively.  Cyclooctane was used 
as an internal standard to calculate reaction conversion and yield. Gas 
chromatography-mass spectrometry (GC/MS) analyses were performed using a 
Hewlett Packard HP 6890 Series Gas Chromatograph, a Hewlett Packard HP 5973 
Mass Spectrometer Detector (MSD), and a J&W Scientific DB*-5 Column (length = 
30 m, inner diameter = 0.325 mm, film thickness = 1.0 µm, catalog number 123-
5033).  The temperature program for the analyses held the temperature constant at 50 
˚C for 3 minutes, heated samples from 50 to 80 ˚C at 30 ˚C/min, holding at 80 ˚C for 2 
minutes, then heating samples from 80 to 200 ˚C at 17 ˚C/min, and holding at 200 ˚C 
for 1.94 minutes.  The MSD temperature was held at 300 ˚C for 15 minutes. 
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Channel Packing.  A 60 cm section of tubing (Swagelok PFA Tubing, 1/8” outer 
diameter) was attached to a Swagelok PFA union packed with glass wool.  A separate 
union (not packed with glass wool) was attached to the inlet side of the 60 cm column.  
Two 10 cm sections of tubing were attached to the channel, serving as the outlet. A 
1/16” female Luer was attached to the inlet.  Functionalized resin was suspended in 
CH2Cl2 and the column slurry packed using a syringe.  
 
Azide Modified AMBERZYME® Oxirane (AO-N3, 2).  Sodium azide (5.26 g, 81 
mmol, 8.1 eq.) and ammonium chloride (2.27 g, 42.4 mmol, 4.2 eq.) were dissolved in 
500 mL 90:10 v/v water in methanol. AMBERZYME® Oxirane (10.0 g, 1.0 mmol 
epoxide/g resin, 10.0 mmol, 1.0 eq.) was suspended in the azide solution and the 
reaction mixture refluxed overnight with gentle stirring.  The resin was filtered using a 
Buchner funnel, washed with deionized H2O (2x 50 mL), MeOH (2x 50 mL), Et2O (1x 
25 mL), and dried under vacuum.  Elemental analysis afforded a loading of 1.0 mmol 
N3/g resin. 
 
Propargyl Ether TEMPO (5). Sodium hydride (150 mg, 6.3 mmol, 1.1 eq) was 
added to DMF (10 mL) and stirred at RT.  4-hydroxy-TEMPO (1.02 g, 5.9 mmol, 1.0 
eq) in DMF (10 mL) was added drop wise to the sodium hydride suspension at 0 ˚C 
and stirred until gas evolution ceased. Propargyl bromide (80% in toluene, 800 µL, 7.4 
mmol, 1.3 eq) in DMF (10 mL) was added at 0 ˚C and the reaction was allowed to 
warm up to RT and stirred overnight. The reaction was quenched with water and the 
aqueous phase was extracted with ethyl acetate (3x 50 mL) and the combined organic 
extracts dried over MgSO4, concentrated and dried under vacuum.  The product was 
purified using column chromatography (silica gel, 1:1  1:2 hexanes/ethyl acetate, Rf 
= 0.40) to yield a dark orange solid (841 mg, 68%).  13C NMR (75 MHz, CDCl3): δ 
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20.619, 32.199, 44.530, 55.298, 59.198, 69.905, 74.238; EM m/z 210 (M+).  To obtain 
NMR spectra, a few drops of phenylhydrazine were added to the NMR tube to reduce 
the product to the corresponding hydroxyl amine. 
 
AO-TEMPO (6).  5 (450 mg, 2.14 mmol, 1.3 eq) and CuI (40 mg, 0.2 mmol, 0.13 eq) 
were dissolved in anhydrous THF (20 mL).  2 (1.64 g, 1.0 mmol N3/g resin, 1.64 
mmol, 1.0 eq) was added to the solution and placed under a N2 atmosphere.  The 
suspension was shaken for 3 days.  The resin was washed with THF (2x 10 mL), 
MeOH (1x 10 mL), 1 M HCl (2x 10 mL), deionized H2O (1x 10 mL), sat. NaHCO3 
(2x 10 mL), deionized H2O (1x 10 mL), MeOH (1x 10 mL) and CH2Cl2 (1x 10 mL), 
and dried under vacuum to yield the white AO-TEMPO resin (1.81 g, 0.46 mmol 
TEMPO/g resin).  The loading was calculated by mass difference. 
 
Representative Primary Alcohol Flow Oxidation Procedure. Benzyl alcohol (0.2 
M) and cyclooctane (0.02 M) in CH2Cl2 or EtOAc was placed in a syringe and placed 
on a syringe pump set to 44 µL min-1 (8.8 µmol alcohol min-1, 1.0 eq min-1). Aqueous 
NaOCl (purchased from Sigma Aldrich and diluted to 0.25 M), adjusted to pH 9.1 
with NaHCO3, mixed with aqueous KBr (0.5 M, 30 µL per mL NaOCl) were placed in 
a separate syringe and placed on another syringe pump set to 56 µL min-1 (1.5 eq 
NaOCl min-1, 0.10 eq KBr min-1).  The phases combined at a Y-junction and passed 
through a 60 cm channel packed with AO-TEMPO (300 mg) submerged in an ice 
bath.  The reaction mixture was collected in a 4 mL screw cap vial until the sample 
had eluted through the channel.  Upon completion of each experiment, the organic 
phase was separated from the aqueous phase using a pipette and transferred to a 
separate 4 mL screw cap vial.  After each trial, the channel was washed with 5 mL 
deionized H2O, 5 mL MeOH, and 5 mL CH2Cl2.  The column was flushed with air 
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prior to each run.  Samples were analyzed by GC and conversions and yields obtained 
by comparing starting material and product to an internal standard. 
 
Representative Secondary Alcohol Flow Oxidation Procedure. 1-phenylethanol 
(0.1 M) and cyclooctane (0.01 M) in CH2Cl2 was placed in a syringe and placed on a 
syringe pump set to 44 µL min-1 (4.4 µmol alcohol min-1, 1.0 eq min-1). Aqueous 
NaOCl (purchased from Sigma Aldrich and diluted to 0.25 M), adjusted to pH 9.1 
with NaHCO3, mixed with aqueous KBr (0.5 M, 30 µL per mL NaOCl) were placed in 
a separate syringe and placed on another syringe pump set to 56 µL min-1 (3.0 eq 
NaOCl min-1, 0.20 eq KBr min-1).  The phases combined at a Y-junction and passed 
through a 60 cm channel packed with AO-TEMPO (300 mg) submerged in an ice 
bath.  The reaction mixture was collected in a 4 mL screw cap vial until the sample 
had eluted through the channel.  Upon completion of each experiment, the organic 
phase was separated from the aqueous phase using a pipette and transferred to a 
separate 4 mL screw cap vial.  After each trial, the channel was washed with 5 mL 
deionized H2O, 5 mL MeOH, and 5 mL CH2Cl2.  The column was flushed with air 
prior to each run.  Samples were analyzed by GC and conversions and yields obtained 
by comparing starting material and product to an internal standard. 
 
4-Chlorobenzyl Alcohol Flow Oxidation Isolated Yield. 4-Chlorobenzyl alcohol 
(0.2 M) and cyclooctane (0.02 M) in CH2Cl2 was placed in a syringe and placed on a 
syringe pump set to 44 µL min-1 (8.8 µmol alcohol min-1, 1.0 eq min-1). Aqueous 
NaOCl (purchased from Sigma Aldrich and diluted to 0.25 M), adjusted to pH 9.1 
with NaHCO3, mixed with aqueous KBr (0.5 M, 30 µL per mL NaOCl) were placed in 
a separate syringe and placed on another syringe pump set to 56 µL min-1 (1.5 eq 
NaOCl min-1, 0.10 eq KBr min-1).  The phases combined at a Y-junction and passed 
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through a 60 cm channel packed with AO-TEMPO (300 mg) submerged in an ice 
bath.  The reaction was collected in a vial and 60 minutes, whereupon the reaction was 
transferred to a separatory funnel and phase separated.  The organic layer was 
concentrated and dried under vacuum to yield a white, crystalline material (64 mg, 
86% yield). 
 
Bleach Titration.  Sodium hypochlorite solution (Sigma Aldrich, reagent grade, 500 
µL) was diluted to 100 mL with deionized H2O in an Erlenmeyer flask equipped with 
a stir bar.  Excess KI and excess H2SO4 (conc.) were added to the flask, yielding a dark 
burgundy solution.  Sodium thiosulfate pentahydrate (1.0 M in deionized H2O) was 
added drop wise to the flask until the color of the solution dissipated (the equivalence 
point).  The concentration of NaOCl in the solution was calculated using Equation 3.1, 
Equation 3.2, and Equation 3.3. 
 
 
                       ClO
- + 2 H+ + 2 I- Cl- + I2 + H2O                       (Equation 3.1) 
 
                           I2 + 2 S2O3
2- 2 I- + S4O6
2-
                             (Equation 3.2) 
 
                           
! 
M NaOCl =  
0.5 x mmol Na2S2O3
0.5 mL NaOCl solution                          (Equation 3.3) 
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CHAPTER 4 
The Use of Copper Flow Reactor Technology for the Continuous Synthesis of 1,4-
Disubstituted 1,2,3-Triazoles 
 
Preface 
In the summer of 2008, I was granted the opportunity to explore the use of 
click chemistry in medicinal chemistry, using a prototype flow reactor at Pfizer La 
Jolla.  A one-pot click reaction was utilized that permitted a large number of organic 
azides to be generated in situ and tethered to acetylene-modified drug head pieces.  A 
proof of concept triazole library was also developed in order to publish the new 
methodology towards flow discovery. 
 
Abstract* 
A library of 1,4-disubstituted 1,2,3-triazoles was synthesized using a copper 
flow reactor.  Organic azides, generated in situ from alkyl halides and sodium azide, 
were reacted with acetylenes using the copper-catalyzed Huisgen 1,3-dipolar 
cycloaddition. This process eliminates both the handling of organic azides and the 
need for additional copper catalyst and permits the facile preparation of numerous 
triazoles in a continuous flow process. 
 
 
 
                                                
* Reproduced in part with permission from: Bogdan, A. R.; Sach, N. W. The Use of 
Copper Flow Reactor Technology for the Continuous Synthesis of 1,4-Disubstituted 
1,2,3-Triazoles.  Adv. Synth. Catal. 2009, 351, 849-854. Copyright 2009 Wiley-VCH 
Verlag GmbH & Co. KGaA. 
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Introduction 
The click reaction between organic azides and acetylenes has gained a 
considerable amount of attention since its discovery in 2001.1-7 The resulting 1,2,3-
triazoles are an interesting class of heterocycles, as they have found use in many 
biological applications, antifungal agents, as well as dyes.8-12 Chemists are attracted to 
click chemistry in drug discovery due to its high dependability, its use in 
combinatorial chemistry, and its compatibility with biological systems.13-15  
 A high percentage of pharmaceutical agents contain either a triazole or 
tetrazole heterocycle (see Diovan, Atacand, Virazole, and Maraviroc, for examples).  
Similar to the heterocycles within these drugs, 1,2,3-triazoles are also of great interest 
due to the biological activity they possess.13  It is therefore conceivable that 
derivatives of these drugs could be synthesized using click chemistry (Figure 4.1). By 
modifying drug headpieces with an acetylene, derivatives of these drugs could 
subsequently be synthesized by varying the organic azide that is used in the reaction. 
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Figure 4.1.  Drug derivative synthesis using click chemistry.   
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Whilst acetylenes can be readily prepared using high-yielding methodologies 
such as the Sonogashira coupling, azide preparation is more problematic. Azides are a 
class of compounds known to readily decompose16 and as such their preparation and 
isolation must be handled with care, particularly on scale.  
Eliminating the need to isolate azides would be a significant advantage and 
while reports have shown that alkyl azides can be generated in situ prior to the copper-
catalyzed cycloaddition, these methodologies have either been slow or relied on 
microwave technology.17-20  
Flow chemistry is an important, emerging field that pushes the boundaries of 
organic synthesis by accessing so-called ‘forbidden chemistries’ through unparalleled 
reaction control.21-29 The numerous advantages of running reactions in flow are often 
attributed to the large surface area-to-volume ratios.23  Small dimensions lead to good 
mixing30-34 and the superb heat transfer within these systems enables excellent control 
of exotherms, limiting the impact of runaway reactions.22 Back-pressure regulation 
technology enables solvent boiling suppression and reaction kinetics can be 
substantially increased.35 In addition, scale-up becomes a facile process compared 
with batch systems and output is measured as a function of time rather than batch 
size.36-38 
 
Results and Discussion 
Realizing the benefits of flow chemistry we sought to explore a one-pot click 
methodology (Scheme 1 and Figure 4.2).  Organic azides could be generated in small 
volumes from their corresponding alkyl halides at high temperatures and immediately 
reacted with acetylenes. By adopting this approach we hoped to overcome the safety 
and supply issues of azides and dramatically increase the monomers available to us, 
enabling a greater number of triazoles to be synthesized. 
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Scheme 4.1. The one-pot click reaction. 
 
 
 
Figure 4.2.  The catalytic cycle of the click reaction. 
 
We report herein the rapid synthesis of a 1,4-disubstituted 1,2,3-triazole library 
in a flow reactor using this one-pot click methodology.  A copper flow reactor has 
been developed to catalyze the reaction, enabling triazoles to be synthesized from 
simple starting materials without the need for additional catalyst. The facile scale-up 
of one triazole is also demonstrated, and the application of this technology to drug 
discovery is discussed. 
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The Conjure Flow Reactor (Figure 4.3) was designed to operate on a scale 
suitable for both medicinal chemistry and process research. The instrument adopts a 
segmented flow approach versus a continuous stream approach in order to minimize 
material consumption and limit reaction size.  Reaction segments are separated by an 
immiscible fluorous spacer, perfluoromethyldecalin, that prevents segment diffusion 
and reaction trailing.39-46 Using this approach, multiple segments can flow through the 
reactor at any one time, maximizing the system’s efficiency and permitting rapid 
library development (medicinal chemistry) or reaction optimization (process research). 
 
 
 
Figure 4.3.  Conjure Flow Reactor schematic. 
 
The reactor diskette consists of a reaction coil made of copper, Hastelloy or 
PTFE tubing placed between two copper plates (Figure 4.4).  Multiple segments can 
be passed through the system sequentially since the internal volume of the reactor 
diskette ranges from 2-10 mL and reaction segments are on the order of 400 µL.  
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Figure 4.4. a) A reactor diskette with the top copper plate removed, exposing the 
copper tubing within (0.75 mm i.d.).  b) An assembled reactor diskette for the flow 
reactor (145 mm x 165 mm x 5 mm). 
 
Heterogeneous catalysis has been used extensively in flow systems and is 
highly recyclable and selective.47-51 Because even Cu(0) sources such as copper wire2 
and copper metal turnings17 are effective catalysts for the click reaction, we used a 
reactor diskette prepared from copper.  We envisioned that no additional copper 
catalyst would be necessary, removing a level of complexity from the system.  Indeed, 
when reaction segments containing sodium azide, an alkyl halide, and acetylene in 
DMF were passed through the copper flow reactor, high conversions were obtained 
within 5 minutes.   
 Depending on the solvent used for this reaction, the rate of copper leaching 
from the reactor diskette greatly varied.  When EtOH was used as the reaction solvent 
at 150 ˚C, elemental analysis showed a copper concentration of 78 ppm.  However, as 
EtOH proved to be a poor solvent for the triazole products, precipitation ultimately 
blocked the channels.  When DMF was chosen as the reaction solvent, elemental 
analysis showed a copper concentration of ~300 ppm.  The addition of QuadraPure 
TU scavenging resin reduced the copper concentration to <5 ppm, effectively 
removing all copper from the system. 
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 Replacing the copper reactor with a Hastelloy reactor diskette prohibited the 
reaction, supporting the necessity of the copper and proving the triazole formation was 
not occurring under thermal conditions.52 The copper reactor was used to catalyze 
hundreds of reactions, never showing a loss of catalytic activity53 and was also shown 
to effectively catalyze other copper-mediated reactions such as the Sonogashira and 
Ullman couplings. 
 
N
NN
NaN3, DMF
150 °C OH
Br
OH
Copper Tubing
71% yield5 minutes  
 
Scheme 4.2.  The optimized one-pot click reaction using 4-ethynyltoluene and 2-
bromoethanol. 
 
We optimized the one-pot click methodology using 4-ethynyltoluene, 2-
bromoethanol and sodium azide in DMF (Scheme 4.2).54  By varying the residence 
time, reactor temperature, and equivalents of alkyl azide, we were able to rapidly 
obtain optimal reaction conditions using minimal amounts of material.55 By linking 
the instrument’s analytical output to DOE software such as Design Expert®, reports 
are generated after the optimization, dictating the optimal reaction conditions for this 
transformation. 
DOE is a common method used to optimize reaction conditions using a 
planned variation of parameters.  Experiments were designed by choosing three 
variables (residence time, reactor temperature, and equivalents of alkyl azide), and 
setting high and low values for each (Table 4.1).  In all, sixteen total experiments were 
performed while running the DOE.  It should also be noted, that each of these 
reactions had a total reaction volume of 400 µL and required no chemical handling. 
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Table 4.1.  Boundary conditions for DOE optimization. 
 
Variable Low High 
Residence Time 5 min 15 min 
Reactor Temperature 100 ˚C 175 ˚C 
Alkyl Azide Eq. 1.0 2.0 
 
Figure 4.5 depicts the correlation between alkyl azide equivalents and 
residence time when the reactor temperature is held constant at 100 ˚C.  It can be 
determined from these data that low temperatures are unfavorable conditions for the 
one-pot click reaction as conversion of greater than 20% are not obtained.  The azide 
displacement of the alkyl halide is most likely not occurring at lower temperatures, 
thereby inhibiting the formation of the 1,4-disubstituted triazoles. 
 
 
 
Figure 4.5. Contour plot for the one-pot click reaction at 100 ˚C. 
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Figure 4.6. Contour plot for the one-pot click reaction with a 5-minute residence time. 
  
 The relationship between alkyl azide equivalents and reactor temperature, with 
the residence time being held constant at 5 minutes, is illustrated in Figure 4.6.  At low 
temperature and 1 equivalent alkyl azide, it can be seen that there is essentially no 
reaction.  As the temperature increases, however, conversions between 45-60% are 
obtained, with higher conversions at higher alkyl azide equivalents.   
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Figure 4.7. Contour plot for the one-pot click reaction using 2.0 eq alkyl azide. 
 
Understanding that excess alkyl azide (2 equivalents) was favorable in this 
one-pot click reaction, the relationship between residence time and reactor temperature 
was explored to determine the optimal reaction conditions.  As can be seen in Figure 
4.7, there is a dramatic increase in conversion with increases in temperature.  
However, there is a very subtle dependence of conversion and residence time.  While a 
15 minute residence time did provide slightly higher conversion, we chose optimal 
reaction conditions in terms of product output, as opposed to yield, and settled on a 5 
minute residence time.  Furthermore, after running a few test substrates, a reactor 
temperature of 150 ˚C was chosen as there appeared to be no significant changes in 
yield.  This lower temperature also made reagents less susceptible to thermal 
degradation.   
 
  71 
I
Cl
Br
OH
N
H
O
Cl
N Cl
Cl
N
N
O
O
O
O
O
Br
Alkyl Halides
Terminal Acetylenes
 
 
Figure 4.8.  Alkyl halides and terminal acetylenes used for the triazole library. 
Using these conditions, a library was prepared combining six different 
acetylenes, six different alkyl halides, and sodium azide (Figure 4.8).  It should be 
noted that the preparation of six acetylene source vials (0.25 M in DMF), six alkyl 
halide source vials (0.5 M in DMF) and a sodium azide source vial (0.5 M in 
DMF/H2O 4:1 v/v) was the only chemical handling necessary to run the library 
synthesis.  Using the optimized conditions for the flow click methodology, thirty 
triazoles were synthesized in a matter of hours in modest to excellent yield (Figure 
4.9).  LC traces of reaction segments were very clean, showing the presence of 
products, unreacted acetylene starting materials, as well as trace amounts of the free 
triazole (formed from the reaction of the terminal acetylene with sodium azide).  For 
reactions resulting in low yields, an optimization could be carried out in order to 
increase the yield.  In this proof of concept work, the optimization conditions from the 
DOE between 4-ethynyltoluene and 2-bromoethanol were the only conditions used.  
The click methodology worked for aliphatic and aromatic acetylenes, as well as 
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primary and secondary alkyl halides.  Low molecular weight azides such as 
azidoethane and 3-azidooxetane were also used safely in the Conjure Flow Reactor. 
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1, 72 % 2, 28 % 3, 72 % 4, 43% 5, 61% 6, 50%
7, 70 % 8, 40 % 9, 60 % 10, 72 % 11, 88 % 12, 46 %
18, 51 % 19, 72 % 20, 92 %
21, 26 % 22, 63 % 23, 77 %
13, 30 % 14, 76 % 15, 39 % 16, 63 % 17, 60 %
28, 58 % 29, 65 % 30, 50 %
24, 50 % 25, 32 % 26, 21% 27, 47 %
 
 
Figure 4.9.  The 1,4-disubstituted 1,2,3-triazole synthesized using the Conjure Flow 
Reactor.  Yields determined by 1H NMR using an internal standard. 
 
 
The batch scale up of processes involving energetic intermediates such as 
organic azides can be dangerous as high concentrations can accumulate, thus creating 
an explosion hazard. Such reactions can require extensive process safety investigation 
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and costly custom engineered facilities. In flow this danger is significantly reduced as 
scale-up is a function of time and flow rate and the volume of active chemistry 
remains small. Through this principle, processes developed using flow technology on 
a small scale can subsequently be used to prepare larger scale batches as compounds 
move through development, minimizing process development and capital equipment 
costs. 
To demonstrate the preparative capability of the Conjure Flow Reactor, the 
click reaction between 4-ethynyltoluene and N-ethyl chloroacetamide was scaled-up 
(Table 4.2). The stoichiometry was adjusted such that only 1 equivalent of alkyl azide 
was generated, thus limiting excess azide (either organic or inorganic) in the output 
stream. After 12 minutes, 115 mg (60%) of triazole 5 was isolated after the simple 
work-up of aqueous precipitation and filtration.  If run continuously, this output 
extrapolates to generating 575 mg of product per hour, or 13.8 g of product per day 
(Table 4.2). 
 
Table 4.2. Triazole synthesis scale-up. 
 
N
NN
O
NHN
H
O
Cl
NaN3, DMF
150 °C
Copper Tubing
200 uL min-1 5  
 
 
Time Triazole Output 
12 minutes 115 mga 
1 hour 575 mg 
1 day 13.8 g 
      a isolated yield 
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Conclusion 
In summary, we have developed a one-pot click reaction using a copper flow 
reactor that permits in situ generation of organic azides and facile preparation of 
triazole libraries.  The use of a custom engineered copper reactor serves as the catalyst 
to facilitate the cycloaddition. Reactions are readily scaled up with fewer safety 
concerns than the corresponding batch processes. The high-throughput, automated 
nature of the instrument greatly adds to the appeal of this process and this technology 
is currently being employed in the drug discovery process to rapidly synthesize vast 
numbers of compounds towards flow discovery.39 
 
Experimental Section 
General Considerations.  All reagents and solvents were used as received.  1H NMR 
analysis was carried out using a Capillary NMR probe (Protasis MRM Division, 
Savoy, IL) on a Varian Inova spectrometer with a Larmor frequency of 499.667 MHz.  
The Capillary NMR probe consisted of a 5 µL flow cell (active volume 2.5 µL) 
double-tuned to 1H and 13C with a deuterium lock channel and z-gradient (Protasis 
MRM Division, Savoy, IL).  The spectrometer was equipped with a CTC HTC-PAL 
autosampler (Leap Technologies, Carrboro, NC).  Samples were prepared using d6-
DMSO spiked with the internal standard 2,5-dimethylfuran.  Peaks were referenced to 
2,5-dimethylfuran (5.8 ppm for 1H).  LC/MS analyses were carried out using an 
Agilent Technologies HPLC (Agilent Technologies 1200 Series diode array detector, 
Agilent Technologies 1200 Series column heater, Agilent 1100 Series fraction 
collector, Agilent 1100 Series pump, and Agilent 1100 Series degasser) interfaced 
with an Agilent Technologies 6120 Quadrupole LC/MS.  Elemental analysis was 
carried out by QTI Analytical. 
 
  75 
LC/MS Analysis.  HPLC analyses was performed using a water (formic acid 0.1% 
w/v / ammonium formate 0.05% w/v) and MeCN (water 5% v/v, formic acid 0.1% 
v/v, ammonium formate 0.05% w/v) based gradient from 0-100% MeCN over 4 
minutes. An Agilent ZORBAX SB-C18 1.8 um (4.6 x 50 mm) column was used at 80 
˚C with a flow rate of 3 mL min-1.  Injections (0.5 µL) were made directly from 
diluted reaction mixtures and ionization monitored in positive mode. 
 
Typical Experimental Procedure for Triazole Library Synthesis.   4-
ethynyltoluene (133.3 µL, 0.25 M in DMF, 0.033 mmol, 1.0 eq), ethyl iodide (133.3 
µL, 0.5 M in DMF, 0.066 mmol, 2.0 eq), and NaN3 (133.3 µL, 0.5 M in DMF/H2O 
4:1 v/v, 0.066 mmol, 2.0 eq) were aspirated from their respective source vials, mixed 
through a PFA mixing tube (0.2 mm i. d.), loaded into an injection loop and injected 
into the flow reactor set at 150 ˚C at a rate of 400 µL min-1 (5 minute residence time).  
Reaction segments were collected in a 96-well plate containing QuadraPure TU 
copper-scavenging resin.  Segments were filtered, concentrated, and analyzed using 
1H NMR. 
 
Experimental Procedure for Scaled-Up Triazole Synthesis.  4-ethynyltoluene 
(133.3 µL, 1.0 M in DMF, 0.1333 mmol, 1.0 eq), N-ethyl chloroacetamide (133.3 µL, 
1.0 M in DMF, 0.1333 mmol, 1.0 eq), and NaN3 (133.3 µL, 1.0 M in DMF/H2O 4:1 
v/v, 0.1333 mmol, 1.0 eq) were aspirated from their respective source vials, mixed 
through a PFA mixing tube (0.2 mm i. d.), and loaded into an injection loop. Six 
reaction segments were injected into the flow reactor set at 150 ˚C, passed through the 
reactor at 200 µL min-1 (10 minute residence time) and collected in a reaction vial 
containing heptane and water.  The yellow precipitate was collected by filtration, 
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washed with water (2x), heptane (2x) and dried under vacuum to yield triazole 5 (115 
mg, 60% yield). 
 
Triazole Library Characterization Data. 
 
N
NN
 
 
1: m/z = 188.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.40 (s, 1H), 7.62 (d, 2H), 
7.17 (d, 2H), 4.31 (q, 2H), 2.23 (s, 3H), 1.39 (t, 3H).  
 
N
NN
 
 
2: m/z = 216.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.46 (s, 1H), 7.65 (d, 2H), 
7.16 (d, 2H), 4.53 (m, 1H), 2.24 (s, 1H), 1.42 (d, 3H), 0.69 (t, 3H).  
 
N
NN OH
 
 
3: m/z = 204.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.35 (s, 1H), 7.63 (d, 2H), 
7.17 (d, 2H), 4.34 (t, 2H), 3.74 (m, 2H), 3.48 (m, 1H), 2.24 (s, 3H). 
 
N
NN
O
 
 
4: m/z = 216.15 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.69 (s, 1H), 7.66 (d, 2H),  
7.17 (d, 2H), 5.77 (m, 1H), 4.96 (t, 2H), 4.86 (t, 2H), 2.24 (s, 3H). 
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N
NN N
H
O
 
 
5: m/z = 245.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.24 (s, 1H), 8.22 (bs, 
1H), 7.64 (d, 2H), 7,16 (d, 2H), 4.99 (s, 2H), 2.24 (s, 3H), 0.94 (t, 3H).  A solvent 
suppression pulse sequence also suppressed the –NCH2CH3 protons (predicted 3.11 
ppm). 
 
N
NN
N
Cl  
 
6: m/z = 285.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.49 (s, 1H), 8.34 (s, 1H), 
7.78 (d, 1H), 7.62 (d, 2H), 7.48 (d, 1H), 7.16 (d, 2H), 5.61 (s, 2H), 2.23 (s, 3H). 
 
N
N
NN
 
 
7: m/z = 175.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.51 (m, 2H), 7,86 (m, 
1H), 7.79 (m, 1H), 7.22 (m, 1H), 4.36 (q, 2H), 1.40 (t, 3H). 
 
N
N
NN
 
 
8: m/z = 203.15 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.56 (s, 1H), 8.50 (m, 
1H), 7.93 (d, 1H), 7.79 (t, 1H), 7.24 (m, 1H), 4.62 (m, 1H), 1.80 (m, 2H), 1.44 (d, 3H), 
0.68 (t, 3H). 
 
N
N
NN OH
 
 
9: m/z = 191.15 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.50 (m, 1H), 8.44 (s, 
1H), 7.93 (d, 1H), 7.79 (t, 1H), 7.24 (t, 1H), 4.39 (t, 2H), 3.75 (m, 2H), 3.52 (bs, 1H). 
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N
N
NN
O
 
 
10: m/z = 203.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.72 (s, 1H), 8.52 (m, 
1H), 7.96 (d, 1H), 7.81 (t, 1H), 7.27 (m, 1H), 5.82 (m, 1H), 4.95 (m, 2H), 4.90 (m, 
2H). 
 
N
N
NN N
H
O
 
 
11: m/z = 232.15 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.52 (m, 1H), 8.42 (s, 
1H), 8.23 (bs, 1H), 7.93 (d, 1H), 7.80 (t, 1H), 7.25 (m, 1H), 5.05 (s, 2H), 0.976 (t, 3H). 
A solvent suppression pulse sequence also suppressed the –NCH2CH3 protons 
(predicted 3.11 ppm). 
 
N
N
NN
N
Cl  
 
12: m/z = 272.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.64 (s, 1H), 8.43 (s, 
1H), 8.34 (s, 1H), 7.82 (s, 1H), 7.78 (t, 2H), 7.46 (t, 1H), 7.26 (bs, 1H), 5.66 (s, 2H). 
 
N
NN
 
 
13: m/z = 202.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 7.70 (s, 1H), 7.16 (m, 
5H), 4.21 (q, 2H), 1.30 (t, 3H). A solvent suppression pulse sequence also suppressed 
the Ar-CH2CH2- protons (predicted 2.9 and 3.1 ppm). 
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N
NN OH
 
 
14: m/z = 218.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 7.67 (s, 1H), 7.15 (m, 
5H0, 4.87 (t, 2H), 3.49 (m, 2H). A solvent suppression pulse sequence also suppressed 
the Ar-CH2CH2- protons (predicted 2.9 and 3.1 ppm). 
 
N
NN
O
 
 
15: m/z = 230.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 7.86 (s, 1H), 7.15 (m, 
5H), 5.68 (m, 1H), 4.90 (t, 2H), 4.76 (t, 2H). A solvent suppression pulse sequence 
also suppressed the Ar-CH2CH2- protons (predicted 2.9 and 3.1 ppm). 
 
N
NN N
H
O
 
 
16: m/z = 259.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.14 (bs, 1H), 7.66 (s, 
1H), 7.16 (m, 5H), 4.89 (s, 2H), 0.96 (t, 3H). A solvent suppression pulse sequence 
also suppressed the Ar-CH2CH2- protons (predicted 2.9 and 3.1 ppm) and the –
NCH2CH3 protons (predicted 3.11 ppm). 
 
N
NN
N
Cl  
 
17: m/z = 299.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.34 (s, 1H), 7.82 (m, 
1H), 7.67 (s, 1H), 7.09 (m, 5H), 5.59 (s, 2H). A solvent suppression pulse sequence 
also suppressed the Ar-CH2CH2- protons (predicted 2.9 and 3.1 ppm). 
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NN
 
 
18: m/z = 232.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.79 (s, 1H), 8.17 (s, 
1H), 7.78 (d, 2H), 7.14 (d, 2H), 5.18 (s, 2H), 4.30 (q, 2H), 1.35 (t, 3H). 
 
O
O
N
NN
 
 
19: m/z = 260.20 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.80 (s, 1H), 8.22 (s, 
1H), 7.79 (d, 2H), 7.14 (d, 2H), 5.18 (s, 2H), 3.23 (m, 1H), 1.72 (m, 2H), 1.40 (d, 3H), 
0.68 (t, 3H). 
 
O
O
N
NN OH
 
 
20: m/z = 248.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.79 (s, 1H), 8.12 (s, 
1H), 7.80 (d, 2H), 7.15 (d, 2H), 5.19 (s, 2H), 4.33 (t, 2H), 3.69 (q, 2H). 
 
O
O
N
NN
O
 
 
21: m/z = 260.15 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.79 (s, 1H), 9.41 (s, 
1H), 7.78 (d, 2H), 7.15 (d, 2H), 5.76 (m, 1H), 4,93 (t, 2H), 4.82 (t, 2H). 
 
O
O
N
NN N
H
O
 
 
22: m/z = 289.15 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.79 (s, 1H), 8.22 (bs, 
1H), 8.12 (s, 1H), 7.78 (d, 2H), 7.15 (d, 2H), 5.20 (s, 2H), 4.97 (s, 2H), 0.94 (t, 3H). A 
solvent suppression pulse sequence also suppressed the –NCH2CH3 protons (predicted 
3.11 ppm). 
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23: m/z = 329.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.79 (s, 1H), 8.36 (s, 
1H), 8.28 (s, 1H), 7.79 (d, 2H), 7.46 (t, 2H), 7.14 (d, 2H), 5.60 (s, 2H), 5.19 (s, 2H). 
 
O
O
N
NN
 
 
24: m/z = 242.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.77 (s, 1H), 8.37 (s, 
1H), 8.23 (d, 1H), 8.17 (d, 1H), 7.65 (d, 1H0, 6.64 (d, 1H), 4.35 (q, 2H), 1.42 (t, 3H). 
 
O
O
N
NN OH
 
 
25: m/z = 258.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.62 (s, 1H), 8.38 (s, 
1H), 8.21 (d, 1H), 8.19 (d, 1H), 7.66 (d, 1H), 6.31 (d, 1H), 4.37 (t, 2H), 3.77 (q, 2H). 
 
O
O
N
NN
O
 
 
26: m/z = 270.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.98 (s, 1H), 8.42 (s, 
1H), 8.22 (m, 2H), 7.67 (d, 2H), 6.29 (d, 2H), 5.79 (m, 1H), 4.98 (t, 2H), 4.88 (t, 2H). 
 
O
O
N
NN N
H
O
 
 
27: m/z = 299.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 8.60 (s, 1H), 8.39 (s, 
1H), 8.20 (m, 2H), 7.96 (d, 2H0, 6.28 (d, 1H), 5.03 (s, 2H), 0.95 (t, 3H).  A solvent 
suppression pulse sequence also suppressed the –NCH2CH3 protons (predicted 3.11 
ppm). 
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O
 
 
28: m/z = 253.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.26 (s, 1H), 8.89 (s, 
1H), 8.72 (s, 1H), 8.13 (d, 1H), 7.79 (t, 1H), 7.68 (t, 1H), 5.89 (m, 1H), 5.01 (t, 2H), 
4.97 (t, 2H). 
 
N
N
NN N
H
O
 
 
29: m/z = 282.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.25 (s, 1H), 8.68 (s, 
1H), 8.58 (s, 1H), 8.29 (bs, 1H), 8.12 (d, 1H), 7.78 (t, 1H), 7.68 (t, 1H), 5.12 (s, 2H), 
0.96 (t, 3H).  A solvent suppression pulse sequence also suppressed the –NCH2CH3 
protons (predicted 3.11 ppm). 
 
N
N
NN
N
Cl  
 
30: m/z = 322.10 [M+H]+. 1H NMR (500 MHz, d6-DMSO) δ 9.24 (s, 1H), 8.75 (s, 
1H), 8.68 (s, 1H), 8.48 (s, 1H), 8.34 (s, 1H), 8.12 (d, 1H), 7.85 (m, 1H), 7.78 (t, 1H), 
7.47 (t, 2H), 5.73 (s, 2H). 
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CHAPTER 5 
The Flow Syntheses of Active Pharmaceutical Ingredients 
 
Preface* 
 In 2007, the startup company Systanix, started by my advisor and former 
McQuade group member Dr. Steven Broadwater, began a nine-month collaboration 
with the engineering firm Foster Miller, Inc.  The goal was to develop common 
synthetic pathways for various active pharmaceutical ingredients (APIs), demonstrate 
these syntheses using traditional batch chemistry, and subsequently transition these 
syntheses into flow reactors.  Sarah Poe, Daniel Kubis and I were hired by Systanix as 
consultants to develop these syntheses and carry them out in flow.  By the time the 
project ended in August of 2007, great progress was made with regards to performing 
these reactions in flow, however due to time constraints, some work remained 
unfinished.  This chapter highlights the batch syntheses of ibuprofen and atropine and 
demonstrates the efforts put forth to develop flow syntheses for these two APIs. 
 
Abstract 
 Syntheses for the APIs ibuprofen and atropine were developed containing 
common reaction pathways.  The syntheses were initially demonstrated in batch and 
were transitioned into flow using a simplified microreactor.  The step-wise synthesis 
of ibuprofen was successfully completed in flow, as was the synthesis of methyl ether-
protected atropine.  While some work in this project remained unfinished, it set a 
foundation for future flow syntheses performed in the group. 
 
                                                
* The author thanks Dr. Steven Broadwater, Dr. Sarah Poe, and Daniel Kubis for their 
contributions to this unpublished work. 
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Introduction 
Although traditional organic synthesis is a wildly successful enterprise, the 
pharmaceutical industry produces 25-100 kg of waste on average for every kilogram 
of product synthesized.1 With increasing oil prices and diminishing natural resources, 
more sustainable methods and technologies are needed to synthesize molecules of 
importance. The issue of sustainable chemistry has recently been gaining a significant 
amount of attention, as indicated by the new green chemistry-oriented journals and 
conferences present in the chemistry community.  Furthermore, the Obama 
Administration recently allocated $200 million for development of chemical 
methodologies and tools to promote green chemistry.  Special interest is specifically 
being paid to invoke innovation in the discovery, development, and production of 
APIs. 
Despite these initiatives aimed to develop new, cleaner syntheses, other issues 
that contribute to the waste associated with pharmaceutical synthesis such as the 
packaging, transport and storage of reagents and products, are typically neglected.2 
Funded by the Defense Advanced Research Projects Agency (DARPA), the goal of 
this project was to develop common syntheses for two APIs in flow, with the ultimate 
goal being on-demand drug production in a portable flow reactor.  By developing 
syntheses that relied on common reagents and reaction conditions, the number and 
types of materials required for synthesis and purification would be minimized.  
Furthermore, the ability for the flow reactor to synthesize APIs on-demand would 
eliminate the need for product packaging and storage.  The molecules studied in this 
project are the APIs ibuprofen (1) and atropine (2) (Figure 5.1). 
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Figure 5.1.  The structures of ibuprofen and atropine. 
 
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to alleviate 
various types of pain, fevers and mild inflammations. As of 2007, ibuprofen was one 
of the top-selling 100 generic drugs globally and was added to a list of essential 
medicines by the World Health Organization that dictates which medicines are 
necessary for providing basic health care.  The BHC Company (now BASF) won the 
1997 Presidential Green Chemistry Challenge for its synthesis of ibuprofen shown 
below in Scheme 5.1.3, 4 
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Scheme 5.1.  The BHC Company’s synthesis of ibuprofen. 
  
Atropine is an anticholinergic agent and is also considered an essential 
medicine by the World Health Organization.  While atropine is commonly extracted 
from natural sources, there are many examples of its synthesis.  One synthesis for 
atropine is shown below in Scheme 5.2 and Scheme 5.3.5-7 
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Scheme 5.2.  The synthesis of atropine. 
 
The first goal of this project was to develop syntheses for ibuprofen and 
atropine that utilized a common set of reactions.  The initial reaction design shown 
below in Scheme 5.3 relied on synthesizing a 2-phenylprop-2-enoic acid derivative (3) 
that could be converted to the final products. 
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Scheme 5.3.  The syntheses of ibuprofen and atropine utilizing 2-phenylprop-2-enoic 
acid intermediates. 
 
 After many unsuccessful attempts at the chemistry in Scheme 5.3, a new set of 
reactions was developed that greatly reduced the number of steps and relied on 2-
arylpropanoates (4) as the common intermediate (Scheme 5.4). 
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Scheme 5.4. The syntheses of ibuprofen and atropine utilizing 2-arylpropanoate 
intermediates. 
 
 This chapter begins by discussing our efforts to synthesize ibuprofen and 
atropine in batch using the reaction design shown in Scheme X.  The remainder of the 
chapter discusses translating these reactions into flow using a simplified microreactor 
platform. 
 
Results and Discussion 
 Batch Syntheses of Ibuprofen and Atropine.  A majority of the batch 
synthesis of ibuprofen was carried out by Sarah Poe and will not be discussed in great 
detail here.  The reactions performed will be highlighted, however, as this chemistry 
was ultimately translated into our flow reactor. 
 The first step of our synthesis involved the Friedel-Crafts acylation of 
isobutylbenzene using propionyl chloride and AlCl3 to afford 4-
isobutylpropiophenone (5).  The second step relied on the PhI(OAc)2-mediated 1,2-
aryl migration8-10 to give methyl ester (6), which was subsequently saponified using 
KOH.  Ibuprofen was obtained after an acidic workup with high purity and yield 
(Scheme 5.5).  
 92 
O
OH
O
1. KOH, MeOHO
O
TMOF, H2SO4
2. H+
AlCl3, CH2Cl2
Cl
O
1
5
6
PhI(OAc)2
 
 
Scheme 5.5.  The batch synthesis of ibuprofen. 
 
 Having demonstrated this successful synthesis of ibuprofen in batch, a 
synthesis of atropine was explored that relied on a somewhat similar set of reaction 
conditions.  A retrosynthetic analysis of atropine reveals a 2-phenylpropanoic ester (7) 
similar to methyl ester (6) in the ibuprofen synthesis (Scheme 5.6).  It was anticipated 
that a similar 1,2-aryl migration could be used to produce (7), starting from a 
substituted propiophenone (8). 
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Scheme 5.6.  The retrosynthetic analysis of atropine revealing a 2-phenylpropanoic 
ester. 
  
The first step of the atropine synthesis utilized a substitution reaction to yield 
3-methoxypropiophenone (8, Scheme 5.7). While the individual steps to synthesize 
ibuprofen and atropine are not identical, they do utilize common reagents in the 
chemical transformations.  This displacement, for instance, relies on the use of a 
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methanolic KOH, which was used in the saponification of methyl ester 6 in the 
ibuprofen synthesis.  
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Scheme 5.7.  The synthesis of 3-methoxypropiophenone. 
 
 The second step of the atropine synthesis used a PhI(OAc)2-mediated 1,2-aryl 
migration to yield methyl ester 7 (Scheme 5.8). 
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Scheme 5.8. The PhI(OAc)2-mediated 1,2-aryl migration of 3-methoxypropiophenone.  
  
Methyl ester 7 permitted three different plausible routes to complete the 
synthesis of atropine (Scheme 5.9).  The first (Scheme 5.9A) would use a 
transesterification using tropine, followed by a deprotection of the methyl ether.  In an 
alternative route, the saponification of methyl ester 7 would be followed by an 
esterification (Scheme 5.9B).  The final possible route relied on the saponification of 
methyl ester 7, followed by treatment with thionyl chloride to activate the carboxylic 
acid to facilitate the tropine esterification (Scheme 5.9C). 
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Scheme 5.9.  Alternative methods for the synthesis of atropine starting from methyl 
ester 7.  A) transesterification; B) esterification; C) esterification using an activated 
carboxylic acid. 
 
 After screening a variety of reaction conditions, the transesterification shown 
in Scheme 5.9A proved to be an unproductive route.  For the direct esterification route 
shown in Scheme 5.9B, a methanolic solution of KOH afforded carboxylic acid 9 in 
an 88% yield, but the subsequent esterification with tropine to give ester 10 was 
unsuccessful.  The most effective route to couple tropine with carboxylic acid 9 was 
using thionyl chloride to make the activated carboxylic acid (Scheme X C).  After 
removing excess thionyl chloride under vacuum, the acid chloride was coupled with 
tropine to form ester 10 in 52% isolated yield.  
 The final step of the atropine synthesis relied on a boron tribromide-mediated 
demethylation (Scheme 5.10). Analysis of this reaction using thin layer 
chromatography indicated that atropine was being formed under these conditions, 
however no isolated yield was obtained. It is possible that the tertiary amine in the 
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tropine moiety was slowly being methylated by the methyl bromide byproduct that is 
formed during the course of the reaction. This method is very promising and could be 
optimized if more time was available. The complete synthesis of atropine is shown 
below in Scheme 5.10. 
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Scheme 5.10.  The complete synthesis of atropine.   
 
 This synthesis of atropine is comparable to other atropine preparations in terms 
of the number of steps.  In the early 1900s, Mackenzie and Ward synthesized tropic 
acid using a five-step process starting from acetophenone (Scheme 5.11).11  The 
coupling of tropic acid with tropine is achieved using anhydrous HCl, generating 
atropine.   
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Scheme 5.11.  The synthesis of atropine using Mackenzie and Ward’s tropic acid 
synthesis. 
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 Ibuprofen Synthesis in Flow.  Having successfully synthesized both 
ibuprofen and atropine in batch, the next goal of this project was to run the reactions in 
a simplified flow reactor setup developed in our group. We have published a series of 
papers highlighting the use of simplified microreactors to organic synthesis.12-16 The 
microreactors consist of perfluoroelastomeric tubing (1.6 mm i.d.), Y-junctions and 
syringe pumps to provide reagent flow (Figure 5.2). 
 
 
 
Figure 5.2.  The flow reaction setup.  Two syringe pumps provide reagent flow to the 
reactor coil. 
 
 The first step of our ibuprofen synthesis in flow was completed using the 
Friedel-Crafts acylation previously optimized in batch (Scheme 5.12). 
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Scheme 5.12. Friedel-Crafts acylation of isobutylbenzene. 
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 To optimize this reaction in flow, we used the setup shown in Figure 5.3. 
These two fluid streams were combined at a Y-junction where they would mix before 
passing through the microchannel.  At the outlet of the reactor, the stream was 
collected in water to quench the reactions.  Reaction times were subsequently varied 
by changing the flow rates.  The optimization of the flow Friedel-Crafts acylation is 
shown in Table 5.1. 
 
 
 
Figure 5.3.  The flow Friedel-Crafts acylation setup. 
 
From Table 5.1, it can be determined that an excess of the acylating agent is 
required to achieve high conversions.  Slower flow rates, and thus longer residence 
times, are also preferred.  Initially the most success was achieved using 2 equivalents 
of both AlCl3 and propionyl chloride (Table 5.1, entries 8-10).  In particular, using a 
0.5 M stock solution of isobutylbenzene was particularly appealing as it provided 
approximately 140 mg hr-1 of 4-isobutylpropiophenone (5).  The reaction was 
optimized further by reducing the equivalents of AlCl3 and propionyl chloride by 25% 
(Table 5.1, entries 12-15).  Having determined these optimal conditions for the flow 
Friedel-Crafts acylation, the second step of the ibuprofen synthesis was optimized in 
flow. 
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Table 5.1.  Results of the flow Friedel-Crafts acylation.a 
 
O
CH2Cl2
5
Cl
O AlCl3
 
 
Entry Eq. 
AlCl3 
Eq. 
Prop. Cl 
Flow Rate 
(µL min-1) 
Residence 
Time (min) 
Conversionb 
(%) 
1 1.5 1.0 30 42.8 76 
2 1.5 1.0 40 32.1 42 
3 2.0 1.0 40 32.1 82 
4 2.0 1.5 40 32.1 86 
5 2.0 1.5 50 25.7 80 
6 2.0 1.5 80 16.0 83 
7 2.0 2.0 40 32.1 78 
8 2.0 2.0 50 25.7 94 
9 2.0 2.0 50 25.7 >99c 
10 2.0 2.0 50 25.7 >99d 
11 2.0 2.0 80 16.0 70 
12 1.5 1.5 50 25.7 98c 
13 1.5 1.5 40 32.1 97c 
14 1.5 1.5 60 21.4 98c 
15 1.5 1.5 65 19.7 97c 
a  Reactions carried out using a 0.1 M stock solution of isobutylbenzene at room 
temperature unless otherwise noted. 
b  Conversion based on GC. 
c  Using a 0.25 M stock solution of isobutylbenzene. 
d  Using a 0.5 M stock solution of isobutylbenzene. 
 
 The second step of the ibuprofen synthesis was successfully completed using 
the PhI(OAc)2-mediated 1,2-aryl migration in our flow reactor (Scheme 5.13).  
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Scheme 5.13. The PhI(OAc)2-mediated 1,2-aryl migration if 4-isobutylpropiophenone. 
 
The setup of the flow reaction is shown in Figure 5.4.  A stream of 
concentrated sulfuric acid was added to a stream of 4-isobutylpropiophenone, 
trimethylorthoformate (TMOF), and PhI(OAc)2 in dichloromethane at room 
temperature.   
 
 
 
Figure 5.4.  The flow 1,2-aryl migration setup. 
 
 Data for the optimization of the PhI(OAc)2-mediated 1,2-aryl migration in flow 
are shown in Table 5.2. 
As can be from Table 5.2, using excess TMOF permits shorter residence times 
(Table 5.2, entries 1-4).  However, one goal of this synthesis was to reduce the amount 
of waste generated during the synthesis. The number of equivalents of TMOF was 
therefore reduced from 17 equivalents to 2 equivalents while maintaining a high yield 
of 96%, albeit at a lower flow rate (Table 5.2, entry 11).  
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Table 5.2. Results of the flow PhI(OAc)2-mediated aryl migration.a 
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Entry Eq. 
TMOF 
Eq. 
PhI(OAc)2 
Eq. 
H2SO4 
Flow Rate 
(µL min-1) 
Residence 
Time (min) 
Conversionb 
(%) 
1 33 1.2 2.0 141.8 9.0 91 
2 33 1.2 2.0 121.5 10.6 >99 
3 17 1.2 2.0 121.5 10.6 94 
4 13.5 1.2 2.0 112.1 10.8 >99 
5 9.8 1.2 2.0 112.1 10.8 97 
6 5.1 1.2 2.0 61.1 19.7 >99 
7 3.0 1.2 2.0 45.9 26.3 93 
8 3.1 1.2 2.0 35.7 33.8 87 
9 3.1 1.2 2.0 56.0 21.5 >99 
10 2.1 1.2 2.0 56.0 21.5 94 
11 2.1 1.2 2.0 45.1 26.8 96 
a  Reactions carried out using a 0.12 M stock solution of 4-isobutylpropiophenone at 
room temperature unless otherwise noted. 
b  Conversion based on GC. 
 
 The final step of the ibuprofen synthesis in flow was successfully completed 
using a methanolic solution of KOH to saponify methyl ester 6 (Scheme 5.14). 
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Scheme 5.14.  The saponification of methyl ester 6 to yield ibuprofen. 
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 Results of the saponification are shown in Table 5.3.  Using a flow rate of 50 
µL min-1 provided an isolated yield of 88%.  It should be noted that this reaction was 
not optimized, and therefore a higher isolated yield could potentially be obtained.   
 
Table 5.3.  Results of the methyl ester saponification in flow.a 
 
OH
O
1. KOH, MeOHO
O 2. H+
16  
 
Entry Eq. 
KOH 
Flow Rate 
(µL min-1) 
Residence 
Time (min) 
Yieldb 
(%) 
1 5 50 25.7 88 
a  Reactions carried out using a 0.20 M stock solution of methyl ester 7 at room 
temperature. 
b  Isolated yield. 
 
 Having identified appropriate flow conditions homogeneous synthesis of 
ibuprofen, efforts were made to develop a similar set of flow reaction conditions for 
the synthesis of atropine. 
 Atropine Synthesis in Flow.  Attempts to put our atropine synthesis into flow 
were also met with success.  The atropine synthesis in the microreactors encountered 
similar problems to the batch synthesis, namely the tropine esterification.  For these 
reasons the route using the activated carboxylic acid shown in Scheme 5.9C was 
explored in flow. 
 The synthesis of 3-methoxypropiophenone 8 was carried out in our 
microreactor using a 0.3 M solution of methanolic KOH (Scheme 5.15).  The 
transformation was carried out at room temperature, eliminating the need to run the 
reaction at low temperatures (as was necessary in batch).  Batch reactions had the 
major byproduct phenyl vinyl ketone, which was not detected. 
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Scheme 5.15.  The synthesis of 3-methoxypropiophenone. 
 
 Results of the ether synthesis are shown in Table 5.4.  It can be seen that the 
reaction was very efficient using a 12.1 minute residence time (Table 5.4, entry 1) and 
almost equally effective using a residence time of 9.3 minutes (Table 5.4, entry 3). 
 
Table 5.4.  Results of the 3-methoxypropiophenone synthesis in flow.a 
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Entry Eq. 
KOH 
Flow Rate 
(µL min-1) 
Residence 
Time (min) 
Conversionb 
(%) 
1 1.5 100 12.1 >99 
2 1.5 120 10.1 98 
3 1.5 130 9.3 98 
4 1.5 150 8.0 94 
a  Reactions carried out using a 0.20 M stock solution of 3-chloropropiophenone and 
0.30 M KOH in methanol at room temperature 
b  Conversion based on GC. 
  
The rearrangement of 3-methoxypropiophenone (8) was also performed 
successfully in our flow reactor (Scheme 5.16). 
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Scheme 5.16.  The 1,2-aryl migration of 3-methoxypropiophenone. 
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 A high conversion was achieved in this reaction using 13.5 equivalents of 
TMOF (Table 5.5).  This reaction was not optimized, however, to determine the 
minimum amount of TMOF that could be used to perform the transformation.  Given 
our prior success with the PhI(OAc)2-mediated 1,2-aryl migration in the synthesis of 
ibuprofen, we are confident that this reaction could be optimized further to reduce the 
amount of waste generated from this process. 
 
Table 5.5.  Results for the 1,2-aryl migration of 3-methoxypropiophenone in flow.a 
 
O
O
7
O
O
8
TMOF
PhI(OAc)2, H2SO4
O
 
 
Entry Eq. 
TMOF 
Eq. 
PhI(OAc)2 
Eq. 
H2SO4 
Flow Rate 
(µL min-1) 
Residence 
Time (min) 
Conversionb 
(%) 
1 13.5 1.2 2.0 132.5 9.1 97 
a  Reactions carried out using a 0.12 M stock solution of 3-methoxypropiophenone 9 at 
room temperature. 
b  Conversion based on GC. 
 
 Treatment of methyl ester 7 with methanolic KOH successfully produced 
carboxylic acid 9 in high yield (Table 5.6).  Table 5.6 shows that a 25.7 minute 
residence time was necessary to reached a 74% isolated yield.  It should be noted 
however that these reaction conditions are not optimized. 
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Table 5.6.  Results for the saponification of methyl ester 7 in flow.a 
 
O
O
7
O
KOH
MeOH
OH
O
O
9  
 
Entry Eq. 
KOH 
Flow Rate 
(µL min-1) 
Residence 
Time (min) 
Yieldb 
(%) 
1 5 50 25.7 74 
a  Reactions carried out using a 0.20 M stock solution of methyl ester 8 at room 
temperature. 
b  Isolated yield. 
 
 In order to couple tropine with carboxylic acid 9, the acid was mixed with one 
equivalent of thionyl chloride before being quenched into a solution of tropine in 
toluene at 80 ˚C (Scheme 5.17).  As the protected atropine 10 generated during the 
course of this reaction precipitates, performing the coupling in flow was problematic 
due to channel blockages.  Following column chromatography, an isolated yield of 
30% was obtained.  As only one equivalent of thionyl chloride was used, no 
intermediate distillation step was required to remove excess thionyl chloride in this 
reaction (which would potentially react with tropine).  Further optimization of this 
reaction would undoubtedly increase the yield. 
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Scheme 5.17.  The coupling of tropine with carboxylic acid 9. 
  
Due to time constraints, the final step of the atropine synthesis, the methyl 
ether deprotection, was not attempted.  Preliminary results for this transformation in 
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batch were promising, however, demonstrating how there is great potential for this 
final reaction to be carried out effectively in flow. 
 
Conclusion 
 We have successfully designed syntheses for two APIs, ibuprofen and 
atropine, which rely on similar reaction pathways using a common set of reagents.  
While elements of our synthesis of ibuprofen have been previously reported,8 we 
developed a new synthesis of atropine that relies on a similar set of reaction 
conditions.  These syntheses were validated in batch and significant headway was 
made toward performing all reactions in flow.  Given more time, these reactions could 
be optimized further and potentially strung together, using in-line microextractors to 
purify the reactions in flow.  Knowledge gained from this project was applied to future 
flow reactions, helping to make a unique continuous flow synthesis of ibuprofen.   
 
Experimental Methods 
General Considerations. Solvents were purified by standard procedures. All other 
reagents were used as received, unless otherwise noted.  1H NMR spectra were 
recorded in CDCl3 on Varian Mercury 300MHz and Inova 400 MHz spectrometers 
operating at 299.763 MHz and 399.780 MHz, respectively, using residual solvent as 
the reference. Gas chromatographic (GC) analyses were carried out on a Varian Model 
3800 using a CP-Sil regular phase column (30.0 m x 0.25 mm i.d.).  The temperature 
program for GC analysis held the temperature constant at 80 ˚C, heated samples from 
80 to 200 ˚C at 17 ˚C/min, and held at 200 ˚C for 2 min.  Inlet and detector 
temperatures were set constant to 220 and 250 ˚C, respectively.  Microreactor 
components included Harvard Apparatus Standard Pump 22 syringe pumps and PFA 
tubing (1.6 mm i. d.).   
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4-isobutylpropiophenone (5) in batch.  Propionyl chloride (1.3 mL, 15.0 mmol, 1.5 
eq) was added dropwise to a solution of isobutylbenzene (1.6 mL, 10.2 mmol, 1.0 eq) 
and AlCl3 (2.0 g, 15.0 mmol, 1.5 eq) in CH2Cl2 (20 mL) at room temperature for 5 
hours.  When the reaction was deemed complete by GC, it was cooled over ice and 
quenched with sat. NaHCO3 (20 mL).  The mixture was extracted with CH2Cl2 (2x 50 
mL), dried over MgSO4, concentrated and dried under vacuum to give 4-
isobutylpropiophenone as a colorless oil (1.81 g, 93% yield): 1H NMR (300 MHz, 
CDCl3): δ 7.89 (d, 2H), 7.23 (d, 2H), 2.99 (q, 2H), 2.53 (d, 2H), 1.89 (m, 1H), 1.22 (t, 
3H), 0.91 (d, 6H); 13C NMR (75 MHz, CDCl3): δ 200.3, 147.2, 134.7, 129.2, 127.9, 
45.3, 31.6, 30.1, 22.3, 8.3. 
 
Methyl 3-methoxy-2-phenylpropanoate (7) in batch.  3-methoxypropiophenone 
(693 mg, 4.22 mmol, 1.0 eq), PhI(OAc)2 (1.63 g, 5.1 mmol, 1.2 eq), and 
trimethylorthoformate (17 mL, 155.4 mmol, 37.0 eq) were stirred at room 
temperature.  Concentrated H2SO4 (450 µL, 8.44 mmol, 2.0 eq) was added drop-wise 
and the reaction was stirred overnight.  The reaction was quenched with H2O, and 
reaction was concentrated in vacuo to remove any organic solvents.  The aqueous 
phase was extracted with Et2O (3x 50 mL), dried over MgSO4, concentrated and dried 
under vacuum.  The product was purified using column chromatography (silica gel, 
80:20 hexanes/EtOAc) to give methyl 3-methoxy-2-phenylpropanoate as a colorless 
oil (497 mg, 61% yield):  1H NMR (300 MHz, CDCl3): δ 7.38 (m, 5H), 3.96 (m, 2H), 
3.70 (s, 3H), 3.60 (dd, 1H), 3.37 (s, 3H). 
 
3-methoxy-2-phenylpropanoic acid (9) in batch. 3-methoxy-2-phenylpropanoate 
(290.8 mg, 1.5 mmol, 1.0 eq) was added to a 3 mL of a 20% w/w solution of KOH in 
MeOH and stirred overnight at room temperature.  The reaction was concentrated, 
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dissolved in EtOAc and H2O.  The aqueous phase was removed and acidified with 1 
M HCl, extracted with EtOAc (3x 15 mL), dried over MgSO4, concentrated and dried 
under vacuum to yield 3-methoxy-2-phenylpropanoic acid as a white solid (200 mg, 
88% yield): 1H NMR (300 MHz, CDCl3): δ 7.34 (m, 5H), 3.96 (m, 2H), 3.62 (dd, 1H), 
3.39 (s, 3H). 
 
Atropine methyl ether (10) in batch. 3-methoxy-2-phenylpropanoic acid (200 mg, 
1.03 mmol, 1.0 eq) was stirred with SOCl2 (650 µL, 8.9 mmol, 8.9 eq) at 60 ˚C until 
gas evolution ceased (~2-3 hr).  Residual SOCl2  was removed under vacuum.  The 
resulting oil was washed with toluene (5 mL), concentrated and dried under vacuum 
overnight.  The acid chloride was dissolved in toluene (5 mL) and heated to 80 ˚C.  
Tropine (149 mg, 1.1 mmol, 1.1 eq) in toluene (5 mL) was added to the acid chloride 
solution and stirred until gas evolution ceased (~3-4 hrs).  During the course of the 
reaction, a white precipitate formed.  The reaction was concentrated and dried under 
vacuum. The product was purified using column chromatography (silica gel, 
75:10:15:2 CHCl3/acetone/MeOH/NH4OH) to give atropine methyl ether (90 mg, 29% 
yield):  1H NMR (300 MHz, CDCl3): δ 7.32 (m, 5H), 5.10 (m, 1H), 3.99 (t, 1H), 3.80 
(dd, 1H), 3.63 (m, 5H), 3.36 (s, 3H), 3.01 (m, 1H), 2.66 (m, 3H), 1.95 (m, 6H). 13C 
NMR (75 MHz, CDCl3): δ 171.6, 136.0, 129.0, 128.2, 127.9, 74.0, 68.0, 60.0, 59.9, 
59.2, 52.6, 40.4, 36.4, 36.3, 25.5, 25.2. 
 
BBr3-Mediated Methyl Ether Deprotection.  Atropine methyl ether (90 mg, 0.3 
mmol, 1.0 eq) was dissolved in dry CH2Cl2 (5 mL) under nitrogen and cooled to -78 
˚C.  BBr3 (1.0 M in CH2Cl2, 900 µL, 0.9 mmol, 3.0 eq) was added dropwise at -78 ˚C 
and allowed to stir for an hour before being warmed to 0 ˚C.  The reaction was 
monitored by TLC (75:10:15:2 CHCl3/acetone/MeOH/NH4OH eluent).   
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Setup of Flow Reactions. For all flow reactions, a 60 cm segment of PFA tubing (1.6 
mm i.d., 1.21 mL total volume) was wrapped into a ‘Figure 8’ pattern around metal 
bars.  A polypropylene Y-junction was connected to the inlet of the tubing and 
syringes were connected to the union using a 10 cm segment of PFA tubing and 
polypropylene female Leur adapter.  Two syringe pumps were used in each system 
and reactions were sampled at the outlet and analyzed by GC to determine reaction 
conversion. 
 
Representative Flow Friedel-Crafts Acylation.  In one syringe was placed a solution 
of isobutylbenzene (0.25 M) in CH2Cl2 and in another syringe was placed a solution of 
propionyl chloride (0.375 M) and AlCl3 (0.375 M) in CH2Cl2.  The two syringes were 
placed on separate syringe pumps set to 25 µL min-1.  Flow was initiated and the 
reaction stream was allowed to pass through the tubing.  The reaction was collected in 
a 4 mL screw cap vial containing 1.5 mL saturated NaHCO3 and 1.5 mL Et2O.  The 
organic layer was sampled and analyzed using GC.  Flow rates and stock solution 
concentrations were varied during the optimization. 
 
Representative Flow PhI(OAc)2-Mediated 1,2-Aryl Migration for the Ibuprofen 
Synthesis.  In one syringe was placed a solution of 4-isobutylpropiophenone (0.18 M), 
PhI(OAc)2 (0.22 M) and trimethylorthoformate (0.36 M) in CH2Cl2 and in another 
syringe was placed concentrated H2SO4.  The two syringes were placed on separate 
syringe pumps and the 4-isobutylpropiophenone syringe was set to 55 µL min-1 and 
the H2SO4 syringe was set to 1.04 µL min-1.  Flow was initiated and the reaction 
stream was allowed to pass through the tubing.  The reaction was collected in a 4 mL 
screw cap vial containing 1.5 mL saturated NaHCO3 and 1.5 mL Et2O.  The organic 
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layer was sampled and analyzed using GC. Flow rates and stock solution 
concentrations were varied during the optimization. 
 
Flow Synthesis of Ibuprofen.  In one syringe was placed a solution of methyl 2-(4-
isobutylphenyl)propanoate (0.2 M) in MeOH and in another syringe was placed a 
solution of KOH (1.0 M) in MeOH.  The two syringes were placed on separate syringe 
pumps set to 25 µL min-1.  Flow was initiated and the reaction stream was allowed to 
pass through the tubing for 2 hours. Samples were taken directly from the outlet 
stream and analyzed by GC, proving the reaction was complete upon exiting the 
reactor.  The reaction was concentrated, dissolved in EtOAc and H2O.  The aqueous 
phase was removed and acidified with 5 M HCl, extracted with EtOAc (3x 15 mL), 
dried over MgSO4, concentrated and dried under vacuum to yield ibuprofen as a 
viscous oil (88% yield): 1H NMR (300 MHz, CDCl3): δ 7.23 (d, 2H), 7.13 (d, 2H), 
3.71 (m, 4H), 2.48 (d, 2H), 1.86 (m, 1H), 1.52 (d, 3H), 0.93 (d, 6H). 
 
Representative Flow 3-Methoxypropiophenone Synthesis.  In one syringe was 
placed a solution of 3-chloropropiophenone (0.2 M) in MeOH and in another syringe 
was placed a solution of KOH (0.3 M) in MeOH.  The two syringes were placed on 
separate syringe pumps set to 50 µL min-1.  Flow was initiated and the reaction stream 
was allowed to pass through the tubing.  Samples were taken directly from the outlet 
stream and analyzed by GC, to determine the reaction conversion.  Flow rates and 
stock solution concentrations were varied during the optimization. 
 
Representative Flow PhI(OAc)2-Mediated 1,2-Aryl Migration for the Atropine 
Synthesis.  In one syringe was placed a solution of 3-methoxypropiophenone (0.18 
M), PhI(OAc)2 (0.22 M) and trimethylorthoformate (2.5 M) in CH2Cl2 and in another 
 110 
syringe was placed concentrated H2SO4.  The two syringes were placed on separate 
syringe pumps and the 4-isobutylpropiophenone syringe was set to 110 µL min-1 and 
the H2SO4 syringe was set to 2.07 µL min-1.  Flow was initiated and the reaction 
stream was allowed to pass through the tubing.  The reaction was collected in a 4 mL 
screw cap vial containing 1.5 mL saturated NaHCO3 and 1.5 mL Et2O.  The organic 
layer was sampled and analyzed using GC. Flow rates and stock solution 
concentrations were varied during the optimization. 
 
Flow Synthesis of 3-Methoxy-2-Phenylpropanoic Acid.  In one syringe was placed 
a solution of methyl 3-methoxy-2-phenylpropanoate (0.2 M) in MeOH and in another 
syringe was placed a solution of KOH (1.0 M) in MeOH.  The two syringes were 
placed on separate syringe pumps set to 25 µL min-1.  Flow was initiated and the 
reaction stream was allowed to pass through the tubing for 1.7 hours. Samples were 
taken directly from the outlet stream and analyzed by GC, proving the reaction was 
complete upon exiting the reactor.  The reaction was concentrated, dissolved in Et2O 
and H2O.  The aqueous phase was removed and acidified with 5 M HCl, extracted 
with Et2O (3x 15 mL), dried over MgSO4, concentrated and dried under vacuum to 
yield 3-methoxy-2-phenylpropanoic acid (74% yield). 
 
Flow Synthesis of Atropine Methyl Ether.  In one syringe was placed a solution of 
3-methoxy-2-phenylpropanoic acid (1.0 M) in toluene and in another syringe was 
placed neat SOCl2. The two syringes were placed on separate syringe pumps and the 
3-methoxy-2-phenylpropanoic acid syringe was set to 30 µL min-1 and the SOCl2 
syringe was set to 2.19 µL min-1.    Flow was initiated and the reaction stream was 
allowed to pass through the tubing for 88 minutes.  At the outlet of the reactor was 
placed a solution of tropine (1.0 M) in toluene at 80 ˚C in which the acid chloride was 
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quenched.  The reaction was concentrated, and the residue was dissolved in CHCl3 and 
added to a solution of saturated Na2CO3.  The aqueous phase was extracted with 
CHCl3 (3x 25 mL), dried over MgSO4, concentrated and dried under vacuum. The 
product was purified using column chromatography (silica gel, 75:10:15:2 
CHCl3/acetone/MeOH/NH4OH) to give atropine methyl ether (240 mg, 30% yield).
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CHAPTER 6 
The Continuous Flow Synthesis of Ibuprofen 
 
Preface 
 After the joint venture between Systanix and Foster Miller, Inc. had come to a 
close, we chose to continue investigating the flow synthesis of one of the two APIs, 
ibuprofen.  Having expanded upon my knowledge of flow chemistry after my time at 
Pfizer, the project was tackled with a fresh perspective and the group’s first 
continuous flow synthesis of an active pharmaceutical ingredient. 
 
Abstract 
 A three-step, continuous flow synthesis of ibuprofen was accomplished using a 
simplified microreactor.  By designing a synthesis in which excess reagents and 
byproducts are compatible with downstream reactions, no intermediate purification or 
isolation steps are required. 
 
Introduction 
Organic synthesis is a powerful enterprise that continues to develop more 
selective and efficient chemical methods and synthetic routes.  To synthesize complex 
molecules, whether in academic laboratories or industrial manufacturing, reactions are 
often performed iteratively in batch reactors.  While these stepwise methods are 
powerful, they are also highly wasteful. The pharmaceutical industry, for example, 
produces 25-100 kg of waste for every kilogram of product synthesized.1 Though 
chemists are constantly striving to create more efficient syntheses, recent reminders of 
a resource-limited world underscore the need for more sustainable methods and 
technologies to synthesize molecules of importance.2 The application of new 
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technologies, such as microreactors, to organic synthesis can be used to achieve this 
goal.3-13 
Microreactors are a developing technology used to perform safer, more 
efficient and more selective chemical transformations in microchannels or narrow-
bore tubing.3-13 The many advantages associated with running reactions in flow are 
attributed to large surface area-to-volume ratios.5 Small dimensions allow for precise 
reaction control through rapid heat transfer and mixing that cannot be obtained in 
batch reactors.14-17 Scale-up of syntheses is also readily achieved by running a single 
reactor for extended periods of time18 or by the addition of more identical flow 
reactors in parallel, a process known as numbering up.19-21 
While the majority of microreactor work in organic synthesis has focused on 
single-step reactions,3-13 recent examples have demonstrated multi-step reaction 
sequences in flow.14, 22-25 Our group has a long-standing interest in the development of 
new methodologies that enable the rapid and efficient synthesis of important small 
molecules.26-29  Specifically, we have aimed to run multi-step reaction sequences in 
one pot (i.e. batch)28, 29 or in series (i.e. microreactors).26, 27 We report herein a three-
step, continuous flow synthesis of ibuprofen using a simplified microreactor29 that 
eliminates the need for purification and isolation steps.   
We previously reported the development of simplified microreactors using a 
combination of polymeric tubing, unions, and syringe pumps.26, 27  In all flow 
reactions described herein, PFA tubing (0.75 mm i.d.) was wrapped around metal bars 
in a serpentine-like manner to assist in mixing and to enable facile reactor 
heating/cooling (Figure 6.1).27 
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Figure 6.1.  The simplified microreactor setup using PFA tubing wrapped around 
metal bars.  Reagent streams are mixed using a PFA tee junction. 
 
 To achieve this continuous flow synthesis, a retrosynthetic analysis of 
ibuprofen was performed, paying careful attention to reaction compatibility.  To be 
successful, the entire synthesis had to be considered as an entity, as opposed to a series 
of independent reactions steps.  In other words, reactions had to be designed such that 
byproducts and excess starting materials from one reaction were compatible with 
downstream reactions.  By doing so, reactions could be performed in sequence without 
any breaks in the synthesis.  The general three-step synthesis of ibuprofen we 
investigated is outlined in Scheme 6.1.30 
 
O
OH
O
Friedel-Crafts 'iodine'
hydrolysis or
O
O
TMOF, H+
saponification
1
2
3 4  
 
Scheme 6.1.  Proposed synthetic route to ibuprofen.  ‘iodine’= I2, or PhI(OAc)2, 
TMOF = trimethylorthoformate. 
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We surveyed multiple conditions for the Friedel-Crafts acylations (Table 6.1).  
Of these, the use of AlCl3 provided the highest yield, but byproducts from this reaction 
proved to be incompatible with downstream steps.  Mixing isobutylbenzene (IBB, 1) 
and propionic acid with triflic acid (TfOH) proved to also be an effective method to 
synthesize 2 (Figure 6.2).31, 32 It is proposed that the reaction of triflic acid with 
propionic acid leads to the generation of a mixed anhydride, a very active acylating 
agent (Figure 6.3).  This TfOH/propionic acid system was not only effective with the 
first step but was also synergistic with the second step.   
 
 
 
Figure 6.2.  The flow Friedel-Crafts acylation reaction setup. 
 
O
O
S
CF3
O
O
OH
O
HO
S
CF3
O
O
 
 
Figure 6.3.  The mixed anhydride formed by the reaction of propionic acid with triflic 
acid.
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Table 6.1.  Reaction conditions screened for the Friedel-Crafts acylation of 
isobutylbenzene. 
 
O
catalyst
1
2  
 
Entry Catalyst Acylating Agent Conversiona 
1 AlCl3 propionyl chloride >99% 
2 SiO2-supported AlCl3 propionyl chloride N.R. 
3 F
F
F
F
F
Tf
Tf
 
propionyl chloride  N.R. 
4 F
F
F
F
F
Tf
Tf
 
propionic anhydride N.R. 
5 TfOH (10%) propionyl chloride  N.R. 
6 TfOH (10%) propionyl anhydride  N.R. 
7 ZnO (50%) propionyl chloride  N.R. 
8 ZnO (100%) propionyl chloride  N.R. 
9 Sc(OTf)3 propionyl chloride N.R. 
10 Sc(OTf)3 (10%) propionic chloride N.R. 
11 Sc(OTf)3 (10%) propionic anhydride N.R. 
12 Sc(OTf)3 (10%), 
LiClO4 
propionic chloride N.R. 
13 Sc(OTf)3 (10%), 
LiClO4 
propionic anhydride N.R. 
14 Zeolite H-β propionic anhydride N.R. 
15 Zeolite H-β propionic acid N.R. 
16 NaFeCl4 (50%) propionic chloride 16% 
17 NaFeCl4 (100%) propionic chloride 70% 
18 TfOH (20 eq) propionic acid >99% 
19 TfOH (5 eq) propionic acid 92% 
a Conversion based upon consumption of starting material by GC. 
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To run flow acylation experiments, a solution of IBB and propionic acid was 
mixed with a stream of TfOH, adjusting flow rates such that 5 equivalents of TfOH 
were being delivered relative to IBB (Figure 6.2).33  The reagent streams were 
combined at a tee junction, resulting in plug flow due to the immiscibility of these 
reagents at low temperature (Figure 6.4a). When heated to 50 ˚C with a 5-minute 
residence time, only a 15% conversion was obtained (Table 6.2, entry 1).  Plug flow 
continued throughout the reactor, suggesting that poor mixing and low temperatures 
lead to low conversion (Figure 6.4b).34  Increasing the reaction temperature produced 
better results, with 150 ˚C giving the highest conversion and yield (Table 6.2, entry 
3).35 By visual inspection, the plugs coalesced at 150 ˚C, resulting in a homogeneous 
outlet stream (Figure 6.4d), indicating efficient mixing. 
   
 
Table 6.2.  The optimization of the flow Friedel-Crafts acylation. 
 
Entry Flow Rate 
(µL/min) 
Residence 
Time (min) 
TfOH 
(equiv) 
Propionic 
Acid (equiv) 
T 
(˚C) 
Conversiona 
1 87.5 5 5 1.0 50 15% 
2 87.5 5 5 1.0 100 52% 
3 87.5 5 5 1.0 150 91% (70%)b 
4 43.8 10 5 1.0 150 92%c 
5 22 20 5 1.0 150 93% c 
6 87.5 5 5 1.1 150 89% 
7 87.5 5 5 1.5 150 85% 
8 87.5 5 4 1.0 150 80% 
a   Conversion determined using GC with dodecane as an internal standard. 
b  Number in parentheses corresponds to isolated yield after column chromatography. 
c Longer residence times led to inconsistent flow rates. 
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Figure 6.4. Reagent flow for the Friedel-Crafts acylation.  Plug flow (a) at the inlet of 
the reactor.  Plugs are colorless, but are photographed in front of dark background to 
assist with visualization.  At a reactor temperature of 50 ˚C, plug flow continues at the 
outlet of the reactor (b).  Increasing the temperature to 100 ˚C decreases the frequency 
of the plugs (c) and provides an increase in conversion.  Increasing the temperature to 
150 ˚C leads to a homogeneous stream at the outlet of the reactor (d).  The reaction 
becomes a dark red color as it proceeds. 
 
As stipulated earlier, in a continuous synthesis requiring no intermediate 
purification steps, all byproducts and excess reagents from prior steps must be 
compatible with downstream reactions.  Therefore, it was essential that the excess 
reagents (TfOH and unreacted IBB) used in the Friedel-Crafts acylation were 
compatible with the second step of our reaction sequence, the 1,2-aryl migration.  
Literature precedence indicates the addition of acid to a mixture of aryl ketones, 
trimethyl orthoformate (TMOF), and PhI(OAc)2 affords 2-arylpropanoates in high 
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yield (Scheme 6.2).30, 36, 37 We selected this reaction as it requires no transition metals, 
and the iodobenzene byproduct has the potential to be recycled.38   
 
O
TMOF, H+
O
O
PhI(OAc)2
2 3  
 
Scheme 6.2.  The PhI(OAc)2-mediated 1,2-aryl migration of 4-isobutylpropiophenone. 
 
Using propiophenone as a test substrate, we discovered that TfOH is 
compatible with the 1,2-aryl migration (Scheme 6.2), providing high yields of methyl 
ester 5 with short residence times (Table 6.3).  Using 9 equivalents of TMOF provided 
near quantitative conversion with 5 equivalents TfOH at 35 ˚C (Table 6.3, entry 1).  
Decreasing the amount of TMOF to 4 equivalents also gave high yields at 35 ˚C 
(Table 6.3, entry 2).  Increasing the temperature to 50 ˚C had the added benefit of 
increasing reaction rates, and thereby permitting faster flow rates to be used (higher 
output) (Table 6.3, entries 3 and 4).  Reducing the amount of TMOF to 2 equivalents 
was detrimental to both the conversion and yield (Table 6.3, entry 5), leading to the 
generation of a major byproduct, presumably 2-methoxypropiophenone.  From these 
data, it was determined that a residence time of 2 minutes was optimal for the second 
step of our multi-step reaction sequence to convert 4-isobutylpropiophenone 2 to 
methyl ester 3. 
 Additional work has also been carried out to perform this reaction 
enantioselectively.  For a discussion on this topic, see Appendix 4. 
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Table 6.3.  The optimization of the flow PhI(OAc)2-mediated 1,2-aryl migration.a 
 
 
 
Entry Flow Rate 
(µL min-1) 
Residence 
Time (min) 
TMOF 
(equiv) 
T 
(˚C) 
Conversionb Yieldb 
1 110 2.0 9.0 35 >98% 78% 
2 110 2.0 4.0 35 >98% 92% 
3 110 2.0 4.0 50 98% 96% 
4 220 1.0 4.0 50 94% 81% 
5 110 2.0 2.0 50 81% 60% 
a Standard reactions conditions used 1.0 eq propiophenone and 1.0 eq PhI(OAc)2, and 
5.0 eq TfOH.  
b Calculated by GC using cyclooctane as an internal standard 
 
With the first two separately optimized, we assembled the system so that the 
product stream from the Friedel-Crafts acylation was immediately relayed into the 1,2-
aryl migration using the conditions outlined above (Figure 6.5).  This system requires 
no additional acid because the TfOH from the Friedel-Crafts acylation also facilitates 
the 1,2-aryl migration.  To achieve efficient mixing of the outlet stream from the first 
step with the PhI(OAc)2/TMOF reagent stream for the second step, a tee junction was 
modified such that the inner diameter was 0.75 mm and packed with glass beads (250-
300 µm).  This mixer was cooled to 0 ˚C and proved to mix the two streams 
effectively,39 resulting in a 70% two-step yield after column chromatography, with 
quantitative conversion of 4-isobutylpropiophenone 2 to methyl ester 3. 
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Figure 6.5.  The two-step reaction sequence. 
 
 The final step in the continuous flow ibuprofen synthesis was achieved by 
saponifying methyl ester 3 with KOH (Figure 6.6).  The outlet from the second step 
was combined with a stream of 5 M KOH and heated to 65 ˚C for 3 minutes. The 
excellent heat transfer of the microreactor allows the acidic stream to be mixed with 
the basic stream without a dangerous exotherm.  Sampling the outlet stream showed 
only the presence of residual IBB, iodobenzene, and trace amounts of methyl ester 3.  
After an acidic work-up, ibuprofen 4 was obtained in 68% crude yield and 51% yield 
(99% purity by GC and NMR) after recrystallization.40 
 
 
 
Figure 6.6.  The three-step, continuous flow synthesis of ibuprofen. 
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Conclusion 
In summary, we have developed a continuous flow synthesis of an active 
pharmaceutical ingredient, ibuprofen, using an efficient three-step process that 
requires no intermediate purifications steps.  Using less than 500 cm of tubing and five 
syringe pumps, the flow synthesis reported herein generates approximately 9 mg/min 
crude ibuprofen.  Addition of parallel reactors or lengthening the channels would 
permit a high throughput synthesis of ibuprofen.  Potential scale-up of this method 
would also benefit from the precise temperature control (from 150 ˚C to 50 ˚C in 
sequential steps) and the excellent control of exotherms (caused by transitioning from 
pH 1 to 14).  Performing this series of reactions on large scale in batch would be 
unfavorable due to the energy requirements needed to safely control these temperature 
changes and exotherms.  Investigations are currently being carried out to apply this 
methodology to other 2-arylpropionic acid derivatives, such as naproxen, and to 
develop recyclable, supported catalysts for the Friedel-Crafts acylation and 1,2-aryl 
migration. 
 
Experimental Methods 
General Considerations. Solvents were purified by standard procedures.  All other 
reagents were used as received, unless otherwise noted.  1H NMR and 13C NMR 
spectra were recorded in CDCl3 on Varian Mercury 300 MHz operating at 300.070 
MHz and 75.452 MHz, respectively, using the residual solvent peak as reference.  
Data are reported as s = singlet, d = doublet, t = triplet, q = quadruplet, m = multiplet.  
Gas chromatographic (GC) analyses were performed using an Agilent 7890A GC 
equipped with an Agilent 7683B autosampler, a flame ionization detector (FID), and a 
J&W Scientific 19091J-413 column (length = 30 m, inner diameter = 320 µm, and 
film thickness = 250 µm).  The temperature program for GC analysis held the 
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temperature constant at 80 ˚C for 1 minute, heated samples from 80 to 200 ˚C at 20 
˚C/min and held at 200 ˚C for 1 minute.  Inlet and detector temperatures were set 
constant at 220 and 250 ˚C, respectively.  Cyclooctane and dodecane used as internal 
standards to calculate reaction conversion and yield.  Gas chromatography-mass 
spectrometry (GC/MS) analyses were performed using a Hewlett Packard HP 6890 
Series Gas Chromatograph, a Hewlett Packard HP 5973 Mass Spectrometer Detector 
(MSD), and a J&W Scientific DB*-5 Column (length = 30 m, inner diameter = 0.325 
mm, film thickness = 1.0 µm, catalog number 123-5033). The temperature program 
for the analyses held the temperature constant at 50 °C for 3 min, heated samples from 
50 to 80 °C at 30 °C/min, holding at 80 °C for 2 min, then heating samples from 80 to 
200 °C at 17 °C/min, and holding at 200 °C for 1.94 min. The MSD temperature was 
held at 300 °C for 15 min. 
 
Microreactor Components.  The selection of the proper materials for this systems 
proved to be very important.  The caustic nature of triflic acid rendered many 
materials, such as polypropylene and polyoxymethylene (Delrin), unusable and led to 
hazardous leaks.  PFA and ETFE materials proved to be highly stable.  
 
 125 
Table 6.4. Microreactor components. 
Equipment Materials 
Pumping Mechanism Harvard Apparatus Standard Pump 22 syringe pumps 
 
Tubing Teflon PFA (perfluoroelastomeric), 0.030” (0.75 mm) 
i.d., 1/16” (1.6 mm) o.d. 
 
Mixers Upchurch Scientific ETFE Tees, 0.020” (0.50 mm) thru-
hole, 2.9 µL swept volume 
 
Nuts Upchurch Scientific Flangeless Nuts, PFA 1/4-28 thread 
for 1/16” o.d. tubing 
 
Ferrules Upchurch Scientific ETFE Flangeless Ferrules 
 
Unions Upchurch Scientific ETFE Standard Union, 1/4-28 
threads 
 
Luer Adapter Upchurch Scientific ETFE Female Leur to 1/4-28 
Female thread, 0.05” (1.3 mm) thru-hole 
 
Iodobenzene diacetate (PhI(OAc)2).  Hydrogen peroxide (30% w/w in water, 10.0 
mL, 0.1 mol, 1 eq) and acetic anhydride (45.0 mL, 0.48 mol, 4.8 eq) were charged into 
a 100 mL round bottom flask equipped with a bubbler and stirred at 40 ˚C for 4 hours.  
Iodobenzene (3.9 mL, 36 mmol, 0.36 eq) was added dropwise at 40 ˚C and allowed to 
stir overnight.  The reaction was cooled to room temperature and partially 
concentrated under vacuum until a white precipitate formed.  The precipitate was 
filtered, washed with Et2O and dried under vacuum to give iodobenzene diacetate as a 
white solid (8.04 g, 71% yield): 1H NMR (300 MHz, d6-DMSO): δ 8.25 (d, J=8.4 Hz, 
2H), 7.67 (t, J=6.6 Hz, 1H), 7.57 (t, J=7.5 Hz, 2H), 1.91 (s, 6H). 
 
Methyl 2-phenylpropanoate.  Propiophenone (1.0 mL, 7.5 mmol, 1.0 eq), PhI(OAc)2 
(2.5 g, 7.7 mmol, 1.03 eq) and trimethyl orthoformate (4 mL, 36.6 mmol, 4.9 eq) were 
charged into a 100 mL round bottom flask equipped with a bubbler at room 
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temperature.  Concentrated H2SO4 (900 µL, 16.2 mmol, 2.2 eq) was added drop wise 
over 5 minutes.  The reaction was stirred at room temperature until TLC indicated the 
reaction was complete (about 15 minutes).  The reaction was quenched with water, 
and the aqueous phase extracted with CH2Cl2 (3x 50 mL), dried over Na2SO4, filtered 
and concentrated in vacuo.  The product was purified by column chromatography 
(silica gel, 95:5 hexanes/EtOAc, Rf = 0.26) to give methyl 2-phenylpropanoate as a 
colorless oil: 1H NMR (300 MHz, CDCl3): δ 7.30 (m, 5H), 3.775 (q, J=7.2 Hz, 1H), 
3.67 (s, 3H), 1.55 (d, J=7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 175.0, 140.6, 
128.7, 127.5, 127.2, 52.0, 45.5, 18.7. 
 
Representative Flow Friedel-Crafts Acylation Optimization Experiment.   
 
 For the flow Friedel Crafts acylation, a 100 cm segment of PFA tubing (0.75 
mm i.d., 441.79 µL total volume) was wrapped into a ‘Figure 8’ pattern and 
submerged into an oil bath set to the desired temperature (50, 100, or 150 ˚C).  An 
ETFE tee was connected to the inlet of the tubing using a PFA flangeless nut.  
Syringes were connected to the tee using a 10 cm segment of PFA tubing and an 
ETFE female Leur adapter. 
 In one syringe was placed a solution of isobutylbenzene, propionic acid and 
dodecane and in another syringe was placed neat triflic acid (11.3 M).  The two 
syringes were placed on separate syringe pumps and flow rates were attenuated to 
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provide the desired stoichiometry.  Flow was initiated and the reaction stream was 
allowed to pass through the tubing.  The reaction was collected in a 4 mL screw cap 
vial containing 1.5 mL saturated NaHCO3 and 1.5 mL Et2O.  The organic layer was 
sampled and analyzed using GC.  Conversion was calculated using dodecane as the 
internal standard.   
 
Flow Friedel-Crafts Acylation Isolated Yield Experiment.   
 
 
 A 50 cm segment of PFA tubing (0.75 mm i.d., 220.89 µL total volume) was 
wrapped into a ‘Figure 8’ pattern and submerged into an oil bath set to 150 ˚C.  An 
ETFE tee was connected to the inlet of the tubing using a PFA flangeless nut.  
Syringes were connected to the tee using a 10 cm segment of PFA tubing and an 
ETFE female Leur adapter. 
 In one syringe was placed a solution of isobutylbenzene (4.3 M) and propionic 
acid (4.3 M) and in another syringe was placed neat triflic acid (11.3 M).  The two 
syringes were placed on separate syringe pumps and flow rates were attenuated to 
provide the desired stoichiometry.  The isobutylbenzene/propionic acid syringe was 
set to 15.1 µL min-1 (64.9 µmol min-1, 1.0 eq min-1 each) and the triflic acid syringe 
was set to 28.7 µL min-1 (324.6 µmol min-1, 5.0 eq min-1).  Flow was initiated and the 
reaction stream was allowed to pass through the tubing.  The reaction was collected in 
a 60 mL separatory funnel containing 20 mL saturated NaHCO3.  The aqueous layer 
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was extracted with Et2O (3x 25 mL), dried over Na2SO4 and filtered.  To the organic 
extracts was added a small amount of silica gel, used to pre-adsorb the product prior to 
column chromatography.  The product was purified using column chromatography 
(silica gel, hexanes  95:5 hexanes/EtOAc, Rf = 0.34) to give 4-
isobutylpropiophenone as light-yellow oil (70% yield, average of two trials): 1H NMR 
(300 MHz, CDCl3): δ 7.89 (d, J=7.8, 2H), 7.23 (d, J=7.8 Hz, 2H), 2.99 (q, J=7.2 Hz, 
2H), 2.53 (d, J=7.2 Hz, 2H), 1.89 (m, J= 6.6 Hz, 1H), 1.22 (t, J= 7.2 Hz, 3H), 0.91 (d, 
J= 6.6 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 200.3, 147.2, 134.7, 129.2, 127.9, 45.3, 
31.6, 30.1, 22.3, 8.3.  MS m/z 190 (M+). 
 
Representative Flow PhI(OAc)2 Rearrangement Optimization Experiment. 
 
For the flow Friedel-Crafts acylation, a 50 cm segment of PFA tubing (0.75 
mm i.d., 220.89 µL total volume) was wrapped into a ‘Figure 8’ pattern and 
submerged into an oil bath set to the desired temperature (35, 50 or 60 ˚C).  An ETFE 
tee was connected to the inlet of the tubing using a PFA flangeless nut.  Syringes were 
connected to the tee using a 10 cm segment of PFA tubing and an ETFE female Leur 
adapter. 
 In one syringe was placed a solution of propiophenone, triflic acid and 
cyclooctane and in another syringe was placed a solution of trimethylorthoformate 
(TMOF) and PhI(OAc)2 in MeOH.  The two syringes were placed on separate syringe 
pumps and flow rates were attenuated to provide the desired stoichiometry.  Flow was 
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initiated and the reaction stream was allowed to pass through the tubing.  The reaction 
was collected in a 4 mL screw cap vial containing 1.5 mL saturated NaHCO3 and 1.5 
mL Et2O.  The organic layer was sampled and analyzed using GC.  Conversion and 
yield were calculated using cyclooctane as the internal standard. 
 
Two-Step Flow Isolated Yield Experiment.   
 
 A 50 cm segment of PFA tubing (0.75 mm i.d., 220.89 µL total volume) was 
wrapped into a ‘Figure 8’ pattern and submerged into an oil bath set to 150 ˚C.  An 
ETFE tee was connected to the inlet of the tubing using a PFA flangeless nut.  
Syringes were connected to the tee using a 10 cm segment of PFA tubing and an 
ETFE female Leur adapter. 
 In one syringe was placed a solution of isobutylbenzene (4.3 M) and propionic 
acid (4.3 M) and in another syringe was placed neat triflic acid (11.3 M).  The two 
syringes were placed on separate syringe pumps and flow rates were attenuated to 
provide the desired stoichiometry.  The isobutylbenzene/propionic acid syringe was 
set to 15.1 µL min-1 (64.9 µmol min-1, 1.0 eq min-1 each) and the triflic acid syringe 
was set to 28.7 µL min-1 (324.6 µmol min-1, 5.0 eq min-1).  Flow was initiated and the 
reaction stream was allowed to pass through the tubing. 
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  To the outlet of the first reactor was attached an ETFE tee using a flangeless 
nut.  An additional syringe was connected to the tee using a 10 cm segment of PFA 
tubing and an ETFE female Leur adapter.  This tee was modified such that the inner 
diameter of the junction was 0.75 mm and packed with glass beads (250-300 µm).  
The outlet of the tee was connected to an 80 cm segment of PFA tubing (0.75 mm i.d., 
353.43 µL total volume), wrapped into a ‘Figure 8’ pattern and submerged into an oil 
bath set to 50 ˚C.  A solution of PhI(OAc)2 (0.5 M) and TMOF (2.0 M) in MeOH was 
placed in this syringe and set to 131.5 µL min-1 (65.8 µmol IBD min-1, 1.01 eq IBD 
min-1 and 259.6 µmol TMOF min-1, 4.0 eq TMOF min-1).  The tee was submerged in 
an ice bath to prevent off-gassing from mixing the two phases. 
The reaction was collected in a 60 mL sepaparatory funnel containing 20 mL 
saturated NaHCO3.  The aqueous layer was extracted with Et2O (3x 25 mL), dried 
over Na2SO4 and filtered.  To the organic extracts was added a small amount of silica 
gel, used to pre-adsorb the product prior to column chromatography.  The product was 
purified using column chromatography (silica gel, hexanes  95:5 hexanes/EtOAc, Rf 
= 0.37) to give methyl 2-(4-isobutylphenyl)propanoate as light-yellow oil (70% yield, 
average of two trials): 1H NMR (300 MHz, CDCl3): δ 7.23 (d, J=8.4, 2H), 7.13 (d, 
J=7.8 Hz, 2H), 3.71 (m, 4H), 2.48 (d, J=7.2 Hz, 2H), 1.86 (m, J= 6.6 Hz, 1H), 1.52 (d, 
J= 7.2 Hz, 3H), 0.93 (d, J= 6.6 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 175.4, 140.7, 
137.9, 129.5, 127.3, 52.1, 45.21, 45.18, 30.3, 22.6, 18.8.  MS m/z 220 (M+). 
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Continuous Flow Ibuprofen Isolated Yield Experiment.   
 
A 50 cm segment of PFA tubing (0.75 mm i.d., 220.89 µL total volume) was 
wrapped into a ‘Figure 8’ pattern and submerged into an oil bath set to 150 ˚C.  An 
ETFE tee was connected to the inlet of the tubing using a PFA flangeless nut.  
Syringes were connected to the tee using a 10 cm segment of PFA tubing and an 
ETFE female Leur adapter. 
In one syringe was placed a solution of isobutylbenzene (4.3 M) and propionic 
acid (4.3 M) and in another syringe was placed neat triflic acid (11.3 M).  The two 
syringes were placed on separate syringe pumps and flow rates were attenuated to 
provide the desired stoichiometry.  The isobutylbenzene/propionic acid syringe was 
set to 15.1 µL min-1 (64.9 µmol min-1, 1.0 eq min-1 each) and the triflic acid syringe 
was set to 28.7 µL min-1 (324.6 µmol min-1, 5.0 eq min-1).  Flow was initiated and the 
reaction stream was allowed to pass through the tubing. 
To the outlet of the first reactor was attached an ETFE tee using a flangeless 
nut.  An additional syringe was connected to the tee using a 10 cm segment of PFA 
tubing and an ETFE female Leur adapter.  This tee was modified such that the inner 
diameter of the junction was 0.75 mm and packed with glass beads (250-300 µm).  
The outlet of the tee was connected to an 80 cm segment of PFA tubing (0.75 mm i.d., 
353.43 µL total volume), wrapped into a ‘Figure 8’ pattern and submerged into an oil 
bath set to 50 ˚C.  A solution of PhI(OAc)2 (0.5 M) and TMOF (2.0 M) in MeOH was 
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placed in this syringe and set to 131.5 µL min-1 (65.8 µmol PhI(OAc)2 min-1, 1.01 eq 
PhI(OAc)2 min-1 and 259.6 µmol TMOF min-1, 4.0 eq TMOF min-1).  The tee was 
submerged in an ice bath to prevent off-gassing from mixing the two phases. 
To the outlet of the second reactor was attached an ETFE tee using a flangeless 
nut.  An additional syringe was connected to the tee using a 20 cm segment of PFA 
tubing and an ETFE female Leur adapter.  The outlet of the tee was connected to a 300 
cm segment of PFA tubing (0.75 mm i.d., 1325.36 µL total volume), wrapped into a 
‘Figure 8’ pattern and submerged into a water bath set to 65 ˚C.  A solution of KOH 
(5.0 M) in MeOH/H2O (4:1 v/v) was placed in this syringe and set to 260.0 µL min-1 
(1300.0 µmol min-1, 20.0 eq min-1).  
The reaction was collected in a 100 mL round bottom flask.  The outlet stream 
was periodically sampled, quenched into EtOAc, and analyzed by GC to determine the 
composition of the reaction stream.  Once the collection was complete, DI H2O (25 
mL) was added to the round bottom flask and the methanol was evaporated using 
rotary evaporation.  The aqueous phase was washed with Et2O (3x 30 mL) and the 
organic washes analyzed by GC.  The aqueous phase was acidified with concentrated 
HCl, and the aqueous phase was extracted with Et2O (3x 30 mL).  The organic extracts 
were repeatedly washed with DI H2O (5x 20 mL) until the pH of the aqueous phase 
was neutral.  The organic extracts were subsequently washed with brine (1x 20 mL), 
dried over Na2SO4, filtered, concentrated and dried in vacuo to yield a light orange 
solid (68% crude yield, average of three trials).  Seed crystals were added to initiate 
crystallization.  The solid was dissolved in Et2O and treated with activated carbon.  
The activated carbon was removed by filtering the suspension through a plug of 
anhydrous MgSO4.  The Et2O was concentrated to yield an off-white solid, which was 
recrystallized with warm heptane.  Ibuprofen has a solubility of ~100 mg 
ibuprofen/250 µL heptane at 50 ˚C and 5 mg ibuprofen/250 µL heptane at 0 ˚C.41 The 
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filtrate was removed and the crystals were dried under vacuum to afford ibuprofen as 
an off-white solid (51% yield, average of three trials). Additional charcoal treatments 
could be performed to remove residual color after recrystallization without impacting 
yield: 1H NMR (300 MHz, CDCl3): δ 7.23 (d, J=8.4, 2H), 7.13 (d, J=7.8 Hz, 2H), 3.71 
(m, 4H), 2.48 (d, J=7.2 Hz, 2H), 1.86 (m, J= 6.6 Hz, 1H), 1.52 (d, J= 7.2 Hz, 3H), 
0.93 (d, J= 6.6 Hz, 6H); 13C NMR (75 MHz, CDCl3): δ 175.4, 140.7, 137.9, 129.5, 
127.3, 52.1, 45.21, 45.18, 30.3, 22.6, 18.8.  MS m/z 220 (M+).  
 
 
 
134 
REFERENCES 
 
1. Sheldon, R. A. J. Chem. Tech. Biotechnol. 1997, 68, 381. 
 
2.   Anastas, P.T.; Kirchhoff, M. M. Acc. Chem. Res. 2002, 35, 686. 
 
3.   Mason, B. P.; Price, K. E.; Steinbacher, J. L.; Bogdan, A. R.; McQuade, D. T. 
Chem. Rev. 2007, 107, 2300.  
 
4. Hessel, V.; Löb, P.; Löwe, H. Curr. Org. Chem. 2005, 9, 765. 
 
5.   Hessel, V.; Löwe, H. Chem. Eng. Technol. 2005, 28, 267. 
 
6.   Hodge, P. Curr. Opin. Chem. Biol. 2003, 7, 362. 
 
7.   Jas, G.; Kirschning, A. Chem.–Eur. J. 2003, 9, 5708. 
 
8.   Kirschning, A.; Monenschein, H.; Wittenberg, R. Angew. Chem., Int. Ed. 2001, 
40, 650. 
 
9. Pennemann, H.; Watts, P.; Haswell, S. J.; Hessel, V.; Löwe, H. Org. Process 
Res. Dev. 2004, 8, 422. 
 
10.   Wirth, T., Ed. Microreactors in Organic Synthesis and Catalysis; Wiley-VCH: 
Weinheim, 2008. 
 
11.   Watts, P.; Wiles, C. Org. Biomol. Chem. 2007, 5, 727. 
 
12.   Fukuyama, C.; Rahman, M. T.; Sato, M.; Ryu, I. Synlett 2008, 2, 151. 
 
13.   Ahmed-Omer, B.; Brandt, J. C.; Wirth, T. Org. Biomol. Chem. 2007, 5, 733. 
 
14.  Yoshida, J.; Nagaki, A.; Yamada, T. Chem. Eur. J. 2008, 14, 7450, and 
references within.  
 
15.  Nagaki, A.; Takabayashi, N.; Tomida, Y.; Yoshida, J. Org. Lett. 2008, 10, 
3937. 
 
16.  Nagaki, A.; Kim, H.; Yoshida, J. Angew. Chem. Int. Ed. 2008, 47, 7833.  
 
17.   van der Linden, J. M. J.; Hilberink, P. W.; Kronenburg, C. M. P.; Kemperman, 
G. J. Org. Process Res. Dev. 2008, 12, 911.  
 
18.   Bogdan, A. R.; Sach, N. W. Adv. Synth Catal, 2009, 351, 849.   
  135 
19.   Ehrfeld, W.; Hessel, V.; Lowe, H. Microreactors: New Technology for Modern 
Chemistry, Wiley-VCH, Weinheim, 2000. 
 
20.   Hornung, C. H.; Mackley, M. R.; Baxendale, I. R.; Ley, S. V. Org. Process 
Res. Dev. 2007, 11, 399. 
 
21.   Acke, D. R. J.; Stevens, C. V. Org. Process Res. Dev. 2006, 10, 417  
 
22.   Sahoo, H. R.; Kralj, J. G.; Jensen, K. F. Angew. Chem. Int. Ed. 2007, 46, 5704. 
 
23.   Baxendale, I. R.; Deeley, J.; Griffiths-Jones, C. M.; Ley, S. V.; Saaby, S.; 
Tranmer, G. K. Chem. Commun. 2006, 2566. 
 
24.   I. R. Baxendale, S. V. Ley, A. C. Mansfield, C. D. Smith, Angew. Chem. Int. 
Ed. 2009, 48, 4017. 
 
25.   D. Grant, R. Dahl, N. D. P. Cosford, J. Org. Chem. 2008, 73, 7219. 
 
26.   Bogdan, A. R.; Mason, B. P.; Sylvester, K. T.; McQuade, D. T. Angew. Chem. 
Int. Ed. 2007, 46, 1698. 
 
27.   Bogdan, A. R.; McQuade, D. T. Beilstein Journal of Organic Chemistry, 2009, 
5, 17. 
 
28.   Poe, S. L.; Kobašlija, M.; McQuade, D. T. J. Am. Chem. Soc. 2006, 128, 
15586. 
 
29.   Poe, S. L.; Kobašlija, M.; McQuade, D. T. J. Am. Chem. Soc. 2007, 129, 9216. 
 
30.   Tamura, Y.; Yakura, T.; Shirouchi, Y.; Haruta, J. Chem. Pharm. Bull. 33, 3, 
1097. 
 
31.   Roberts, R. M. G.; Sadri, A. R. Tetrahedron, 1983, 39, 137.  
 
32.   Effenberger, F.; Epple, G. Angew. Chem. Int. Ed., 1972, 11, 300. 
 
33.   In our flow reactor, the use of PFA tubing and unions was critical to withstand 
the caustic nature of TfOH. For a detailed description of the materials used, see 
the supporting information.   
 
34.   Batch reactions with vigorous mixing at low temperature were also slow, 
indicating that mixing is not the only variable that impacts reaction rate. 
 
35.   This reaction generated ~5% of the 1,2-adduct, as indicated by GC and 
GC/MS.  This by-product was ultimately converted to the 1,2-derivative of 
  136 
ibuprofen in the continuous flow synthesis, and was removed after 
recrystallization. 
  
36.   Singh, O. V.; Prakash, O.; Garg, C. P.; Kapoor, R. P. Ind. J. Org. Chem. 1989, 
28B, 814.  
 
37.   Prakash, O.; Goyal, S.; Moriarty, R. M.; Khosrowshahi, J. S. Ind. J. Org. 
Chem. 1990, 289B, 304. 
 
38.   Iodobenzene is the byproduct of the 1,2-aryl migration.  It can be converted 
back to PhI(OAc)2 by treatment with peracetic acid.  
 
39.   It was found to be necessary to cool the tee junction due to significant off-
gassing that occurred when held at room temperature.  This off-gassing did not 
occur during the optimization and therefore this tee junction did not need to be 
cooled. 
 
40.   The low yield from the recrystallization most likely stems from 
recrystallization of ibuprofen on small scale.  As larger batches of ibuprofen 
were recrystallized, higher yields were obtained. 
 
42. Gordon, R. E.; Amin, S. I. U.S. Patent 4,476,248, 1984. 
 
 
 
137 
CHAPTER 7 
Progress Toward Multi-Step Reaction Sequences using Solid-Supported Catalysis 
 
Abstract 
 This chapter highlights progress toward performing multi-step, catalytic 
reaction sequences in our simplified microreactor.  Two new solid-supported catalysts 
were synthesized to facilitate asymmetric reactions in flow.  Preliminary results of one 
of these catalysts, a supported proline derivative, indicate high enantioselectivity can 
be obtained in flow, an unprecedented result for organocatalysis.   Multi-step reaction 
sequences are proposed using the catalysts already developed in the group, as are 
designs for continuous flow syntheses of other important small molecules. 
 
Introduction 
 Since the early 2000s, the application of microreactors to organic synthesis has 
continued to garner a lot of attention.1-12 Early publications applying this new 
technology to organic synthesis focused on the ability to perform single reaction steps 
more efficiently in flow.  More recently, however, research groups have been pushing 
the limits of these systems by performing multiple reactions in sequence with little to 
no purification.13-16   
The modularity of microreactors enables multiple reaction steps to be 
performed in sequence by mixing the outlet stream from one reactor with another 
reagent stream.   This setup thereby minimizes the number of work-up steps for an 
entire process, offering potentially higher yields, selectivity, purity, and efficiency.  
Designing a continuous synthesis is a significant challenge, however, as it requires the 
entire synthesis to be considered as an entity, as opposed to a series of independent 
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reactions steps.  To be successful, excess regents and byproducts from one reaction 
must be compatible with downstream reactions.  
Multi-step reaction sequences in flow have been reported in the literature, but 
these syntheses are essentially void of any catalytic steps.13-16 One could argue that 
catalysis is one of the most significant innovations in organic chemistry as its use 
oftentimes increases reaction efficiency and selectivity.17 The reduced use of raw 
materials such as solvents and reagents, as well as the ability to introduce chemical 
complexity into a molecule are just a few of the benefits of catalysis.18 Few reports 
describe multi-step catalytic reactions in flow (Figure 7.1), although recent advances 
using catalysts in flow for single reaction steps19-22 suggest that coupling these 
catalysts in series may soon be accomplished.  
 
 
 
Figure 7.1.  Multi-step, catalytic reaction sequence in flow. 
 
Perhaps an even more promising avenue is the use of heterogeneous catalysis 
in these flow.23-27  Catalysts are typically the most expensive component of a reaction 
mixture and can be difficult to separate. Immobilizing a catalyst for use in flow is 
advantageous as the catalyst is essentially performing the reaction and being removed 
simultaneously.28  These solid-supported catalysts will be isolated in separate catalyst 
beds and users need not worry about catalyst compatibility since these species will 
never interact with one another.  As a result, a level of complexity is potentially 
removed while running a multi-step sequence as catalyst fouling is a non-issue.  The 
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use of flow enables long-term activity as no agitation or stress is exerted on these 
supported catalysts, which oftentimes shortens the lifetime of these materials.  
Therefore, a high throughput of product can potentially be achieved as these catalytic 
systems can be used continuously.26, 27  
In this chapter, the development of new strategies to make small molecules 
continuously in microreactors will discussed using our simplified packed-bed 
microreactor platform.  Two new asymmetric catalysts were synthesized for use in 
multi-step reaction sequences.  Furthermore, other potential multi-catalyst flow 
syntheses for important small molecules will be proposed. 
 
Results and Discussion 
 The Development of New Solid-Supported Catalysts for Flow Chemistry. 
Catalysis has been studied extensively in flow; however most of these reactions are 
nonselective.1-12  Few examples do exist that perform asymmetric transformations, 
however, that use homogeneous and heterogeneous flow catalysis, the majority of 
which use chiral ligands and transition metals.28  We set out to develop new solid-
supported catalysts to perform enantioselective transformations in our simplified 
microreactor with the ultimate goal of running two or more steps relying solely on 
catalytic reactions. 
 Over the past few years, the field of organocatalysis has been gaining attention 
due to the ever-expanding number of selective transformations described in the 
literature.29-37  Recently, Seeberger and co-workers developed a system that uses a 
proline derivative in flow to facilitate the aldol condensation between benzaldehyde 
and acetone (Figure 7.2).38  In this example, the reaction was performed at higher 
temperatures and with shorter reaction times than similar batch reactions.  While there 
 140 
is no significant increase in yield or selectivity compared to traditional methods, this is 
still the first example using organocatalysis in flow. 
 
O O
N
H
N
H
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NN
60 ˚C, 20 min
in flow
(5 mol % in DMSO)
O OH
79% yield
75% ee
+
 
 
Figure 7.2.  Seeberger’s aldol condensation in flow. 
 
 We chose to explore organocatalysis in flow using the simplified packed-bed 
microreactor platform developed in our group.26, 27  In doing so, we were determined 
to demonstrate that an immobilized proline derivative39 (AO-proline, Figure 7.3) could 
provide excellent yields and selectivities in flow.  Furthermore, as the starting material 
of this reaction is an aldehyde, it could potentially be coupled to our TEMPO packed-
bed microreactor27 discussed earlier in this dissertation. 
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O
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N
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Figure 7.3.  The structure of AO-proline. 
 
We prepared the AO-proline packed-bed reactor using the azide-functionalized 
Amberzyme Oxirane resin (AO-N3, Scheme 7.1).26, 27 
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Scheme 7.1.  The preparation of AO-N3. 
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Scheme 7.2.  The synthesis of AO-proline. 
 
 Using AO-N3, AO-proline was synthesized using a four-step reaction 
sequence, starting from N-Boc-4-hydroxyproline (Scheme 7.2).39  After carboxylate 
protection, NaH and propargyl bromide were used to synthesize proline derivative 1.  
Using click chemistry, this protected proline derivative was tethered to AO-N3 using 
CuI.  Protected AO-proline was subsequently treated with TFA to cleave both 
protecting groups.   
 Though proline catalysis is quite versatile, limitations exist, such as slow 
reaction rates and the need for high catalyst loadings.40, 41 Furthermore, immobilizing a 
catalyst on a support frequently decreases the catalyst’s activity.42  Flow chemistry is 
best utilized when reaction rates are fast, indicating that these issues may have 
detracted chemists from exploring supported proline catalysis in flow. 
 Our group has recently developed a bifunctional urea (2, Figure 7.4) that 
significantly increases the rate of proline-catalyzed α-aminoxylations and Mannich 
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reactions.  This work was performed by Sarah Poe and will not be discussed in great 
length here.43 
 
N
H
N
H
O
N
2  
 
Figure 7.4.  The bifunctional urea used in AO-proline-catalyzed flow reactions. 
  
It is proposed that urea 2 accelerates the rate of enamine formation, and thus 
significantly increases reaction rates (Table 7.1, entries 1 and 2).  Furthermore, the 
addition of this urea does not impact the yield or the enantioselectivities of the α-
aminoxylation of aldehydes (Table 7.1, entries 3-9). 
 
Table 7.1.  Results of the α-aminoxylation of aldehydes. 
 
O
R O
H
O
R
NHPh
L-proline (5 mol%)
PhNO
urea 2 (5 mol%)
EtOAc, 0 ˚C  
 
Entry R Time (hrs) Yield (%)a ee (%) 
1 nBu 0.67 NR - 
2 nBu 0.67 81 98 
3 nBu 2.0 96 99 
4 Me 3.0 90 98 
5 iPr 3.5 97 99 
6 nHex 5.0 84 99 
7 CH2Ph 3.5 84 >99 
8 Ph 2.0 55 99 
9 CH2CHCH2 2.5 75 99 
a Products were reduced to the corresponding 2-aminoxy alcohols prior to isolation. 
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 The α-aminoxylation of hexanal was later performed substituting proline with 
AO-proline (Scheme 7.3).  Initially, the reaction was run without the urea additive and 
reaction rates were slow.  The reaction was then run in the presence of urea 2 to 
determine if the same effect was observed when using a solid-supported proline. 
 
O
O
H
O
NHPh
AO-proline (5 mol%)
PhNO
urea 2 (5 mol%)
CHCl3, 0 ˚C  
 
Scheme 7.3. The AO-proline-catalyzed α-aminoxylation of hexanal. 
 
 
 
 
Figure 7.5. The AO-proline-catalyzed α-aminoxylation of hexanal with and without 
urea additive. 
 
 Figure 7.5 shows data for the α-aminoxylation of hexanal in batch, with and 
without urea 2 using AO-proline as the catalyst.  As can be seen, a substantial increase 
in rate occurs when urea 2 is present.  It was therefore determined that urea 2 should 
be added to the flow α-aminoxylation to help facilitate reaction.   
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 Using the simplified procedure developed within our group,26, 27 flow reactions 
were performed by packing fluoroelastomeric tubing (60 cm, 1.6 mm i.d.) with the 
AO-proline resin (~400 mg).  For the flow experiments, a solution of PhNO in 
chloroform was mixed with a solution of urea 2 and hexanal in chloroform at a Y-
junction, and the reaction stream was allowed to pass through the AO-proline packed-
bed cooled to 0 ˚C.  At the outlet of the reactor was a solution of ethanolic NaBH4, 
used to reduce the product to the 2-aminoxy alcohol. Preliminary results indicated the 
α-aminoxylation of hexanal could be successfully performed in flow.  While a yield 
was not obtained for this reaction, an enantioselectivity of 95% was obtained, which is 
only slightly lower than batch reactions with proline (Figure 7.6). 
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95% ee
 
 
Figure 7.6.  Results of the flow α-aminoxylation of hexanal. 
 
 Another solid-supported catalyst synthesized was a triphenylethanol derivative 
(AO-PTPE, Figure 7.7) used to add alkyl zincs to aldehydes (Scheme 7.4).44-47 
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Figure 7.7.  The structure of AO-PTPE. 
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Scheme 7.4.  The asymmetric addition of diethyl zinc to benzaldehyde using AO-
PTPE. 
  
AO-PTPE was synthesized using the route shown in Scheme 7.5.46  The 
synthesis starts with an asymmetric epoxidation of triphenylethylene, followed by a 
LiClO4-mediated epoxide ring opening with piperazine.  This intermediate is 
subsequently treated with 6-chloro-1-hexyne and base to give the acetylene-modified 
ligand 3, which is clicked on to AO-N3 using CuI. 
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Scheme 7.5.  The synthesis of AO-PTPE. 
 
 While the enantiomeric purity of the final catalyst was not determined, the ee 
of the epoxide was determined to be >99% after recrystallization.  The assumption is 
being made that AO-PTPE is also of comparable enantiomeric purity.   
 To date, the activity of AO-PTPE is yet to be tested.  However, during the 
development of this chemistry, similar work by Pericas was carried out to perform 
asymmetric 1,2-additions in flow.47  Pericas’ system proved to be highly efficient 
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(very short residence times), demonstrating high conversions and enantioselectivities 
for a number of aldehydes.  We are optimistic that this system will work with AO-
PTPE in flow and that we will be able to perform multi-step catalytic reaction 
sequences using this catalyst.   
 
Future Direction 
 Multi-step Catalytic Reaction Sequences in Flow.  Our group has published 
a number of papers detailing the creation and characterization of multi-catalyst 
systems in batch.48, 49  Using the packed-bed microreactor platform that we have 
developed,26, 27 we hope to achieve a similar goal by performing two or more catalytic 
reactions continuously in flow.   
 Using the solid-supported catalysts previously developed in our group, various 
proof-of-concept multi-step reaction sequences could be tested.  All proposed reaction 
sequences using our technology start with the AO-TEMPO-catalyzed oxidation of an 
alcohol to an aldehyde, followed by an asymmetric reaction step.  This method is 
advantageous as aldehydes have limited availability compared to alcohols and are 
susceptible to various forms of degradation, such as over-oxidization, hydrate 
formation, or polymerization.14 
 By coupling the AO-TEMPO packed-bed microreactor with the AO-proline or 
AO-PTPE packed-bed microreactors, various two-step reaction sequences could be 
performed.  After the AO-TEMPO flow oxidation, microextractors used by the Jensen 
group15 will most likely be a necessity to separate the organic and aqueous phases.  As 
the aqueous stream is diverted to waste, the organic aldehyde stream is relayed into the 
next reaction.  Using this methodology, we propose three multi-step reaction 
sequences, two using AO-proline packed-beds and one using the AO-PTPE packed-
bed (Figure 7.8). 
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Figure 7.8.  The proposed two-step, catalytic reaction sequences in flow.  AO-
TEMPO and AO-proline are coupled together in an oxidation/α-aminoxylation 
sequence (top), AO-TEMPO and AO-proline are coupled together in an 
oxidation/Mannich reaction sequence (middle), or AO-TEMPO and AO-PTPE are 
coupled together in an oxidation/1,2-addition sequence (bottom). 
 
 
 Following the alcohol oxidation, the first two multi-step sequences rely on an 
AO-proline-catalyzed α-aminoxylation or Mannich reaction.  It is being assumed that 
the urea 2 is required in these cases to increase the rate of the AO-proline catalyzed 
steps.  The final two-step reaction sequences would convert the aldehyde from the 
AO-TEMPO oxidation to the 1-aryl-1-propanol derivative using AO-PTPE.  The 
microextractors developed by Jensen and co-workers are a necessity as they have been 
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demonstrated to quantitatively remove water from organic streams, indicating that the 
second, water-sensitive step may take place without great difficulty. 
 In addition to these two-step sequences being proposed, a three-step purely 
catalytic synthesis could be achieved as seen in Figure 7.9.  The system relies on a 
similar motif as presented in the cases described above, but the alcohol eluting from 
the AO-PTPE packed-bed could subsequently be relayed into an AO-DMAP packed-
bed to acylate the alcohol. 
 
 
 
 
Figure 7.9. The proposed three-step, catalytic reaction sequence in flow. AO-TEMPO, 
AO-PTPE, and AO-DMAP are coupled together in an oxidation/1,2-addition/acylation 
sequence. 
 
 Multi-Step Catalytic Reaction Sequences for APIs in Flow.  Chemical 
processing would substantially benefit from the use of solid-supported catalysis in 
flow.  As previously stated, these flow reactions can rely on catalytic packed-beds to 
constantly perform the reactions and separate catalysts simultaneously.  The catalysts 
presumably have long-term activity as there is no mechanical degradation of the 
support, indicating that continuous processing is an option.   
 While we have demonstrated the continuous flow synthesis of the API 
ibuprofen, the route does have its downfalls. The current route employed uses excess 
triflic acid to facilitate the Friedel-Crafts acylation.  Using large quantities of acid is 
typically problematic as these materials cannot be regenerated and ultimately end up 
in aqueous waste streams.50  Ideally this step would be performed with a solid-
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supported catalyst such as a zeolite.  In addition, the second step of the ibuprofen 
synthesis, the PhI(OAc)2-mediated 1,2-aryl migration, would be facilitated by a solid-
supported oxidant that could be regenerated in-line.  Following hydrolysis, ibuprofen 
could be obtained in a more efficient manner (Figure 7.10). 
 
 
 
Figure 7.10.  The proposed continuous flow synthesis of ibuprofen using a supported 
Friedel-Crafts acylation and a supported oxidant that is regenerated inline. 
 
 We also propose a continuous flow synthesis to the anticonvulsant drug 
pregabalin (Figure 7.11).  Our group has reported the synthesis of pregabalin using a  
 
OH
O
NH2
pregabalin  
 
Figure 7.11.  The structure of pregabalin. 
 
novel one-pot reaction to produce an important nitroester intermediate in the synthesis 
(Scheme 7.6).48, 49  Isovaleraldehyde is converted to a nitroester in one-pot, which is 
reduced and hydrolyzed to give pregabalin in high yield and enantioselectivity. 
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Scheme 7.6.  The one-pot reaction used to synthesize the nitroester intermediate. 
 
 
 To synthesize pregabalin in flow, isoamyl alcohol would be converted to 
isovaleraldehyde using the AO-TEMPO flow oxidation.  A major complication with 
the one-pot synthesis shown is Scheme 7.6 was the instability of isovaleraldehyde. 
Purification steps were necessary before carrying out the reaction as impure aldehyde 
gave significantly lower yields.  Having the ability to generate the aldehyde in situ and 
relay it into the second reaction step is therefore highly advantageous.  The second 
step of the synthesis would use an immobilized primary amine catalyst to facilitate the 
nitroalkene formation.  In batch, this reaction can also be problematic as increased 
reaction times lead to an undesired dinitro product.  By limiting the reaction times in 
flow, the desired nitroalkene should be obtained preferentially in high yield.  
Subsequent catalytic packed-beds would perform the asymmetric addition of dimethyl 
malonate to the nitroalkene, followed by a nitro group reduction, and hydrolysis to 
yield pregabalin in a continuous flow process (Figure 7.12). 
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Figure 7.12.  The proposed continuous flow synthesis of pregabalin. 
 
Conclusion 
 Our group has had a long-standing interest in the development of new 
methodologies that enable the rapid and efficient synthesis of small molecules.  New 
solid-supported catalysts have been developed for use in two- or three-step reaction 
sequences in flow to generate products with stereocenters.  Preliminary results indicate 
that these supported catalysts are capable of obtaining high enantioselectivity in flow.   
Finally, our group has successfully synthesized two drugs, pregabalin and 
ibuprofen, using multi-step reaction sequences in batch and flow, respectively.   Using 
the chemistry developed in these systems, it is our ultimate goal to perform these 
syntheses continuously in flow relying heavily on the use of solid-supported catalysts.  
By developing innovative, new strategies to make drugs continuously in 
microreactors, there are potential environmental and socioeconomic benefits. These 
continuous routes will ensure that drugs are produced more efficiently, selectively and 
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with a higher degree of safety.  This increased efficiency would in due course generate 
less waste and reduce the cost of syntheses, limiting the environmental impact of the 
synthesis, and potentially lowering the cost of important small molecules. 
 
Experimental Section 
General Considerations.  Solvents were purified by standard procedures.  All other 
reagents were used as received, unless otherwise noted. 1H NMR and 13C NMR 
spectra were recorded in CDCl3 on Varian Mercury 300 MHz operating at 300.070 
MHz and 75.452 MHz, respectively, using the residual solvent peak as reference.  
ATR-IR was performed on a Nicolet Avatar DTGS 370 infrared spectrometer with 
Avatar OMNI sampler and OMNIC software. Elemental analysis was performed by 
Robertson Microlit Laboratories, Inc., in Madison, New Jersey. Gas chromatographic 
(GC) analyses were performed using an Agilent 7890A GC equipped with an Agilent 
7683B autosampler, a flame ionization detector (FID), and a J&W Scientific 19091J-
413 column (length = 30 m, inner diameter = 320 µm, and film thickness = 250 µm).  
The temperature program for GC analysis held the temperature constant at 80 ˚C for 1 
minute, heated samples from 80 to 200 ˚C at 20 ˚C/min and held at 200 ˚C for 1 
minute.  Inlet and detector temperatures were set constant at 220 and 250 ˚C, 
respectively. High performance liquid chromatography (HPLC) was performed using 
a chromatograph using a CHIRALPAK IA column (250 mm x 4.6 mm) and 
CHIRALPAK IA guard column (1 cm x 0.4 cm). Retention times for R and S isomers 
were determined by using (DL)-proline instead of (L)-proline in the general 
procedure. All chromatograms were obtained using a wavelength of 254 nm. 
 
Azide Modified AMBERZYME® Oxirane (AO-N3):  Sodium azide (5.26 g, 81 
mmol, 8.1 eq.) and ammonium chloride (2.27 g, 42.4 mmol, 4.2 eq.) were dissolved in 
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500 mL 90:10 v/v water in methanol. AMBERZYME® Oxirane (10.0 g, 1.0 mmol 
epoxide/g resin, 10.0 mmol, 1.0 eq.) was suspended in the azide solution and the 
reaction mixture refluxed overnight with gentle stirring.  The resin was filtered using a 
Buchner funnel, washed with deionized H2O (2x 50 mL), MeOH (2x 50 mL), Et2O (1x 
25 mL), and dried under vacuum.  Elemental analysis afforded a loading of 1.0 mmol 
N3/g resin. 
 
t-Butyl (2S,4R)-N-Boc-4-hydroxyprolinate.  N-Boc-4-hydroxyproline (2.0 g, 8.65 
mmol, 1.0 eq), tBuBr (40 mL, 0.36 mol, 41.2 eq), Et3NBn+Cl- (2.0 g, 8.8 mmol, 1.0 
eq), and K2CO3 (32.0 g, 0.23 mol, 26.8 eq) were added to dimethylacetamide (40 mL), 
placed under nitrogen and stirred at 55 ˚C overnight.  H2O was added to the reaction 
mixture until it turned white, and the aqueous phase was extracted with ether (3x 50 
mL).  The organic extracts were dried with MgSO4, filtered, concentrated and dried 
under vacuum to give a viscous oil.  The oil was purified by column chromatography 
(silica gel, 1:1 hexanes/EtOAc) to give the title compound as a viscous oil (80% 
yield): 1H NMR (300 MHz, CDCl3): δ 4.43 (bs, 1H), 4.24 (m, 1H), 3.55 (m, 2H), 2.24 
(m, 1H), 1.43 (d, 18H). 13C NMR (75 MHz, CDCl3): δ 172.4, 154.4, 81.3, 80.4, 69.4, 
58.7, 54.8, 39.3, 28.5, 28.2. 
 
t-Butyl (2S,4R)-N-Boc-4-propargyloxyprolinate (1). NaH (247.0 mg, 10.3 mmol, 
1.5 eq) was stirred in DMF (20 mL) at 0 ˚C under nitrogen.  t-Butyl (2S,4R)-N-Boc-4-
hydroxyprolinate (1.97 g, 6.9 mmol, 1.0 eq) in DMF (20 mL) was added by a syringe 
and stirred for 20 minutes at 0 ˚C.  Propargyl bromide (80% w/w in toluene, 1.1 mL, 
10.3 mmol, 1.5 eq) was added dropwise 0 ˚C and the reaction was allowed to warm up 
to room temperature overnight.  The reaction was quenched with H2O (10 mL) and the 
aqueous phase was extracted with CH2Cl2 (3x 50 mL).  The organic extracts were 
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dried with MgSO4, filtered, concentrated and dried under vacuum to give a viscous oil. 
The oil was purified by column chromatography (silica gel, 4:1 hexanes/EtOAc) to 
give the title compound as a viscous oil (72% yield): 1H NMR (300 MHz, CDCl3): δ 
4.15 (m, 4H), 3.56 (m, 2H), 2.42 (m, 1H), 2.24 (m, 1H), 2.03 (m, 1H) 1.41 (d, 18H). 
13C NMR (75 MHz, CDCl3): δ 172.8, 154.0, 100.3, 81.2, 80.1, 79.4, 75.7, 74.9, 58.6, 
56.5, 51.1, 36.6, 28.4, 28.1. 
 
Protected AO-Proline Resin.  t-Butyl (2S,4R)-N-Boc-4-propargyloxyprolinate (434 
mg, 1.33 mmol, 1.1 eq) and CuI (50 mg, 0.26 mmol, 0.2 eq) were suspended in 
anhydrous THF (20 mL).  AO-N3 (1.18 g, 1.0 mmol N3/g resin, 1.18 mmol, 1.0 eq) 
was added to the solution and placed under a N2 atmosphere.  The suspension was 
shaken for 3 days.  The resin was washed with CH2Cl2 (3x 10 mL). 
 
AO-Proline.  Protected AO-proline (taken directly from the previous step) was 
suspended in CH2Cl2 (20 mL), TFA (3.0 mL) was added, and the reaction was allowed 
to stir overnight at room temperature.  The resin was washed with CH2Cl2 (2x 10 mL), 
MeOH (2x 10 mL), 10% TEA in THF (2x 10 mL), 1 M HCl (3x 10 mL), 10% TEA in 
THF (3x 10 mL), MeOH (2x 10 mL), and Et2O (2x 10 mL), and dried under vacuum 
to yield the off-white AO-proline resin (1.30 g, 0.57 mmol proline/g resin).  The 
loading was calculated by mass difference. 
 
Channel Packing:  A 60 cm section of tubing (Swagelok PFA Tubing, 1/8” outer 
diameter) was attached to a Swagelok PFA union packed with glass wool.  A separate 
union (not packed with glass wool) was attached to the inlet side of the 60 cm column.  
Two 10 cm sections of tubing were attached to the channel, serving as the outlet. A 
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1/16” female Luer was attached to the inlet.  Functionalized resin was suspended in 
CH2Cl2 and the column slurry packed using a syringe.  
 
1-(2-(dimethylamino)ethyl)-3-phenylurea (2). Phenyl isocyanate (1.08 mL, 10 
mmol, 1 eq) was added dropwise to a solution of N,N-dimethylethylenediamine (1.1 
mL,10 mmol, 1 eq) in CHCl3 (10 mL) at room temperature and the reaction was 
stirred for 30 min. The solvent was removed in vacuo and the product was 
recrystallized from EtOAc to afford white crystals (1.8 g, 87%). 1H NMR (300 Hz, 
CDCl3) δ 7.35 (d, 2H), 7.22 (t, 2H), 6.97 (t, 1H), 6.36 (t, 1H), 3.30 (q, 2H), 2.42 (t, 
2H), 2.12 (s, 3H); 13C NMR (75 Hz, CDCl3) δ 157.8, 139.9, 129.2, 122.7, 120.0, 60.1, 
45.5, 38.7. 
 
General Procedure for Aminoxylation of Aldehydes.  Nitrosobenzene (214 mg, 2.0 
mmol, 1.0 eq), (L)-proline (11.6 mg, 0.1 mmol, 0.05 eq) and 1-(2-
(dimethylamino)ethyl)-3-phenylurea (20.8 mg, 0.1 mmol, 0.05 eq) were added to a 7 
mL screw cap vial equipped with a stir bar.  Ethyl acetate (4 mL) was added to the 
vial, upon which the reaction mixture turned green.  The reaction mixture was 
submerged in an ice bath and stirred for 15 minutes.  The appropriate aldehyde (6.0 
mmol, 3.0 eq) was added to the reaction mixture in one portion at 0 ˚C.  The reaction 
mixture was continuously stirred at 0 ˚C until the reaction color changed from green to 
yellow and was complete by GC. 
 The reaction was transferred to a suspension of sodium borohydride (300 mg, 
8.0 mmol, 4.0 eq) in ethanol (10 mL) at 0 ˚C.  An additional 5 mL of ethanol was used 
to rinse the reaction vessel and added to the sodium borohydride suspension.  After 20 
minutes, the reaction mixture was poured into a separatory funnel containing 25 mL 
saturated aqueous NaHCO3 and the aqueous phase extracted with CH2Cl2 (3 x 20 mL).  
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The combined organic extracts were dried with MgSO4, filtered, concentrated in 
vacuo, and dried under vacuum to remove any residual starting materials.  The 
resulting residue was purified using column chromatography to afford the desired 
compounds.  Enantioselectivities were determined using chiral HPLC analysis. 
 
(R)-2-(N-Phenyl-aminooxy)-propan-1-ol.  Prepared according to the general 
procedure using propionaldehyde (437 µL, 6.0 mmol, 3.0 eq) for 3 hours to afford the 
title compound as a yellow oil (300 mg, 90 % yield, 98 % ee) after column 
chromatography (silica gel, 4:1 hexanes/EtOAc, Rf = 0.09).  The enantiomeric ratio 
was determined by HPLC using a CHIRALPAK IA and IA guard column (5 % 
IPA/hexanes, 1 mL/min); (S) isomer tr= 20.2 min and (R) isomer tr= 22.0 min. 1H 
NMR (300 Hz, CDCl3) δ 7.28 (m, 2H), 7.00 (m, 3H), 4.13 (m, 1H), 3.76 (m, 2H), 1.26 
(d, 3H); 13C NMR (75 Hz, CDCl3) δ 148.8, 131.1, 129.1, 122.1, 80.2, 65.8, 15.5. 
 
(R)-2-(N-Phenyl-aminooxy)-hexan-1-ol. Prepared according to the general procedure 
using hexanal (750 µL, 6.0 mmol, 3.0 eq) for 2 hours to afford the title compound as a 
yellow oil (400 mg, 96 % yield, 99 % ee) after column chromatography (silica gel, 4:1 
hexanes/EtOAc, Rf = 0.18).  The enantiomeric ratio was determined by HPLC using a 
CHIRALPAK IA and IA guard column (5 % IPA/hexanes, 1 mL/min); (S) isomer tr= 
15.0 min and (R) isomer tr= 17.6 min. 1H NMR (300 Hz, CDCl3) δ 7.28 (m, 2H), 6.99 
(m, 2H), 3.95 (m, 1H), 3.81 (m, 2H), 2.50 (bs, 1H), 1.68 (m, 1H), 1.40 (m, 6H), 0.93 
(t, 3H); 13C NMR (75 Hz, CDCl3) δ 148.7, 129.0, 122.1, 114.6, 84.0, 64.7, 29.7, 28.0, 
22.9, 14.0. 
 
(R)-2-(N-Phenyl-aminooxy)-octan-1-ol. Prepared according to the general procedure 
using octanal (940 µL, 6.0 mmol, 3.0 eq) for 5 hours to afford the title compound as a 
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yellow oil (400 mg, 84 % yield, 99 % ee, Rf = 0.14) after column chromatography 
(silica gel, 4:1 hexanes/EtOAc).  The enantiomeric ratio was determined by HPLC 
using a CHIRALPAK IA and IA guard column (5 % IPA/hexanes, 1 mL/min); (S) 
isomer tr= 13.9 min and (R) isomer tr= 16.0 min. 1H NMR (300 Hz, CDCl3) δ 7.28 (m, 
2H), 7.00 (m, 4H), 3.95 (m, 1H), 3.78 (m, 2H), 2.62 (bs, 1H), 1.48 (m, 10H), 0.91 (t, 
3H); 13C NMR (75 Hz, CDCl3) δ 148.7, 129.0, 122.2, 114.8, 84.1, 64.8, 31.8, 30.1, 
29.3, 25.9, 22.7, 14.2. 
 
(R)-2-(N-Phenyl-aminooxy)-pent-4-en-1-ol. Prepared according to the general 
procedure using 4-pentenal (621 µL, 6.0 mmol, 3.0 eq) for 2.5 hours to afford the title 
compound as a yellow oil (290 mg, 75 % yield, 99 % ee) after column 
chromatography (silica gel, 4:1 hexanes/EtOAc, Rf = 0.14).  The enantiomeric ratio 
was determined by HPLC using a CHIRALPAK IA and IA guard column (5 % 
IPA/hexanes, 1 mL/min); (S) isomer tr= 20.2 min and (R) isomer tr= 23.1 min. 1H 
NMR (300 Hz, CDCl3) δ 7.28 (m, 2H), 7.05 (s, 1H), 7.00 (m, 3H), 5.89 (m, 1H), 5.14 
(dt, 2H), 4.04 (m, 1H), 3.89 (m, 2H), 2.94 (m, 1H), 2.38 (m, 2H); 13C NMR (75 Hz, 
CDCl3) δ 148.6, 134.2, 129.2, 122.6, 117.9, 114.9, 83.5, 64.6, 34.8. 
 
(R)-3-methyl-2-(N-Phenyl-aminooxy)-butan-1-ol. Prepared according to the general 
procedure using isovaleraldehyde (650 µL, 6.0 mmol, 3.0 eq) for 3.5 hours to afford 
the title compound as a yellow oil (380 mg, 97 % yield, 99 % ee, Rf = 0.18) after 
column chromatography (silica gel, 4:1 hexanes/EtOAc).  The enantiomeric ratio was 
determined by HPLC using a CHIRALPAK IA and IA guard column (5 % 
IPA/hexanes, 1 mL/min); (S) isomer tr= 13.4 min and (R) isomer tr= 15.4 min. 1H 
NMR (300 Hz, CDCl3) δ 7.28 (m, 2H), 7.03 (bs, 1H), 7.01 (m, 3H), 3.88 (m, 2H), 3.75 
(m, 1H), 2.84 (bs, 1H), 2.04 (m, 1H), 1.04 (dd, 6H); 13C NMR (75 Hz, CDCl3) δ 
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148.6, 129.1, 122.5, 115.1, 88.7, 63.4, 28.8, 18.9, 18.7. 
 
(R)-3-phenyl-2-(N-Phenyl-aminooxy)-propan-1-ol. Prepared according to the 
general procedure using phenylpropionaldehyde (793 µL, 6.0 mmol, 3.0 eq) for 3.5 
hours to afford the title compound as a yellow oil (410 mg, 84 % yield, >99 % ee) 
after column chromatography (silica gel, 4:1 hexanes/EtOAc, Rf = 0.09).  The 
enantiomeric ratio was determined by HPLC using a CHIRALPAK IA and IA guard 
column (5 % IPA/hexanes, 1 mL/min); (S) isomer tr= 25.8 min and (R) isomer tr= 31.2 
min. 1H NMR (300 Hz, CDCl3) δ 7.18 (m, 7H), 6.97 (bs, 1H), 6.86 (t, 1H), 6.78 (d, 
2H), 4.08 (m 1H), 3.78 (m, 1H), 3.66 (m, 1H), 3.02 (dd, 1H), 2.80 (dd, 1H), 2.38 (bs, 
1H); 13C NMR (75 Hz, CDCl3) δ 148.5, 138.0, 129.6, 1291, 128.6, 126.6, 122.3, 
114.7, 85.2, 64.0, 36.6. 
 
(R)-2-phenyl-2-(N-Phenyl-aminooxy)-ethan-1-ol. Prepared according to the general 
procedure using phenylacetaldehyde (766 µL, 6.0 mmol, 3.0 eq) for 2 hours to afford 
the title compound as a yellow oil (250 mg, 55 % yield, 99 % ee) after column 
chromatography (silica gel, 4:1 hexanes/EtOAc, Rf = 0.20).  The enantiomeric ratio 
was determined by HPLC using a CHIRALPAK IA and IA guard column (5 % 
IPA/hexanes, 1 mL/min); (S) isomer tr= 25.9 min and (R) isomer tr= 28.9 min. 1H 
NMR (300 Hz, CDCl3) δ 7.30 (m, 7H), 7.00 (m, 4H), 5.03 (dd, 1H), 3.98 (m, 1H), 
3.86 (m, 1H), 2.58 (bs, 1H); 13C NMR (75 Hz, CDCl3) δ 148.1, 138.0, 129.1, 128.7, 
128.6, 127.2, 122.5, 115.0, 86.6, 66.1. 
 
Representative Flow α-Aminoxylation Experiment. PhNO (0.2 M) and mesitylene 
(0.02 M) in chloroform was placed in a syringe and placed on a syringe pump set to 50 
µL min-1 (10 µmol PhNO min-1, 1.0 eq min-1).  Hexanal (0.6 M) and urea 2 (0.02 M) 
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in chloroform was placed in a syringe and placed on a syringe pump set to 50 µL min-1 
(30 µmol hexanal min-1, 3.0 eq min-1, 1.0 µmol urea 2 min-1, 0.1 eq min-1).  The 
phases combined at a Y-junction and passed through a 60 cm channel packed with 
AO-proline (~400 mg) submerged in an ice bath.  The reaction mixture was collected 
in a 20 mL screw cap vial submerged in an ice bath containing ethanolic NaBH4.  
After the reaction collection was complete, the reaction was quenched with sat. 
NaHCO3, and the aqueous phase extracted with CH2Cl2 (2x 10 mL).  Organic extracts 
were dried over MgSO4, concentrated and analyzed by HPLC. The enantiomeric ratio 
was determined by HPLC using a CHIRALPAK IA and IA guard column (5 % 
IPA/hexanes, 1 mL/min); (S) isomer tr= 15.0 min and (R) isomer tr= 17.6 min. 
 
(S)-2,2,3-triphenyloxirane.  Triphenylethylene (1.02 g, 4.0 mmol, 1.0 eq), (R,R)-
Jacobsen catalyst (130.1 mg, 0.2 mmol, 0.05 eq), and 4-PPNO (150 mg, 0.88 mmol, 
0.22 eq) were stirred in CH2Cl2 (20 mL) at room temperature.  NaOCl (11 mL, 8.14 
mmol, 2.04 eq, adjusted to pH 11.3 using NaHCO3) was added dropwise and the 
reaction was stirred overnight.  The reaction was filtered through Celite and the layers 
were separated.  The organic phase was washed with H2O (2x 25 mL), dried over 
MgSO4, filtered and concentrated.  The residue was purified by column 
chromatography (silica gel, 9:1 hexanes/EtOAc) to give the title compound as a white 
solid (84% yield, 88% ee).  Recrystallization with hexanes improved the ee to >99%.  
Enantiomeric excess determined using NMR with Eh(hfc)3 as a chiral shift reagent.  
1H NMR (300 MHz, CDCl3) 7.05-7.36 (m, 15H), 4.33 (s, 1H). 13C NMR (75 Hz, 
CDCl3) δ 141.3, 135.82, 135.79, 129.6, 128.8, 128.23, 128.18, 128.09, 128.03, 127.95, 
127.13, 126.7, 69.0, 68.4 
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(R)-2-(1-piperazinyl)-1,1,2-triphenylethanol. (S)-2,2,3-triphenyloxirane (206.4 mg, 
0.76 mmol, 1.0 eq), piperazine (2.0 g, 23.2 mmol, 30.6 eq) and LiClO4 (220.5 mg, 2.1 
mmol, 2.7 eq) were heated to 140 ˚C for 5 hours.  The reaction was cooled to room 
temperature and H2O (15 mL) and CH2Cl2 (15 mL) were added to dissolve the residue.  
The phases were separated and the organic phase was washed repeatedly with H2O (8x 
10 mL).  The organic phase was extracted with 1 M HCl (30 mL), and the aqueous 
phase was with CH2Cl2 (2x 20 mL) to remove an unknown impurity.  The aqueous 
phase was the basified with 10 M NaOH and the aqueous layer extracted with CH2Cl2 
(5x 10 mL).  The organic extracts were washed with water (10 mL), dried over 
MgSO4, filtered, concentrated, and dried under vacuum to yield a the title compound 
as a white solid (92% yield): 1H NMR (300 MHz, CDCl3) 7.70 (d, 2H), 6.98-7.31 (m, 
13H), 5.58 (bs, 1H), 4.56 (s, 1H), 2.71 (m, 4H), 2.39 (m, 2H), 2.06 (m, 2H). 
 
(R)-2-(4-(hex-5-yn-1-yl)-piperazin-1-yl)-1,1,2-triphenylethanol (3). (R)-2-(1-
piperazinyl)-1,1,2-triphenylethanol (503 mg, 1.4 mmol, 1.0 eq), 6-chloro-1-hexyne 
(200 µL, 1.65 mmol, 1.2 eq) and cesium carbonate (1.4 g, 4.3 mmol, 3.1 eq) were 
stirred in acetonitrile (40 mL) at 70 ˚C for 3 days.  The reaction was concentrated and 
the residue was dissolved in equal volumes of H2O and CH2Cl2.  The aqueous phase 
was extracted with CH2Cl2 (2x 20 mL), and the organic extracts were dried over 
MgSO4, filtered concentrated, and dried under vacuum. The residue was purified by 
column chromatography (silica gel, 1:1 hexanes/EtOAc) to give the title compound as 
a white solid (44% yield). 1H NMR (300 MHz, CDCl3) 7.68 (d, 2H), 6.98-7.31 (m, 
13H), 6.2 (bs, 1H), 4.58 (s, 1H), 2.14-2.45 (m, 12H), 1.90 (t, 1H), 1.47 (m, 4H). 
 
AO-PTPE. (R)-2-(4-(hex-5-yn-1-yl)-piperazin-1-yl)-1,1,2-triphenylethanol (104.4 
mg, 0.24 mmol, 1.2 eq) and CuI (5.0 mg, 0.026 mmol, 0.13 eq) were suspended in 
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anhydrous THF (20 mL).  AO-N3 (200.6 mg, 1.0 mmol N3/g resin, 0.20 mmol, 1.0 eq) 
was added to the solution and placed under a N2 atmosphere.  The suspension was 
shaken for 3 days.  The resin was washed with THF (3x 10 mL), H2O (2x 10 mL), 1 M 
HCl (3x 10 mL), H2O (1x 10 mL), sat. NaHCO3 (3x 10 mL), H2O (2x 10 mL), MeOH 
(2x 10 mL), Et2O (2x 10 mL), and dried under vacuum to yield the white AO-PTPE 
resin (225.9 mg, 0.26 mmol PTPE/g resin).  The loading was calculated by mass 
difference. 
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APPENDIX  1 
Supporting Information for Chapter 2 
 
Residence Time Determination. Three columns (10 cm, 30 cm, and 60 cm) were 
packed with AO resin. A dye solution was prepared by dissolving 15 mg of Disperse 
Red 1 in 20 mL CH2Cl2. A 5 mL syringe was filled with the dye and passed through 
the channel. Using a flow rate of 2.0 mL/min, the residence time was determined for 
all three packed columns. The residence time was measured from initial appearance of 
the dye on the column to the appearance of a pink hue at the outlet of the channel. This 
was repeated in triplicate for all three column lengths and residence time increased 
linearly with channel length. Between trials, the channel was rinsed with 3 mL of 
methylene chloride. 
 
Table A1.1. Residence time as a function of column length. 
Column Length (cm) Average Residence Time (sec) St. Dev. 
60 13.82 0.33 
30 5.90 0.35 
10 1.75 0.13 
 
A second set of experiments was conducted to determine the relationship 
between the flow rate and residence time. A 30 cm column was packed with 137 mg 
of AO. The residence times were measured using the above procedure. 
 
 
 
 
 
 
 166 
 
Table A1.2. Residence time as a function of flow rate. 
Flow Rate (mL/min) Average Residence 
Time (sec) 
St. Dev. 
3.90 2.60 0.05 
2.00 5.05 0.45 
1.00 11.20 0.68 
0.40 30.56 0.99 
0.20 68.20 1.73 
0.10 141.70 2.83 
 
 The data from Table A1.2 was used to devise an equation relating residence 
times to column length and flow rate (Equation A1.1). 
 
                             
! 
Residence Time =
Column length
30
" 22811x#1.1         (Equation A1.1) 
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APPENDIX  2 
Supporting Information for Chapter 3 
 
For data relating to residence time determination, see Appendix 1 and Equation A1.1. 
 
 
 
 
Figure A2.1.  AT-IR spectrum of acetylene-modified TEMPO.
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APPENDIX  3 
Supporting Information for Chapter 4 
 
Design of Experiments (DOE) Data. 
N
NN
NaN3, DMF
! OH
Br
OH
 
Scheme A3.1. Model reaction for DOE. 
 
Table A3.1. Conditions screened in DOE. 
Variable Low High 
Temperature 100 ˚C 175 ˚C 
Residence Time 5 minutes 15 minutes 
Equivalents 4-ethynyltoluene 0.5 1.0 
*four center points 
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Table A3.2.  Results of DOE. 
Equivalents 
4-ethynyltoluene 
Residence 
Time (min) 
Temp (˚C) HPLC Area 
Percent Product 
0.75 5 100 4.8 
0.5 5 137.5 32.6 
1.0 5 137.5 9.2 
0.75 5 175 65.6 
0.5 10 100 9.8 
1.0 10 100 4.1 
0.75 10 137.5 44.7 
0.75 10 137.5 58.4 
0.75 10 137.5 40.3 
0.75 10 137.5 40.3 
0.5 10 175 86.2 
1 10 175 72.5 
0.75 15 100 15.4 
0.5 15 137.5 40.1 
1 15 137.5 - 
0.75 15 175 - 
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APPENDIX  4 
Supporting Information for Chapter 6 
 
 
Figure A4.1.  The three-step flow reaction setup. 
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Figure A4.11.  GC/MS trace of recrystallized ibuprofen. 
 
 
  184 
Development of a Stereoselective 1,2-Aryl Migration.  Naproxen is an NSAID 
similar to ibuprofen with a 2-arylpropanoate core (Figure A4.12).  Unlike ibuprofen, 
 
O
OH
O
naproxen  
 
Figure A4.12.  The structure of naproxen. 
 
however, the stereocenter is essential in order to achieve any biological activity.  
Syntheses often result in the racemic form of naproxen and use a resolution step to 
obtain the S-isomer.  Resolution steps like this ultimately lead to half of the product 
being discarded.  For this reason, we looked at performing the PhI(OAc)2-mediated 
1,2-aryl migration stereoselectively using a chiral amine (Scheme A4.1).  We propose 
this reaction will proceed as illustrated in Figure A4.13. 
 
O
O H2N
OH
O
R
PhI(OAc)2, MeOH
O
OMe
O
 
 
Scheme A4.1.  The stereoselective PhI(OAc)2-mediated 1,2-aryl migration. 
  185 
 
 
Figure A4.13.  The proposed catalytic cycle of the stereoselective PhI(OAc)2-
mediated 1,2-aryl migration 
  
 Preliminary experiments have been unsuccessful thus far, but we are confident 
that with more work this transformation could be achieved.  Catalysts and reaction 
conditions attempted to date are shown in Table A4.1 using propiophenone as the 
starting material.   
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Table A4.1.  Results of the stereoselective 1,2-aryl migration. 
 
O
PhI(OAc)2, MeOH
OMe
O
chiral amine
 
 
Entry Catalyst Result 
1 
N
H
COOH
 (10 mol%) 
 
N.R. 
2 
N
H
COOH
 (20 mol%) 
 
N.R. 
3 
N
H
COOH
 (10 mol%) 
 
N.R. 
4 
N
H
OTMS
Ph
Ph
 (20 mol%) 
 
N.R. 
5 
N
H
N
H
N
N
N
 (10 mol%) 
 
N.R. 
6 
HN
N
O
Ph
 (20 mol%) 
 
N.R. 
7 
HN
N
O
Ph
 (10 mol%) 
 
N.R. 
8 
H2N
OH
O  (20 mol%) 
 
N.R. 
9 
N
N
H
O
N
H
S
NH2  
 (10 mol%) 
 
N.R. 
 
